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Abstract 
The African sleeping sickness parasite Trypanosoma brucei evades the immune 
system of its mammalian host by periodically switching the variant surface 
glycoprotein (VSG) that forms its cell-surface coat. This process of antigenic 
variation utilises a large archive of VSG genes, which are primarily subtelomeric 
and appear to evolve rapidly. Subtelomeres are the location of multi-member, 
variable gene families in many organisms, and often seem to have an elevated 
rate of mutation. The VSG archive is a particularly striking example of an 
organism taking advantage of this environment to promote hyperevolution. The 
aim of this project was to investigate the changes that occur in VSG evolution. In 
collaboration with researchers at the Sanger Institute, genomes from two time-
separated isolates of the same trypanosome strain were sequenced and 
assembled. The quality of the genome assemblies was assessed, and the 
genomes concluded to be of sufficient quality for further analysis. Chromosome 
core genes and VSG N-terminal domain (NTD) genes and pseudogenes were 
annotated in each genome, and mutations between the genomes in each gene 
were catalogued. VSG NTDs had a significantly higher mutation frequency than 
core genes, and the specific patterns of mutations differed significantly between 
the two genome regions. These results together implied that VSG are subject to 
different mutational processes from core genes. However, mutation frequency 
did not appear to differ between VSG NTDs and other subtelomeric sequence, 
indicating that it is the subtelomeres in general that are subject to elevated 
mutational activity. Further examination of the VSG NTDs within each new 
genome reinforced published observations in the reference genome strain VSG 
archive of extensive substructuring and abundance of pseudogenes. Finally, to 
address the question of which mechanisms may be involved in elevating the 
mutation rate in subtelomeres, an attempt was made to characterise two 
members of a gene family predicted to encode error-prone lesion bypass DNA 
polymerases, a class of enzymes that have been suggested to have a role in the 
systematic generation of mutations. Such results as were obtained suggested 
that the genes examined may not encode active polymerases, and the results did 
not provide any evidence for a role for these polymerases in VSG hyperevolution. 
Overall, however, the project has uncovered considerable detail of how 
hypermutation proceeds in this highly variable gene family.  
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1 Introduction 
1.1 Overview 
1.1.1 Hyperevolution 
Look abroad thro’ Nature’s range, 
Nature’s mighty law is change. 
Robert Burns 
Change is a constant in biology, when considering DNA sequences. It appears to 
be either impossible or undesirable for organisms to maintain their genomes 
without some change, because an organism with a zero mutation rate has never 
been described. However, although everything changes, not everything changes 
in the same way. Rates of mutation vary between organisms (Lynch, 2010b), as 
might be expected from variation in DNA replication machinery, genome size, 
environment and selection pressures. Interestingly, mutation rates also vary 
between different genome sites within an organism (Hodgkinson & Eyre-Walker, 
2011; Martincorena & Luscombe, 2013). Thus, hyperevolution, a significantly 
faster rate of sequence change than average, can occur on the scale of species, 
for example the rapid mutation rates of some bacteria compared with that of 
mammals; but can also be occurring within an organism, for example ectopic 
recombination in subtelomeres increasing the rate of mutation near chromosome 
ends. 
1.1.2 Hyperevolution in trypanosome antigenic variation genes 
The African sleeping sickness parasite Trypanosoma brucei possesses a large, 
highly variable family of variant surface glycoprotein (VSG) genes that it uses for 
antigenic variation. The gene family is located in the subtelomeres, which are 
genome regions that often have an elevated rate of mutation compared with 
chromosome cores and are often the location of members of variable multi-gene 
families (Mefford & Trask, 2002; Brown et al, 2010). The trypanosome VSG gene 
family is an excellent example of hyperevolution in subtelomeres, and is exciting 
to study because of the importance of the genes to parasite survival, and 
because the hyperevolution of VSGs is intertwined with the process of antigenic 
variation. In this Introduction, I will describe the importance of variation 
generated in subtelomeres, and why hyperevolution of VSGs is both intrinsically 
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interesting to parasitologists but also of wider interest in the context of 
subtelomere evolution. 
1.2 Subtelomere hyperevolution 
1.2.1 Organisation of linear chromosome ends 
Eukaryotes, and some prokaryotes (Bentley et al, 2002b; Kobryn & Chaconas, 
2001), maintain their genetic material in the form of linear chromosomes. The 
maintenance of such chromosomes poses a problem, due to the existence of free 
ends of DNA at their extremities. As well as being exposed to nuclease activity, 
free ends of DNA usually trigger a DNA damage response (van Gent et al, 2001), 
because they are often the result of DNA damage causing a double-stranded 
break. The DNA damage response causes the cell to attempt repair and disrupts 
the cell cycle. The response can also involve recombination of DNA ends, which 
for chromosome ends could result in chromosome fusion (McEachern et al, 2000) 
or other inappropriate recombination. The linear structure of chromosomes also 
poses a problem for replication, because the standard DNA machinery requires a 
3′ RNA primer, and hence cannot replicate the 3′ ends of linear DNA (de Lange et 
al, 1990). Telomeres, the ends of linear chromosomes, are therefore 
sequestered into specialised complexes that prevent the free DNA ends from 
interacting with other cellular components (Blackburn, 2001). Eukaryotic 
telomeres usually consist of tandem repeats of a short, G-rich sequence, which 
are usually replicated by the specialised enzyme telomerase (Blackburn, 2005). 
Telomeres are frequently organised in clusters at the nuclear periphery, a 
location that facilitates telomeric silencing and double-stranded break repair, 
and is also important in meiosis for accurate chromosome pairing and 
recombination (Gotta et al, 1996; Nimmo et al, 1998; Therizols et al, 2006). 
Most of the chromosome is core sequence: in this region, homologous 
chromosome pairs share gene content, gene order and intergenic sequence, in 
an arrangement maintained by homologous recombination. However, frequently 
there is a transitionary region between the chromosome core and the telomere 
repeats, known as the subtelomere (Figure 1-1), which is more complex than the 
simple telomere repeats but is not particularly conserved between homologous 
chromosomes (Louis & Vershinin, 2005). The content of subtelomeric sequences 
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varies widely between organisms, but in virtually all eukaryotes studied they are 
composed of a combination of various repeats (Pryde et al, 1997). These repeats 
are usually found in the subtelomeres of multiple chromosomes, and different 
blocks of repeats have different distributions with little regard to chromosome 
core homology (Mefford & Trask, 2002). The haploid nature of subtelomeres 
presents a challenge for sequencing efforts, compounded by the regions’ 
repetitive nature and variability between strains within a species (Louis, 1995). 
 
Figure 1-1 – Schematic diagram of the ends of pair of homologous chromosomes showing 
chromosome cores, subtelomeres and telomere repeats. 
Blocks of the same colour indicate homologous sequences, i.e. the cores of homologous 
chromosomes share syntenic, homologous genes; the subtelomeres share some 
homologous sequences but also contain sequences and parts of genes from the cores, 
from other parts of the genome, and some unique sequences. 
One of the first organisms in which subtelomeres were characterised was 
Saccharomyces cerevisiae. Yeast subtelomeres are combinations of highly 
conserved repeat elements (X and Y′) (Chan & Tye, 1983); repeat elements found 
in variable numbers of chromosome ends, including open reading frames (ORFs) 
and probable former transposable elements (Louis, 1995); and, most 
chromosome-internally, sequence unique to each subtelomere (Louis & Haber, 
1992). Human subtelomeres have also been well characterised and consist of 
several elements: subtelomeric repeats, which appear in numerous subtelomeric 
regions; segmental duplications of regions from within the chromosome core; 
and single-copy sequences unique to each subtelomere (Riethman et al, 2005). 
Parts of the subtelomeres are transcribed; transcribed regions are distributed 
throughout the subtelomeres and include repeat regions and segmental 
duplications as well as the subtelomere-unique sequences (Flint et al, 1997; 
Riethman et al, 2004). 
Subtelomeres have been characterised in a number of other organisms, including 
Plasmodium falciparum (Gardner et al, 1998; Figueiredo et al, 2000; Scherf et al, 
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2001); T. brucei (discussed below), Trypanosoma cruzi (Moraes Barros et al, 
2012), Drosophila melanogaster (Mason & Biessmann, 1995) and Arabidopsis 
thaliana (Kotani et al, 1999; Arabidopsis Genome Initiative, 2000). These studies 
reveal that repeated elements and segmental duplications are a common theme 
in subtelomere structure, but that the extent and composition of subtelomeres 
varies widely. Subtelomeres are highly polymorphic between chromosomes and 
between individuals, and between organisms there is very little conservation of 
their sequences or lengths (Mefford & Trask, 2002; Pryde et al, 1997). 
1.2.2 Subtelomeres as sites of highly variable gene families 
Most subtelomeric sequence is non-coding, but in many species the subtelomeres 
contain genes, encoding proteins with a wide variety of functions, which will be 
described in this section. Subtelomeric genes often belong to large, highly 
diverse gene families. For example, the gene families used by some eukaryotic 
parasites in antigenic variation (discussed further below), where diversity of the 
genes is critical to parasite survival in a mammalian host, are often subtelomeric 
(Barry et al, 2003). In the human malaria parasite P. falciparum, three 
subtelomeric families are involved in antigenic variation: the var genes, with 
approximately 60 members, most of which are subtelomeric; and the rif and 
stevor gene families, which are closely related to one another, belong to the 
same superfamily and likely have similar structure, and contain about 200 and 40 
members respectively (Gardner et al, 1998; Scherf et al, 2008; Hernandez-Rivas 
et al, 1997; Duffy & Tham, 2007; Kyes et al, 1999; Cheng et al, 1998). 
Plasmodium vivax, another human malaria parasite, possesses a different 
subtelomeric gene set, the 600 to 1000-member vir superfamily, which may be 
involved in antigenic variation (Fernandez-Becerra et al, 2009). T. brucei also 
undergoes antigenic variation, for which it utilises an archive of VSG genes that 
are primarily subtelomeric and number between 1000 and 2000 in the reference 
genome strain TREU 927 (Berriman et al, 2005; Marcello & Barry, 2007b). 
Another subtelomeric antigenic variation system is used by Pneumocystis carinii, 
which uses up to 100 major surface glycoproteins in small subtelomeric clusters 
(Stringer & Keely, 2001). Other examples of variable subtelomeric gene families 
with relevance to the organism’s ecological niche include disaccharide 
utilisation genes in yeast (Brown et al, 2010) and various surface protein genes 
in Trypanosoma cruzi (Moraes Barros et al, 2012). 
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As an entirely different example, vertebrate olfactory receptor genes allow the 
detection and differentiation of thousands of millions of chemicals, and 
comprise the largest gene superfamily in the vertebrate genome (Glusman et al, 
2001; Olender et al, 2008). Although most of the 900 olfactory receptor genes 
and pseudogenes in humans are located in chromosome cores, at least eight 
distinct genes are subtelomeric, and four of these are present in multiple copies 
that vary in copy number between individuals (Trask et al, 1998). At least one 
subtelomeric olfactory receptor gene is transcribed, so it is likely that these 
genes are not simply accidentally copied pseudogenes (Linardopoulou et al, 
2001). 
Although most characterised bacterial genomes are circular, there are a few 
species that possess linear chromosomes, and hence telomere equivalents. One 
example is the soil bacterium Streptomyces coelicor, which has a very large 
single linear chromosome. The core of this chromosome contains essential genes 
and is syntenic with the circular chromosomes of Mycobacterium tuberculosis 
and Corynebacterium diptheriae, with which it appears to share a common 
ancestor. However, nearly a million base pairs (Mb) of sequence at either end is 
Streptomyces-specific, and can tolerate extensive deletions and amplifications 
without compromising viability in laboratory conditions (Volff & Altenbuchner, 
1998; Bentley et al, 2002b). These regions appear to be analogous to eukaryotic 
subtelomeres and contain ‘contingency’ genes, which are highly mutable loci 
encoding proteins that interact with the unpredictable aspects of the 
environment (Moxon et al, 1994). Such genes help the bacterium survive in the 
varied soil environment, for example encoding proteins to produce secondary 
metabolites (Bentley et al, 2002a). It is hypothesised that the linearisation of 
the Streptomyces genome occurred as a specific adaptation to accommodate the 
extra genes and promote their diversity (Barry et al, 2003). 
1.2.3 Polymorphism and hyperevolution of subtelomeres 
Because there are numerous variable subtelomeric gene families, often of 
crucial importance to their host organisms, subtelomeres are coming to be 
recognised as having a key role in variation in organisms (Riethman et al, 2005; 
Brown et al, 2010). The importance of a subtelomeric location for variable 
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multi-gene families appears to lie with the rapid rate of change associated with 
these genomic regions. 
Detailed examination of the human reference genome has revealed that human 
subtelomeres are complex, dynamic mosaics formed and shaped by the 
interaction of several processes. Segmental duplications arise throughout the 
subtelomeres, often as a result of aberrant non-homologous end-joining, and 
appear just as readily in regions containing genes as in non-coding sequence. 
Duplicated segments may then be modified by interchromosomal recombination, 
which means that blocks of sequence on separate subtelomeres do not evolve 
completely independently (Linardopoulou et al, 2005). Sister chromatid 
exchange occurs at rates several orders of magnitude higher in subtelomeres 
than in chromosome cores, indicating that rates of DNA breakage and repair are 
also elevated in subtelomeres (Rudd et al, 2007). The evolution of these 
patchworks of sequence is rapid: half of known human subtelomere sequence 
has arisen in human-specific events, and almost every subtelomeric block 
examined in multiple individuals shows some variation in copy number and 
location (Brown et al, 1990; Trask et al, 1998; Baird et al, 2000; Mefford & Trask, 
2002; Linardopoulou et al, 2005). Gene copy number variation is therefore 
regarded as a key characteristic of human subtelomeres, being detectable at 
almost every subtelomere (Redon et al, 2006; Riethman, 2008a). 
In general, what is known about subtelomeres in other organisms bears out a 
picture of a highly polymorphic and dynamic genome region. In P. falciparum, 
the size of chromosomes can vary by up to 300 thousand base pairs (kb) between 
strains, due to differences in subtelomeres caused by homologous 
recombination; and single nucleotide polymorphisms (SNPs) are also over-
represented in these regions (Corcoran et al, 1988; de Bruin et al, 1994; 
Volkman et al, 2002). Further, the subtelomeric var genes have been shown to 
undergo frequent ectopic recombination (Freitas-Junior et al, 2000). Size 
polymorphisms of similar scale are seen in kinetoplastid parasites (Fu & Melville, 
2002). Analysis of the VSG genes occupying the subtelomeres in the genome 
strain of T. brucei allowed inference of the occurrence of multiple types of 
mutation, including segmental duplication and recombination but also point 
mutations and short insertion-deletion mutations (indels) (Bernards et al, 1986; 
Marcello & Barry, 2007b). 
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Processes that duplicate genes are considered key in diversification and 
generation of novel function, because selection for the original function is 
somewhat relaxed for the new gene copy (Lynch & Conery, 2000; Moran et al, 
2011). Relaxation of selection may allow random events to take a leading part in 
shaping evolution of the duplicate gene. Subtelomere hyperevolution may be an 
important process acting to provide such duplications (Riethman, 2008b). In 
yeast, comparative analysis of eight species revealed that subtelomeric gene 
families varied more in copy number and contained more members than families 
with no subtelomeric members, and the same study provided evidence for rapid 
functional divergence within selected subtelomeric families (Brown et al, 2010). 
The key role of subtelomeres in generating gene diversity is also illustrated by 
the evolution of the olfactory receptor genes. Although most of these genes are 
not subtelomeric, analysis of the evolutionary relationships between them 
suggested that a major event in the expansion of the olfactory receptor gene 
family was the duplication of a core chromosomal cluster into the subtelomere 
of chromosome 1, from where it was duplicated into numerous new locations 
(Glusman et al, 2001). 
Even without considering the effects of selection on mutations and duplications, 
there are several possible factors that can be envisaged to contribute, to a 
greater or lesser degree, to the hyperevolution of subtelomeres compared with 
chromosome cores: a greater tendency to undergo the mutations observed, for 
example sequence that makes double-stranded breaks more likely, or the 
presence of retrotransposons; greater tolerance of mutations in the cell, for 
example by altered repair and damage-sensing pathways; and novel mechanisms 
actively generating mutations. Roles have been suggested for several of these 
factors in bringing about differences in mutation profile between specific 
regions (Sharp et al, 2005; Cooper et al, 2007; Marcello & Barry, 2007b), but 
little is understood about how subtelomeres in general are particularly prone to 
mutation.  
All these data suggest that genes located in subtelomeres are subject to a higher 
mutation rate than those in chromosome cores, that this increased rate is 
important in organism and gene diversity, and that rather than subtelomeric 
genes being specifically targeted, hyperevolution is an inherent property of 
subtelomeres. It appears that subtelomeric hyperevolution occurs by a 
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combination of multiple gene conversions and segmental duplications with 
smaller-scale mutations. 
1.3 Trypanosoma brucei and its impact 
1.3.1 African trypanosomes 
The genus Trypanosoma is a monophyletic clade within the unicellular protist 
group Kinetoplastida (Simpson et al, 2006). Members of Trypanosoma are 
obligate, flagellated parasites; and the subgroup of African salivarian 
trypanosomes causes a set of diseases that impose severe health and economic 
burdens on the affected areas. Salivaria currently comprises at least six species: 
Trypanosoma brucei, Trypanosoma evansi, Trypanosoma equiperdum, 
Trypanosoma congolense, Trypanosoma simiae and Trypanosoma vivax (Gibson, 
2007). In addition to sleeping sickness in humans, which is caused by two 
T. brucei subspecies, salivarian trypanosomes also cause several diseases in 
animals. Nagana is a disease of ungulant livestock (most often cattle), 
characterised by fever and wasting, and caused by T. brucei, T. congolense and 
T. vivax. These parasites are transmitted by tsetse flies (and thus confined to 
the tsetse belt of Africa), and also infect wild animals, causing diseases referred 
to generally as animal African trypanosomiases. Surra has similar symptoms to 
nagana, is caused by T. evansi and affects numerous large domestic and wild 
mammals including cattle, horses, camels and buffalo. Surra has a wider range 
than nagana, being found in Asia, Africa and South America, and is transmitted 
mechanically (i.e. there are no insect-specific life cycle stages) by a wide range 
of vectors, namely blood-sucking insects of the genera Tabanus, Stomoxys, 
Atylotus and Lyerosia. Dourine is a disease of equines caused by T. equiperdum, 
which has a cosmopolitan distribution and is transmitted between hosts during 
coitus. T. simiae causes an acute porcine trypanosomiasis in tropical Africa (Brun 
et al, 1998; Gibson, 2007; Lai et al, 2008). T. brucei subspecies are the most 
intensively studied, because of their importance as the only African trypanosome 
that causes human disease, and because they are the most readily cultured in 
the laboratory. 
Tsetse flies (genus Glossina) are the insect vectors for African trypanosomes, 
although several species of the parasite have expanded beyond the range of 
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these insects by evolving tsetse-independent transmission, as mentioned above. 
The range of the vector is the so-called ‘tsetse belt’, stretching across the 
humid and semi-humid zones between the south edge of the Sahara (14ºN) and 
the north edge of the Kalahari desert (29ºS) (Barrett et al, 2003), an area 
covering ten million square kilometres and including parts of 36 countries (Black 
et al, 2001). 
1.3.2 The life cycle of T. brucei 
The life cycle of T. brucei contains several morphologically distinct stages 
(Figure 1-2), comprising several extracellular mammal-specific stages followed 
by several insect-specific stages (Vickerman, 1985), and alternates proliferative 
stages with quiescent stages adapted for transmission between hosts or 
movement between parts of a single host (Barry & McCulloch, 2001). 
Development in the mammalian host begins when an infected tsetse bites, 
taking a blood meal and injecting metacyclic stage parasites from its salivary 
glands into dermal connective tissue. From the point of entry, trypanosomes 
move into the draining lymph vessels and then into the bloodstream, where they 
differentiate into the proliferative long slender trypomastigote. This stage 
inhabits the circulatory and lymphatic systems and, later in infection, the brain 
and cerebrospinal fluid. The long slender form can either divide to increase the 
population, with a doubling time of about 6 h, or differentiate to the non-
proliferative stumpy form (Vickerman, 1985). The stumpy form remains in G0 
phase and has a limited lifespan, and is adapted for uptake by tsetse during 
feeding (Macgregor & Matthews, 2010). 
Parasites are exposed to the mammalian immune system throughout the 
mammal life cycle stages, and they protect themselves from both innate and 
adaptive mammalian immune effectors with a surface coat composed of 
approximately 10 million molecules of variant surface glycoprotein (VSG). This 
structure is present in all mammal-specific life cycle stages, and also in the 
metacyclic stage as a preadaptation for mammalian infectivity. An individual 
parasite can be tackled by an immune response raised against a particular VSG, 
but the adaptive response is evaded at the population level because some 
parasites spontaneously switch to express another VSG, in a process of antigenic 
variation (see below). The rapid proliferation of the long slender form, coupled 
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with killing by the adaptive immune response, contributes to a fluctuating 
parasitaemia with characteristic waves (Vickerman, 1985; Lythgoe et al, 2007). 
The dynamics of parasitaemia are also affected by the density-dependent 
dynamics of differentiation into stumpy form, because when a long slender form 
parasite differentiates to stumpy form the cell can no longer contribute to 
increasing parasite numbers. This process is predicted to be important to 
parasitaemia dynamics when numerous different VSGs are expressed at one time 
in the population, and has been shown to be dominant in chronic infections 
(Gjini et al, 2010; Macgregor et al, 2011). 
 
Figure 1-2 – Life cycle of T. brucei. Reproduced from Barry & McCulloch, 2001. 
Scanning electron micrographs of each life cycle stage are shown to scale, with an 
erythrocyte shown next to the long slender form. Curved red arrows indicate the potential 
for division of replication-capable life cycle stages, and straight arrows indicate 
differentiation into the next stage. White lines divide the different environments of 
mammalian tissue, the tsetse alimentary tract and the tsetse salivary glands. 
When another tsetse bites the infected host, the insect ingests blood containing 
long slender and stumpy form parasites. Long slender parasites cannot 
proliferate in the tsetse, but stumpy form parasites differentiate into the 
proliferative procyclic form. Procyclic form parasites either divide to increase 
the population or differentiate to the mesocyclic form. Mesocyclic form 
parasites migrate to the salivary gland via the lumen of the gut, a step that 
appears to be a bottleneck in the life cycle (van den Abbeele et al, 1999; Oberle 
et al, 2010), and undergo an asymmetric cell division. The larger daughter cell is 
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discarded and the other is the progenitor of the epimastigote form, a third 
proliferative stage that colonises the tsetse salivary gland. Epimastigotes can 
divide, or transform into metacyclic stage parasites that begin the life cycle 
again when the tsetse bites another host (Barry & McCulloch, 2001). 
1.3.3 African trypanosomiases 
Human African trypanosomiasis (HAT), or sleeping sickness, is caused by two 
T. brucei subspecies: T. b. gambiense and T. b. rhodesiense. The third 
subspecies, T. b. brucei, cannot infect humans. T. b. gambiense causes the 
chronic form of HAT, in west and central Africa, which accounts for around 90% 
of total HAT cases. T. b. rhodesiense causes the acute form of HAT in east and 
southern Africa. Infection with T. b. rhodesiense will eventually cause death if 
untreated; death is also a frequent outcome of untreated T. b. gambiense 
infection but tolerance and self-cure have also been reported (Jamonneau et al, 
2012). Death will occur within a few weeks or months of infection with T. b. 
rhodesiense, whereas T. b. gambiense infections can last for several years 
before patients show major clinical signs (Cattand et al, 2001). 
HAT has two clinically distinct stages: stage one (early), a generalised 
haemolymphatic infection, and stage two (late), when parasites have crossed 
the blood-brain barrier and invaded the central nervous system. Early stage 
disease has several symptoms, most of which are non-specific, including general 
malaise, rash, headache, weight loss, arthralgia and fatigue (Kennedy, 2008). 
One of the most common symptoms is an irregular fever that fluctuates with the 
waves of parasite proliferation (Stich et al, 2002). In stage two of infection, 
damage caused by the parasites and the host reaction results in a chronic 
encephalopathy, with severe headache and loss of concentration and co-
ordination (Stich et al, 2002). Untreated, infection will eventually result in coma 
and death (Hide, 1999). 
Early stage disease is treated with the drugs pentamidine and suramin, which 
are effective against T. b. gambiense and T. b. rhodesiense respectively. These 
drugs cannot cross the blood-brain barrier, so are ineffective if the disease has 
progressed to the late stage (Wilkinson & Kelly, 2009). Melarsoprol, an arsenic-
based drug, is effective against late-stage infection by both parasites, but it is 
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highly toxic, causing a reactive encephalopathy in around 10% of patients, 
resulting in death in 5% of all patients receiving this drug (Kennedy, 2008). 
Additionally, drug resistance and treatment failure are recognised problems 
(Legros et al, 1999). Alternative treatments are becoming available for late-
stage T. b. gambiense disease: the drug eflornithine, which has few side effects, 
is being increasingly used, but is required in large doses that often make its use 
impractical (Barrett et al, 2003). Nifurtimox is a drug developed and licensed for 
use against South American trypanosomiasis, which is caused by a distinct 
trypanosome, but the drug has been used successfully against T. b. gambiense in 
combination with both melarsoprol and eflornithine; and an eflornithine-
nifurtimox combination has been recommended by the WHO as a first-line 
treatment for the late-stage disease (Wilkinson & Kelly, 2009). 
Animal trypanosomiases are similar to human sleeping sickness: wasting diseases 
that often will eventually result in death. A broader range of parasites cause 
disease in non-human animals than in humans, and the range includes T. 
congolense, T. vivax, T. evansi, T. equiperdum and all three subspecies of T. 
brucei (both human-infective subspecies plus T. b. brucei). T. b. rhodesiense 
and T. b. brucei have wide host ranges, including both domestic and wild 
animals. T. b. brucei is non-human-infective, and T. b. rhodesiense is considered 
primarily an animal parasite; that is, East African sleeping sickness is a zoonosis 
(Welburn et al, 2006). T. b. gambiense is considered to have its main reservoir 
in humans (Smith et al, 1998) but has also been identified in domestic pigs, and 
a number of wild animals including monkeys and duikers (Njiokou et al, 2006; 
Maudlin, 2006). 
Different host species have varying degrees of trypanosome tolerance or 
resistance. Most cattle species and other domestic animals, if infected, will 
succumb to disease and usually die, as will a number of game animals including 
gazelle, jackal and monkey species (Black et al, 2001). Other species, for 
example bushbuck and hyena, and some African breeds of cattle such as 
N’dama, are susceptible to infection, but have a degree of trypanotolerance 
that allows parasitaemia to persist for some time without killing the animal, 
which may self-cure. Some species, for example baboons, are completely 
resistant to trypanosome infection (Mulla & Rickman, 1988). Humans are 
innately resistant to infection by most African trypanosome species due to the 
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trypanosome lytic factors (TLF) of human serum: TLF1, which is a minor subclass 
of human high density lipoprotein (Hajduk et al, 1992); and TLF2, which is a high 
molecular weight protein complex (Raper et al, 1999). T. b. rhodesiense can 
infect humans by expressing the serum resistance associated protein (SRA), 
which prevents TLF-mediated lysis (Xong et al, 1998). The mechanism of action 
of SRA is still debated but the protein appears to be able to neutralise TLF1 once 
it has been taken up by the parasite (Vanhamme et al, 2003; Pérez-Morga et al, 
2005; Oli et al, 2006; Stephens & Hajduk, 2011). T. b. gambiense resistance is 
SRA-independent, and the two subgroups of T. b. gambiense have different 
human serum resistance mechanisms: group 1 resistance arises partly from 
reduced expression of and mutations in the haptoglobin/haemoglobin receptor 
responsible for mediating TLF1 uptake, so TLF1 is not internalised (Kieft et al, 
2010; Symula et al, 2012); while in group 2 TLF1 is internalised but prevented 
from bringing about lysis by an unknown mechanism (Capewell et al, 2011). 
1.4 Antigenic variation in trypanosomes 
1.4.1 Introduction to antigenic variation 
In the process of antigenic variation, individual members of a clone or genotype 
of a pathogen periodically alter the molecules that they expose to the host 
immune system, such that an adaptive immune response raised against the first 
set is ineffective against the second set. This has two possible benefits for the 
pathogen: it allows infection to persist in the host, increasing the clone’s 
chances of being transmitted to a new host (Barbour & Restrepo, 2000; Barry & 
McCulloch, 2001); and it allows re-infection of a previously infected host, 
overcoming herd immunity (Futse et al, 2008). There are three main 
requirements that allow a pathogen to use this strategy: access to a large 
number of genes encoding the antigens; the ability to express only one of these 
at once (allelic exclusion); and the ability to switch which gene is active (Borst & 
Genest, 2006). A large permanent repertoire is not essential, as there is an 
alternative strategy to provide numerous variants: the capacity to generate 
temporary genes from a small permanent repertoire. For example, short 
segments from different pseudogenes can be assembled in various combinations 
to form distinct functional genes, as occurs in Anaplasma marginale (Brayton et 
al, 2002), and also in T. brucei, where the strategy operates in conjunction with 
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the use of a large permanent repertoire (see below). A high mutation rate for 
the antigen genes is advantageous, and is another alternative to a large 
permanent repertoire. Rapid mutation is important particularly in the case of 
viruses, which cannot directly encode many antigenic alternatives 
simultaneously due to the restricted size of their genome (Barry & McCulloch, 
2001). 
The strategy of antigenic variation is used by a number of pathogens other than 
T. brucei (Deitsch et al, 1997). For example, P. falciparum varies its erythrocyte 
membrane protein 1, which is displayed on the surface of the infected red blood 
cell, by expressing one of 60 var genes (Kraemer & Smith, 2006). Giardia 
lamblia, which causes an intestinal disease, has an immunogenic variable 
surface protein coat made by expressing one from about 190 possible genes 
(Prucca et al, 2008). Several Borrelia species use antigenic variation strategies, 
including the bacteria causing relapsing fever (Borrelia hermsii) and Lyme 
disease (Borrelia burgdorferi), which have surface coats of variable major 
protein and variable major protein-like protein respectively (Barbour & Restrepo, 
2000). These pathogens, and numerous others including Neisseria species 
(bacterial species causing meningitis and gonorrhoea), the bacterium A. 
marginale (which infects cattle and goats) and the fungus P. carinii, all display 
antigenic variation as they persist in, or re-infect, their host (Deitsch et al, 
1997). 
1.4.2 Structure and function of VSG 
Antigenic variation in T. brucei occurs in the VSGs that form the protective 
surface coat. Approximately five million VSG homodimers form a 12-15 nm layer 
on the outer surface of the plasma membrane of bloodstream form (BSF) and 
metacyclic form trypanosomes (Vickerman, 1985; Barry & McCulloch, 2001). By 
blocking antibody access to invariant potential antigens, such as glucose 
transporters and signalling proteins, the VSG coat enables the trypanosome to 
avoid the adaptive immune response (Overath et al, 1994; Barry & McCulloch, 
2001). It also conceals invariant surface molecules and the cell membrane from 
the innate immune system, which they may activate (Ferrante & Allison, 1983; 
Schwede & Carrington, 2010). 
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The VSG coat itself is strongly immunogenic, and antibodies are raised by the 
host against the VSG that is exposed on the cell surface: this is why antigenic 
variation is required. Expression of VSG genes is tightly controlled, and only one 
gene at a time is expressed by each parasite. However, in addition to this single 
expressed gene, parasites possess a large number of silent VSGs, and long 
slender trypanosomes can switch which VSGs they express. A switch occurs 
stochastically in a fraction of the population, i.e. the antigen is varied. Switches 
are spontaneous, occurring even when parasites are grown in culture (Horn & 
Cross, 1997), and allow a fraction of the population to pre-emptively avoid an 
adaptive immune response. When antibodies appear against the original VSG, 
the parasites that have switched VSG survive to continue the infection, and 
proliferate to cause a new wave of parasitaemia (Barry & McCulloch, 2001). 
Parasites can probably express any one of thousands of VSGs capable of forming 
the surface coat, ensuring the success of trypanosome antigenic variation. 
VSG probably has no function on the cell surface beyond forming the coat. VSG 
polypeptides form dimers with each subunit attached to the cell plasma 
membrane via a glycosylphosphatidylinositol (GPI) anchor (Ferguson, 1999). Most 
VSGs consist of 400 to 500 amino acid residues and contain two domains 
(Johnson & Cross, 1979; Carrington et al, 1991). The 350 to 400 residue N-
terminal domain (NTD) is highly variable, with less than 20% sequence identity 
between different VSGs, and probably contains most of the epitopes against 
which antibodies are raised (Miller et al, 1984b; 1984a; Marcello & Barry, 
2007b). The most conserved feature in the NTD primary sequence is the position 
of the cysteine residues that form disulphide bridges (Carrington et al, 1991). 
NTDs are divided into two types (A and B), based on the pattern of cysteines; 
originally a third group (C) was described, but this was later shown to be a 
subset of the A group (Carrington et al, 1991; Marcello & Barry, 2007b). The 
remainder of the VSG sequence, forming the C-terminal domain (CTD) is more 
conserved (around 40% sequence identity between genes) (Blum et al, 1993; 
Carrington et al, 1991). There are six CTD types (1 to 6), again defined by their 
patterns of cysteine residues (Carrington et al, 1991; Marcello & Barry, 2007b). 
Three CTD types appear to comprise two subdomains rather than a single CTD. 
From VSG studied so far, any combination of CTD and NTD types seems possible 
(Marcello & Barry, 2007b). 
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Despite the extensive variety in primary sequence in the NTD, higher-order 
structure appears to be conserved in the two VSGs for which the NTD structure 
has been solved (Freymann et al, 1990; Blum et al, 1993) (Figure 1-3). However, 
it should be pointed out that both these VSGs are type A, and no type B 
structure has been obtained experimentally. Two extended, antiparallel α 
helices interact to form a coiled coil (coloured blue in Figure 1-3), followed (in 
the primary sequence) by a surface-exposed region composed primarily of 
unstructured loops (coloured red in Figure 1-3). This ‘VSG fold’ appears to occur 
in a range of other trypanosome cell surface proteins with various functions, an 
arrangement which is thought to allow close packing of any VSG with the 
invariant proteins (Carrington & Boothroyd, 1996; Field & Boothroyd, 1996). The 
elongated NTD projects perpendicular to the plasma membrane, with the CTD 
adjacent to the membrane and covalently bound to the GPI anchor which 
attaches each monomer to the cell surface. The surface loops are unstructured, 
and so most amino acid changes here will not affect the protein folding 
fundamentally. Furthermore, the structure of the NTD is principally based on α 
helices, which do not depend on a specific primary sequence, but rather have 
requirements that can be provided by a number of residues and sequences. 
These structural features explain why the sequence of the NTD has great 
latitude for variation even though the higher-order structure is conserved. 
 
Figure 1-3 – Structures of VSG NTDs. 
A) MITat 1.2, Freymann et al, 1990, PDB ID: 1VSG, B) ILTat 1.24, Blum et al, 1993, PDB ID: 
2VSG. Solved structures from the indicated publications were downloaded from the RCSB 
Protein Data Bank (www.pdb.org) and visualised with PyMol. In each structure, one subunit 
is coloured grey; in the other, the coiled-coil helices are coloured blue, the surface loops 
are coloured red and the remaining, CTD-proximal region is coloured green. 
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1.5 Control of VSG expression 
1.5.1 Control strategy 
Given the critical role of VSG expression in antigenic variation, its regulation 
must achieve two things: only one VSG must be made at any one time (allelic 
exclusion), and the specific VSG made must periodically change. A further 
requirement is that VSG should only be produced at the appropriate life cycle 
stages. Although most regulation of protein production in the trypanosome 
occurs post-transcriptionally (Vanhamme & Pays, 1995), VSG expression appears 
to be an exception that is controlled at the level of transcription, and a VSG 
gene requires to be associated with an active promoter in order to be expressed. 
VSG production, therefore, is regulated by controlling which promoter is active 
and which gene is positioned so as to be transcribed from this promoter. 
1.5.2 Allelic exclusion 
VSG genes are transcribed from specialised telomeric environments, the VSG 
expression sites (ES) (Pays et al, 2001). Although there are several thousand VSG 
genes in the genome, transcription can occur only from these expression sites. 
There are two types of ES, metacyclic (MES) and bloodstream (BES), which are 
activated in the fly salivary glands and mammalian bloodstream respectively. 
MES and BES have somewhat different control mechanisms (Barry et al, 1998). 
VSG ES are transcribed by RNA polymerase I (Pol I) (Lee & van der Ploeg, 1997; 
Günzl et al, 2003). In other organisms Pol I exclusively transcribes ribosomal 
DNA, while mRNA can only be synthesised by RNA polymerase II (Pol II). 
Trypanosomes are able to use Pol I to produce mRNA because they have 
separated the usual coupling of Pol II RNA synthesis with mRNA maturation 
processes such as 5′ capping (Günzl et al, 2003; Benz et al, 2005). However, 
most trypanosome protein-coding genes are still transcribed by Pol II (Vanhamme 
& Pays, 1995), so transcription of VSG by Pol I has implications for control of VSG 
expression. 
Restriction of VSG transcription to ES prevents the transcription of most archive 
VSGs. However, a striking feature is that although theoretically there can be up 
to 23 BES (Young et al, 2008a), plus approximately 20 MES (Horn & Barry, 2005), 
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only one ES at a time is used to produce protein (Barry & McCulloch, 2001). In 
probably all BES, polymerase is recruited and transcription is initiated, but 
transcriptional elongation is inhibited at all but the single active BES (Vanhamme 
et al, 2000). In the inactive MES, transcription initiation is inhibited (Graham & 
Barry, 1995). It is thought that this strict control of BES is achieved by 
specialised nuclear sublocalisation of the active ES (Navarro & Gull, 2001), 
coupled with effective repression of inactive ES. 
The active ES does not localise within the nucleolus, as might have been 
expected from its transcription by Pol I (Chaves et al, 1998). Instead it is found 
in the expression site body (ESB), a subnuclear region where only the active ES 
appears to be transcribed (Navarro & Gull, 2001). This provides an explanation 
for the differential expression of BES: it is suggested that the ESB provides 
factors required to escape abortion of elongation, but can only accommodate 
one (the active) ES at a time, and all others are excluded and thus silenced 
(Navarro & Gull, 2001; Borst, 2002). Because DNA rearrangements are not 
required to switch which ES is active, several pathways of epigenetic control 
have been suggested to be involved in regulation. Depletion of proteins involved 
in chromatin remodelling (Hughes et al, 2007) and chromatin methylation 
(Figueiredo et al, 2008) has been shown to cause derepression of VSG in silent 
BES. Derepression also occurs on depletion of the trypanosome homologue of a 
yeast protein involved in the telomere position effect (Yang et al, 2009), a 
phenomenon in which genes located near telomeres are silenced (Gottschling et 
al, 1990; Glover & Horn, 2006), although inhibition or deletion of homologues of 
several other such genes appeared to have no effect on BES repression (Conway 
et al, 2002b; Alsford et al, 2007; Glover et al, 2007). Other proteins 
demonstrated to have a role in VSG silencing include ORC1, which is involved in 
DNA replication (Tiengwe et al, 2012b; Benmerzouga et al, 2012); histones, and 
histone chaperones (Povelones et al, 2012; Alsford & Horn, 2012). However, 
none of these studies described derepression of inactive BES to the levels of 
transcription seen from the active BES (Morrison et al, 2009), so it is clear that 
considerable detail remains to be elucidated. 
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1.5.3 VSG switching 
The second key requirement for successful antigenic variation is that at least 
some parasites in the infecting population must switch the VSG that forms the 
surface coat. In non-laboratory-adapted strains, switching occurs at a rate of  
10-2 to 10-3 switches/cell/generation (Turner, 1997). There are two main 
mechanisms whereby the VSG expressed can be changed: transcriptional (in situ) 
switching, and recombinational switching. Transcriptional switching involves 
silencing of the VSG previously being transcribed, accompanied by activation of 
the VSG (and associated genes) in another BES, without DNA rearrangement 
(Morrison et al, 2009). It is presumed that this mechanism of switching involves a 
change of the BES occupying the ESB (Borst, 2002), but details of how the 
change is initiated are not known, although there are indications that chromatin 
modification plays a role (Figueiredo et al, 2008), and that cell division is an 
important event for switching (Landeira et al, 2009). 
Transcriptional switching, however, probably plays a minor role in generation of 
antigenic diversity in natural infections, not least because the pool of different 
VSGs available by this mechanism is small. The main mechanism driving 
antigenic variation is recombinational switching (Robinson et al, 1999). There 
are more than 1600 VSG genes in the genome strain of T. brucei (Marcello & 
Barry, 2007b), but most are located in subtelomeric arrays rather than ES (see 
section 1.6). Recombination reactions allow genes from this archive of silent, 
promoterless loci to be moved to the active ES, replacing the VSG there 
previously and thus changing which VSG is expressed. 
There are three main types of recombinational switching, and it is not clear 
whether they share molecular mechanisms, nor whether each type of switch can 
be achieved by several different mechanisms (Morrison et al, 2009). The first 
type of switching is duplicative gene conversion (Robinson et al, 1999), in which 
a complete VSG gene is copied from a silent, promoterless site into the active 
BES (Barry, 1997). The second type of recombinational switching results in 
assembly of novel, mosaic VSG genes by combining different regions of 
pseudogenes (Thon et al, 1989; 1990). The third type, termed reciprocal 
recombination, exchanges chromosome ends between the active BES and an 
inactive, telomere-proximal VSG, so VSGs are swapped but the site of 
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transcription initiation is not changed (Pays et al, 1985). However, this 
mechanism has been studied mainly in a laboratory-adapted strain (Rudenko et 
al, 1996; Aitcheson et al, 2005), and its relevance to antigenic variation in 
natural infections is unclear but probably minor (Verstrepen & Fink, 2009). 
The pathways of homologous recombination are expected to be important in 
transferring silent VSGs to the active ES (Barry & McCulloch, 2001). A number of 
trypanosome homologues of proteins important in eukaryotic homologous 
recombination (San Filippo et al, 2008) have been tested for their effect on VSG 
switching. Several of these homologues were found to cause a decrease in the 
frequency of switching when mutated, including RAD51, the driver of 
homologous recombination (McCulloch & Barry, 1999); the RAD51-related protein 
RAD51-3, though other RAD51 paralogues appear to have no or a minor role 
(Proudfoot & McCulloch, 2005; Dobson et al, 2011); and BRCA2 (Hartley & 
McCulloch, 2008). It has been suggested that recombinational switching is 
initiated by double-stranded DNA breaks, which are usually repaired by 
homologous recombination (Barry, 1997; Horn, 2004). Twofold evidence for this 
hypothesis was provided by a study in which the induction of double-stranded 
breaks just upstream of the VSG gene in the active ES increased switching 
frequency, and spontaneous double-stranded breaks were detected in the same 
region (Boothroyd et al, 2009). 
Switching has a semi-predictable order, such that the same VSGs are usually 
used to form a coat at broadly similar times in different infections with the same 
strain (Morrison et al, 2005). However, this order is not thought to be the result 
of the parasite favouring different switching mechanisms at different times, but 
rather, it emerges from the interaction of two features of antigenic variation: 
the existence of different types of switching mechanism, and the continuous 
pressure of immune selection. Since the various switching mechanisms involve, 
at least to some extent, different mechanisms and factors, they have different 
probabilities of occurring. For example, recombinational switching to activate 
VSGs resident in telomeric ES has a relatively high probability of occurring, 
because telomeres tend to interact with one another, promoting recombination 
(Barry et al, 2003), and because the inactive ES provides a long stretch of 
sequence homologous to the active ES (Hertz-Fowler et al, 2008), which also 
makes recombination more likely. By contrast, the assembly of an intact mosaic 
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VSG has a relatively low probability, because a single segmental conversion has a 
low probability of occurring due to the short regions of homology often involved, 
and assembly of a mosaic VSG requires a string of such events (Marcello et al, 
2007b). Moreover, as there is no evidence so far of any mechanism to check 
mosaic genes for functionality, it can be inferred that even once a mosaic has 
been assembled, it may not be able to produce an effective coat. 
The probability of each type of switch is thought to remain constant throughout 
infection. However, genes which have a high probability of activation will likely 
be first used to make surface coats, and thus seen by the immune system, quite 
early in infection. Therefore, although such genes will be frequently re-
activated at later stages of infection, parasites that do so will be rapidly killed, 
because an immune response against their surface coat has already been raised 
(Barry & McCulloch, 2001). At this later stage of infection, although mosaic 
formation still has the same relatively low probability of occurring as it did at 
the early stages, when it does occur it will confer an antigenically novel surface 
coat upon the parasite, and thus allow escape from the immune response. These 
low-probability events will therefore make up a large proportion of successful 
switches at later stages of infection. In the discussion of different mechanisms I 
will refer to their importance at a particular stage of infection; this is not to be 
understood to mean that they do not occur at other stages, but that at stages 
where they are important, switches using these mechanisms constitute most of 
the successful switches that allows parasites to continue to proliferate. 
1.6 Architecture of the VSG archive 
1.6.1 T. brucei genome structure 
The genome of T. brucei consists of 11 pairs of conventional diploid 
chromosomes (the ‘megabase chromosomes’), approximately 100 
minichromosomes of 30 to 150 kb, and several intermediate chromosomes of 200 
to 700 kb (Williams et al, 1982; Melville et al, 1998; 1999). There are estimated 
to be between 1600 and 2000 VSG genes in the genome of the reference strain 
TREU 927 (Berriman et al, 2005; Marcello & Barry, 2007b). VSG genes are found 
on all chromosome types, in four different locus types, which will now be 
described. 
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1.6.2 VSG expression sites 
Two of the locus types are the VSG ES, which are adjacent to the telomeres of 
megabase and intermediate chromosomes. Genes in ES at the time of inoculation 
are important early in infection, as described above (Barry & McCulloch, 2001). 
There are estimated to be between five and 23 BES, with numbers varying 
between strains and subspecies due to the dynamic and unstable nature of 
telomeres (Becker et al, 2004; Hertz-Fowler et al, 2008; Young et al, 2008b). ES 
are usually between 40 and 80 kb in length, although ES as small as 24 kb have 
been observed (Zomerdijk et al, 1990; Berriman et al, 2002; Becker et al, 2004). 
A stylised representation of the structure of a BES is shown in Figure 1-4. The 
genes in the BES are all transcribed from a single, strong Pol I promoter 
(Zomerdijk et al, 1990); this type of polycistronic transcription is usual for 
trypanosome protein coding genes (Vanhamme & Pays, 1995). The VSG gene is 
always the most telomere-proximal gene, located adjacent to the telomere 
repeats (Vanhamme et al, 2001). Upstream of the VSG gene is an array of up to 
10 kb of imperfect 70 base pair (bp) repeats. These AT-rich repeats are the 5′ 
limit of recombinational switching (Campbell et al, 1984; Liu et al, 1985; Shah 
et al, 1987). Such 70-bp repeats are also found associated with array VSG genes 
(see below), and are thought to provide the regions of homology necessary for 
homologous recombination of silent VSGs into the ES. In a low-switching, 
laboratory-adapted strain, deletion of 70-bp repeats did not abolish 
recombination of VSGs into the active BES (McCulloch et al, 1997), but the 
relevance of this observation is unclear because the strain used seems to be 
defective in recombinational switching, so the low level of switching that does 
occur probably differs in mechanism from recombinational switching in other 
strains (Barry, 1997). It is hypothesised that the 70-bp repeats are optimised to 
be prone to the double-stranded breaks that may initiate VSG switching (Alsford 
et al, 2009; Boothroyd et al, 2009), and indeed their sequence contains TAA 
motifs that have been shown to be physically unstable (Ohshima et al, 1996). 
Between the 70-bp repeats and the promoter are several expression-site 
associated genes (ESAGs) (Cully et al, 1985), which encode various proteins, 
including likely surface receptors, transporters and signalling molecules (Pays et 
al, 2001). Some ESAGs are conserved between all characterised BES, while 
others are present only in some (Hertz-Fowler et al, 2008; McCulloch & Horn, 
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2009). Upstream of the promoter, and thus untranscribed, are several kb of 50-
bp repeats (Zomerdijk et al, 1990), followed centromere-proximally by regions 
containing RIME and INGI retrotransposon and retrotransposon hot spot (RHS) 
sequences (Bringaud et al, 2002). 
 
Figure 1-4 – Schematic diagram of a VSG bloodstream expression site. 
Triangles represent short repeats (50-bp, 70-bp and telomere repeats); filled arrows 
represent genes, with Ψ denoting a pseudogene; the flag represents the promoter. 
Expression from MES occurs in the metacyclic form and in BSF during the first 
few days of infection. The MES are unique among trypanosome protein-coding 
genes in being transcribed monocistronically, with a dedicated metacyclic-VSG 
promoter (Alarcon et al, 1994; Graham & Barry, 1995; Ginger et al, 2002). MES 
are used to express VSG in the fly salivary glands, at least partially as a 
preadaptation for mammalian infection, for which they may be essential. Their 
number is uncertain, but there may be up to 27 (Turner et al, 1988). Despite 
their monocistronic transcription, upstream of the promoter there is an 
untranscribed region containing ESAGs and ESAG pseudogenes, suggesting MES 
may have arisen from BES (Graham et al, 1999). As with the BES, in the MES the 
VSG gene is immediately telomere-proximal, but the promoter is much closer, 
located approximately 5 kb from the gene (Ginger et al, 2002). Between the 
gene and the promoter there are some of the 70-bp repeats seen in the BES, but 
here there are considerably fewer, usually only two or three. MES have also been 
described that do not contain any 70-bp repeats (Lenardo et al, 1986; Graham et 
al, 1999). Change in the MES VSG repertoire is slow, but turnover does occur 
(Barry et al, 1983). 
1.6.3 Silent VSG 
Although ES harbour a small pool of different VSGs, by far the majority of VSG 
genes lie elsewhere in the genome, where they are unexpressed, but can be 
copied into ES. Silent VSGs are found in two locus types: minichromosome 
subtelomeres, and megabase chromosome subtelomeric arrays. 
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Minichromosomes are linear molecules between 30 and 150 kb in size, consisting 
mainly of 177-bp repeats, and ending with standard telomere repeats (Weiden et 
al, 1991; Wickstead et al, 2004). Most, though not all, of the minichromosomes 
contain VSG genes, flanked upstream by a set of 70-bp repeats (Williams et al, 
1982; van der Ploeg et al, 1984; Donelson, 2003). Each subtelomere can contain 
one VSG, located within 5 kb of the telomere repeats, and likely to be an intact 
gene (Alsford et al, 2001; Horn & Barry, 2005). There are approximately 100 
minichromosomes in the T. brucei genome, making up around 10% of nuclear 
DNA, so there are potentially up to 200 minichromosomal VSGs, although few 
have been characterised (van der Ploeg et al, 1984; Barry et al, 2005). As the 
minichromosome sequence essentially consists only of the VSG gene and the 
tandem repeats, it has been suggested that minichromosomes have evolved to 
provide a pool of readily-accessible VSG genes (Wickstead et al, 2004; Barry & 
McCulloch, 2001). Intact minichromosomal VSGs tend to be important quite early 
in infections, presumably since only a single recombinational step is required to 
activate them, although they have shorter stretches of homology to the active 
ES than do VSGs in inactive ES (Robinson et al, 1999; Morrison et al, 2005). 
The remainder of the VSG archive is contained in arrays located in the 
subtelomeres of the megabase chromosomes (Berriman et al, 2005) (Figure 1-5). 
Experimental infections examining a small number of VSGs have suggested that 
intact array genes usually become important later in infection than do 
minichromosomal genes, but still relatively early in infection (Morrison et al, 
2005; Marcello & Barry, 2007b). Later in infection, however, mosaic VSGs 
assembled from pseudogenes appear to dominate, as explained above (Marcello 
& Barry, 2007b; Hall et al, 2013). The subtelomeric subarchive is arranged in 
tandem arrays, usually oriented away from the telomere, although some arrays 
contain strand switches in which the array changes orientation. In the genome 
strain trypanosome, an array can contain between three and around 250 genes 
and pseudogenes. Although VSG genes can be grouped into subfamilies by their 
N- and C-terminal domains, this organisation is not reflected in the arrangement 
of VSGs within and between arrays (Berriman et al, 2005; Marcello & Barry, 
2007b). Array VSGs are arranged as cassettes similar to those of VSGs in other 
chromosomal loci. This cassette structure is thought to provide the silent VSGs 
with homology for recombination into BES. Within the cassette, upstream of the 
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gene is at least one 70-bp repeat, and at the 3′ end there is a partially conserved 
region including coding and untranslated regions (Michels et al, 1983; Liu et al, 
1983; Marcello & Barry, 2007b). The arrays are also interspersed with the 
retrotransposon INGI, particularly around strand switches (Berriman et al, 2005). 
 
Figure 1-5 – Subtelomeric VSG arrays of TREU 927. 
Subtelomeric VSG arrays in the TREU 927 genome assembly. Gene annotations were 
downloaded from TriTrypDB (Aslett et al, 2010) and filtered to include only those where the 
gene product description or primary name was ‘VSG’ or ‘variant surface glycoprotein’. 
Chromosomes are represented by solid black lines; red lines projecting above the line of 
the chromosome represent VSG genes, pseudogenes or gene fragments on the forward 
strand; those projecting below represent the same on the reverse strand. Chromosome 
numbers are shown in boxes, numbers in italics above arrays indicate the number of genes 
at each subtelomere. For chromosome 11, the assembly consists of a main contiguation 
and two much smaller fragments: only the main contiguation is shown, although the 
fragments also contain VSGs. The scale bar indicates the lengths of chromosomes in Mb. 
The arrays are effectively haploid, as they are not conserved between 
homologous chromosome pairs, and therefore the published trypanosome 
genome of eleven chromosomes does not cover the entire silent archive (Melville 
et al, 1999; Berriman et al, 2005; Hutchinson et al, 2007). Comparison between 
the assembled cores of megabase chromosomes and the physical size of these 
chromosomes, as estimated by pulsed-field gel electrophoresis (S. Melville, 
unpublished), has been used to estimate the size of the VSG arrays in the 
genome strain. This approach suggests that the arrays total approximately 8 Mb 
containing 1600 genes, half to two thirds of which have been analysed (Marcello 
& Barry, 2007b). However, the size of homologous chromosomes can vary widely 
between strains (Melville et al, 2000). A large amount of the difference between 
strains may lie in the VSG arrays, as has been shown for chromosome 1, one copy 
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of which in one strain has over half of its length devoted to VSGs, amounting to 
around 3 Mb and potentially 600 VSG (Callejas et al, 2006; Marcello & Barry, 
2007b). 
Although the VSG arrays contain a large amount of DNA, analysis of the sequence 
has revealed that in TREU 927 only a small proportion (4.5%) of the annotated 
silent VSG cassettes contain fully functional genes (Figure 1-6). A further 9.5% 
are atypical genes, which may encode proteins with inconsistent VSG folding or 
post-translational modifications. Most (65%) are in fact pseudogenes, containing 
frameshifts or in-frame stop codons; and 21% are incomplete genes, encoding 
fragments of the protein, mostly CTDs (Berriman et al, 2005; Marcello & Barry, 
2007b). This does not mean, however, that only 5% of the archive is useful for 
antigenic variation. Non-functional genes are still able to act as substrates for 
the recombinational process that generates novel genes that are mosaics or 
hybrids of genomic VSGs (Thon et al, 1990; Kamper & Barbet, 1992; Morrison et 
al, 2005; Marcello & Barry, 2007b). These mosaic genes are probably assembled 
by multiple steps of segmental gene conversion, as the recombination events are 
usually between sequences with only short stretches of homology (Conway et al, 
2002b; Taylor & Rudenko, 2006). The predominance of pseudogenes in the 
archive means that the generation of mosaic VSGs might assume greater 
importance than was previously thought (Marcello & Barry, 2007b), and detailed 
analysis of the VSGs expressed during infection reinforced this importance (Hall 
et al, 2013). 
 
Figure 1-6 – Composition of the TREU 927 VSG archive. 
Although the TREU 927 archive is estimated to contain around 1600 VSG, not all of the 
archive genes are present in the assembled genome. Around 900 genes have been 
annotated and analysed and it is these genes that are shown. Data are from Marcello & 
Barry, 2007b. An ‘incomplete’ gene is usually an isolated NTD or CTD. The number of genes 
in each category is indicated in the appropriate segment. 
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1.6.4 Role of archive composition and substructure in generation 
of antigenic variation 
A VSG archive provides functional VSGs of sufficient antigenic diversity to 
achieve three things: the survival and persistence of a population of parasites in 
the mammalian host; the overcoming of herd immunity by allowing re-infection 
of previously infected hosts; and the possibility of competition between strains 
(Barry et al, 2005; Marcello & Barry, 2007a). The composition and substructure 
of the archive are well suited to providing such an antigenic range, in a number 
of ways. Simply the scale of the archive provides a considerable resource, even 
if only full-length, intact VSG genes are considered. If the VSGs analysed so far 
are representative of the entire archive, functional genes in the arrays number 
between 50 and 100 (Marcello & Barry, 2007b), and there are up to 200 on 
minichromosomes, which although not well characterised are probably mostly 
intact (Marcello et al, 2007). As described above, other pathogens successfully 
persist by antigenic variation using no more different variants than there are 
intact VSG genes: for example, P. falciparum uses only around 60 var genes. 
Of course, the potential repertoire of VSGs is much greater than this, because of 
the parasite’s ability to produce functional genes by combining pseudogenes, a 
process that is thought to be key to trypanosome survival (Kamper & Barbet, 
1992; Barbet & Kamper, 1993). It has further been argued that the use of 
recombined pseudogenes rather than full-length genomic genes has been 
actively selected for as a means of overcoming herd immunity: if pseudogenes 
are used then mosaic VSGs will be assembled anew in every infection, meaning a 
somewhat different string of antigens will be produced every time (Marcello & 
Barry, 2007a; Barry et al, 2012). Analysis of the archive found around 40% of VSG 
sequences belong to small, high-identity subfamilies, usually with two or three 
members. This subfamily structure is suggested to be key to mosaic formation by 
providing regions of high identity between donor genes, allowing them to 
recombine readily (Marcello & Barry, 2007b). The other key feature of the VSG 
archive that promotes antigenic diversity is its fast rate of evolution, which will 
be discussed in the next section. 
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1.7 Evolution of the VSG archive 
1.7.1 Hyperevolution of VSGs 
The VSG archive appears to evolve rapidly. Strains that have minor differences 
in housekeeping genes can have large differences in their VSG repertoires, and 
repertoires have diverged to become strain-specific (Bernards et al, 1986; 
Hutchinson et al, 2007). An individual VSG gene will be invisible to selection 
unless it is expressed, which for most genes is probably only rarely. 
Furthermore, because there are so many genes, it seems likely that any single 
gene could be lost with very little effect on the overall capacity of a population 
for antigenic variation. It therefore seems unlikely that hyperevolution is the 
result of strong diversifying selection on individual VSG genes. More likely is the 
hypothesis that mechanisms have evolved, either de novo or through adaptation 
of existing processes, to generate mutations of various sorts in VSGs, leading to 
the observed hypermutation (Barry et al, 2012). 
Analysis of the VSG arrays in the genome strain led to the proposal that there is 
a dynamic equilibrium between gene duplication and rapid diversification. The 
process results in the previously described subfamily structure that promotes 
mosaic formation, and produces novel genomic VSG genes. Inferred mutations 
from this analysis include duplication of whole genes and gene segments, point 
mutations and short indels, in addition to larger-scale contractions and 
expansions of the arrays mediated by the INGI retrotransposon (Marcello & Barry, 
2007b). 
Segregation of subtelomeric VSG genes from chromosome cores provides a means 
for them to be subject to different activities. For example, divergence of VSG 
repertoires between strains is hypothesised to be due to cessation of meiotic 
genetic exchange between telomeres and between subtelomeres. Meiotic 
recombination tends to homogenise gene sequences between homologous 
chromosomes, so its absence would allow different changes to accumulate in 
different strains (Hutchinson et al, 2007). Furthermore, because subtelomeres in 
general are subject to hyperevolution, it is proposed that the subtelomeric 
location of the VSG arrays is key to the evolutionary mechanisms that lead to 
diversification (Marcello & Barry, 2007b). 
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1.7.2 Possible mechanisms of evolution 
Subtelomeres have been observed to undergo elevated levels of ectopic and 
homologous recombination (Freitas-Junior et al, 2000; Mefford et al, 2001; Rudd 
et al, 2007), and it is likely that these processes promote segmental duplication 
and the generation of new combinations of VSG sequence. Because the archive is 
very large, and the segments converted can be very small, it is possible that 
such recombination would generate sufficient antigenic diversity for the parasite 
to successfully persist in infections. However, it is by no means clear that 
recombination is able to generate enough diversity, and  it may be necessary for 
new variation to be introduced into the archive. Further, inference of the events 
of VSG evolution by comparing genes within the TREU 927 archive suggests that 
smaller-scale sequence diversification such as point mutation and short indels 
are also important (Marcello & Barry, 2007b). No detailed study has been made 
of the processes causing these mutations in subtelomeres, and it is not clear 
whether they are genuinely different from those occurring in chromosome cores, 
or whether the difference is because relaxed selection on individual VSGs allows 
mutations to accumulate.  However, there are several mechanisms that could 
plausibly play a role in elevating mutagenic processes in VSG, and these are 
discussed in the following sections. 
1.7.2.1 Recombination and repair activities 
Ongoing characterisation of recombination and repair pathways in T. brucei is 
revealing that many proteins involved in these pathways in other organisms have 
homologues in T. brucei that act in similar processes, although there are some 
large differences (reviewed in Machado et al, 2006). Trypanosome components 
of homologous recombination and DNA repair activities include RAD51, a key 
recombinase enzyme (McCulloch & Barry, 1999; San Filippo et al, 2008); five 
RAD-51 paralogues, which are thought to act as accessory factors to the enzyme 
(Proudfoot & McCulloch, 2005); BRCA2, a regulator of homologous recombination 
that interacts with RAD51, although the role of BRCA2 appears to be somewhat 
different in trypanosomes from other organisms (Hartley & McCulloch, 2008; 
Oyola et al, 2009; Trenaman et al, 2012); the multifunctional MRE11 (Tan et al, 
2002; Robinson et al, 2002); and several mismatch repair proteins, MSH2, MSH3, 
MSH8, MLH1 and PMS1 (Bell et al, 2004). In addition to homologous 
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recombination, there is a second, RAD51-independent pathway of 
microhomology-based recombination, for which components have not been 
characterised (Conway et al, 2002a; Barnes & McCulloch, 2007; Glover et al, 
2008). For most of these proteins, the effects of deletion have been 
characterised, and two in particular had striking effects on the trypanosome’s 
subtelomeres. 
MRE11 is the central protein in a tripartite nuclease complex that in yeast and in 
mammals is important in maintaining genomic integrity, apparently through its 
involvement in checkpoint signalling and DNA replication, and is required for 
homologous recombination (D'Amours & Jackson, 2002). Deletion of both alleles 
of the MRE11 gene in T. brucei resulted in gross chromosomal rearrangements, 
which involved only decreases in chromosome size (i.e. loss of sequence rather 
than duplicative translocations), and did not appear to affect telomeres or BES 
VSG but involved loss of array VSG genes in at least half of clones examined 
(Robinson et al, 2002). Chromosomal rearrangements were not detectable in the 
intermediate chromosomes and minichromosomes. The pattern of chromosomal 
rearrangements is in contrast to that in S. cerevisiae cells lacking MRE11, where 
90% of rearrangements are either duplicative translocations or additions of new 
telomeres (Chen & Kolodner, 1999). Further analysis with chromosome core 
markers showed the loss of trypanosome sequence to be almost exclusively 
restricted to subtelomeres (A. Browitt, A. MacLeod, J.D. Barry, unpublished). 
BRCA2 is also important in eukaryotic genome stability, and is involved in 
regulation of homologous recombination. In mammals and in Leishmania 
infantum, the protein appears to regulate RAD51 by binding it and facilitating its 
transport to the nucleus (Davies et al, 2001; San Filippo et al, 2008; Genois et al, 
2012). In T. brucei, BRCA2 does interact with RAD51, but it does not appear to 
act in RAD51 transport to the nucleus (Trenaman et al, 2012). Deletion of the T. 
brucei BRCA2 gene in BSF parasites, though not in the procyclic form, resulted in 
gross chromosomal rearrangements similar to those resulting from MRE11 
deletion: most chromosomes that changed appeared to become smaller; 
rearrangements were detectable in only the megabase chromosomes; and VSG 
loss occurred in at least some cases (Hartley & McCulloch, 2008; Trenaman et al, 
2012). The findings for these two key DNA repair genes suggest that these 
activities may act differently, or with a different rate, in subtelomeres 
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compared with chromosome cores. It can be envisaged that such differences in 
exposure to recombination and repair processes could result in differences in 
mutation profiles. 
1.7.2.2 Error-prone polymerases 
Cells have many strategies to allow survival following DNA damage, as its 
consequences may be catastrophic. One such strategy involves the use of lesion 
bypass polymerases, which can insert bases opposite to DNA lesions that act as 
blocks to replicative polymerases. Most eukaryotic lesion bypass polymerases 
belong to the Y family, and have specialised structures that include the classic 
DNA polymerase fold and catalytic residues despite having very little sequence 
identity to replicative polymerases (Waters et al, 2009). Their active sites are 
larger and more open than that of other DNA polymerases, a difference that 
allows accommodation of bulky adducts. Lesion bypass polymerases also make 
fewer contacts with the DNA substrate than do replicative polymerases (Prakash 
et al, 2005). These structural features, coupled with lack of 5′-3′ proofreading 
activity, give lesion bypass DNA polymerases low replicative fidelity, with error 
rates that range from two to seven orders of magnitude higher than that of 
replicative polymerases (Yang, 2005; Waters et al, 2009). A second consequence 
is reduced stability of the DNA-polymerase complex, a feature that, although it 
promotes translesion synthesis, also decreases enzyme processivity on 
undamaged DNA (Prakash et al, 2005). 
In addition to their function in tolerance of DNA damage, the low fidelity of 
lesion bypass polymerases led to the suggestion that they have a role in the 
systematic generation of mutations (Radman, 1999). Such a mutagenic process is 
seen, for example, in the somatic hypermutation that occurs in immunoglobulin 
genes in B cells, promoting antibody diversity, and is also used by cells to 
generate adaptive mutations (Goodman, 2002). It has further been suggested 
that error-prone DNA polymerases have a role in generating mutations in 
trypanosome VSG genes, in a process involving DNA synthesis primed by 
homologous recombination (McKenzie & Rosenberg, 2001). Several human lesion 
bypass polymerases have mutation profiles that are similar to the indels and 
point mutations that are predicted to occur in VSG arrays (Marcello & Barry, 
2007b). However, it is likely that there will be species differences in the specific 
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types and frequencies of mutation each polymerase introduces, and perhaps 
more relevant than a particular mutation profile is the fact of a T. brucei-
specific expansion in the DNA polymerase κ (pol κ) gene family. 
Human pol κ has moderate processivity and low fidelity. Its most frequent error 
type is single-base substitutions (5.8×10-3/base/replicative cycle) followed in 
frequency by single-base deletions (1.8×10-3/base/replicative cycle) and then 
single-base insertions, and it can also cause larger or more complex deletions 
and additions (Johnson et al, 2000; Ohashi et al, 2000a; 2000b; Hile & Eckert, 
2008). Leishmania major has three copies of the pol κ gene and T. cruzi has two, 
but T. brucei has ten tandemly arranged copies (Rajão et al, 2009). The T. 
brucei family of pol κ genes, which has diverged into two groups based on the 
sequence of the DNA binding domain, models well onto the solved structure of 
human pol κ, and has mutated residues lining the substrate-binding and active 
sites (Uljon et al, 2004; J.D. Barry, and B. Marchetti, unpublished). It is 
hypothesised that T. brucei has adapted pol κ to specifically mutate 
trypanosome subtelomeres. 
1.7.2.3 The VSG archive as a model for evolution of subtelomeres 
The evolution of subtelomeres is clearly important in the variation of organisms, 
but little is understood about the mechanisms that generate diversity in these 
chromosomal regions. I therefore suggest that the VSG archive of T. brucei is a 
suitable model to study specific mutations in subtelomere evolution and the 
mechanisms possibly involved. Several considerations make this system 
appropriate to use as a model. Firstly, the VSG archive as a whole is critical for 
parasite survival in the mammalian host, with a strong selective pressure acting 
on the phenotype — diversity of antigenic coat — and thus on the mechanisms 
that generate diversity. Secondly, as noted in the previous section, the archive 
evolves at a rapid rate, with divergence detectable in isolates separated by only 
a short evolutionary time. Thirdly, suitable resources exist to study this parasite: 
the genome of one strain has been sequenced and assembled to a high standard 
(Berriman et al, 2005) and several other strains have also been sequenced or 
efforts are under way (Jackson et al, 2010; Wellcome Trust Sanger Institute 
(http://www.sanger.ac.uk/resources/downloads/protozoa/trypanosoma-
brucei.html), 2013; this thesis); and a large collection of isolates from similar 
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areas and known dates (from the 1960s onwards) exists, from which the archives 
can be compared. Finally, work on areas such as VSG switching has already 
provided some clues as to mechanisms that might play a part in hyperevolution 
of the subtelomeric archives. 
1.8 Aims of the project 
The broad purpose of the work described in this thesis was to investigate the 
processes occurring in hyperevolution of VSG genes in T. brucei. The first aim of 
the project was to test the hypothesis that the subtelomeric VSGs are subject to 
different and more rapid mutagenic processes than are genes in the chromosome 
cores. The strategy used was to identify the changes that had occurred in the 
VSG archive between two very closely-related isolates of the same trypanosome 
strain, and compare them with the changes that had occurred in the core genes. 
This aim required the sequencing and assembly of the genomes of the two 
isolates, the annotation and pairing of VSGs in and between the genomes, and 
the identification of mutations that had occurred. The second aim was to test 
the hypothesis that members of the expanded pol κ gene family may have a role 
in mutagenesis in the VSGs. The strategy used was to express and purify one 
gene from each of the two pol κ subfamilies, characterise their mutation profiles 
to determine whether either was consistent with the mutations observed in 
VSGs, and examine their subcellular localisation, in particular whether the 
proteins colocalised with subtelomeres. 
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2 Methods and Materials 
2.1 Bioinformatic methods 
For all programs described, default settings and parameters were used unless 
otherwise stated. Full names of programs and appropriate references are given 
in Table 2-1, along with a short description of its function in this work. 
2.1.1 Assembly 
2.1.1.1 Assembly algorithms and settings 
Assembly was carried out mainly at the Sanger Institute by Dr Thomas Otto. 
First, the EATRO 2340 454 libraries were assembled de novo using Celera 
assembler. The resulting contigs were ordered against T. b. gambiense strain 
DAL 972 (Jackson et al, 2010), using ABACAS, with minimum alignment length of 
300 bp and identity cutoff of 97%. After ordering, the 6 kb and 8 kb 454 libraries 
were mapped to the new assembly and a custom script was used to find 
positions with fewer than three reads in proper pairs mapped, and to break the 
contigs at these positions. Finally, IMAGE was used to close gaps, with the 
following k-mer sizes, in order: 55 (4 iterations), 49 (7 iterations), 41 (6 
iterations) and 37 (4 iterations). 
The EATRO 3 Illumina reads were trimmed using SGA (version sga-0.9.9) using 
the following sequence of commands: ‘sga filter -t 10 -d 32’; ‘sga-0.9.9 index -t 
10 --disk=50000’; ‘sga-0.9.9 correct -k 31 -x 3 -t 10 --discard’. The trimmed 
reads were assembled with Velvet Columbus, using the EATRO 2340 assembly as 
the reference. A custom script was used to change the base call to N (i.e. 
ambiguity) for any position not covered by at least two reads. ABACAS was used 
as before to order the resulting contigs to EATRO 2340. IMAGE was used for 13 
iterations with a k-mer of 31. 
2.1.1.2 Read mapping 
Illumina reads were mapped to assembled genomes using the Burrows-Wheeler 
aligner. The mapping was performed for each set of reads (forward and reverse) 
by the algorithm bwa aln using a maximum insert size of 800, then forward and 
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reverse read mappings were joined with bwa sampe. Further processing was 
performed with SAMTools 0.1.17, to convert .sam files to .bam files using 
samtools view, and to order and index .bam files using samtools sort and 
samtools index. Mapped reads were visualised with BamView in Artemis. To look 
at coverage, the samtools mpileup command was used, with the flag -g. From 
the mpileup output, plots for each contig of the number of reads and the 
number of good-quality reads (having a Phred-scaled base quality score of at 
least 23 at that position) mapped to each position were generated with the 
scripts pileup2plot.pl and pileup2plot_qual.pl, and coverage statistics calculated 
with the script coverage_from_plots.pl. 
2.1.2 Genome annotation 
2.1.2.1 RATT 
Annotations of TREU 927 core genes were transferred automatically to the 
EATRO genome assemblies using RATT. The configuration file used was 
RATT.config_euk, provided with the program, and the transfer type used was 
Strain. 
2.1.2.2 Annotation of NTDs in full-length VSG genes 
ORFs in the subtelomeres were annotated with Artemis, using a minimum length 
of 430 amino acids. The resulting ORF sequences were processed using the script 
extract_genes.pl to trim them to the first in-frame ATG and then exclude genes 
that were not between 1290 and 1650 bp in length. The filtered genes were 
concatenated with a spacer sequence between each one consisting of 1 kb of 
sequence randomly drawn from TREU 927 chromosome 10. This concatenated 
sequence was screened for windows likely to contain VSG NTD or CTD sequence 
by using SVM-VSG, a support vector machine-based program provided by Dr Jon 
Wilkes, using the script arrayFinder.pl with the settings arrayGuide.txt followed 
by the script array2vsg.pl. ORFs that were predicted to contain both NTD and 
CTD sequence, i.e. were likely to be full-length VSG genes, were extracted from 
the concatenated file by the script extract_vsg.pl. 
To separate the NTD and CTD, the ORFs were translated in frame 1 and queried 
with hidden Markov models (HMM) for NTD type A, NTD type B and CTD (provided 
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by Dr Bill Wickstead, University of Nottingham) using hmmsearch from the 
HMMer 3.0 suite of programs. If an NTD was found, the end of the NTD was used 
to define the domain boundary, and the NTD type of the gene was defined 
according to which HMM had a hit. If no NTD was found the ORF was queried 
with the CTD HMM, and the conserved CTD cysteines in the DNA sequence of the 
HMM hit were located by eye. The domain boundary was defined as 50 residues 
upstream of the first conserved cysteine, and the NTD type was defined as 
‘unknown’. The ‘VSG translation’ (see section 4.5.4) of these NTDs was simply 
the frame 1 translation. 
2.1.2.3 Annotation of NTDs in VSG pseudogenes 
Windows containing likely NTD sequence were located in contigs longer than 
10 kb using SVM-VSG, as for the concatenated ORFs; and windows containing 
assembly gaps were excluded. Translations were produced for the window 
sequences in all three frames, then the translations were queried with the NTD 
A-type and B-type HMMs using hmmsearch. The results were parsed using the 
script hmmer_3frames.pl (parameters: eval=0.001, length=40, length2=300, 
met_range=20, dis_limit=50, max_overlap=200). Windows in which an NTD could 
not be annotated using HMMer were used in BLASTX to query a protein BLAST 
database generated with makeblastdb using NTDs from the appropriate genome 
that had been annotated with HMMer and from full-length genes. The results 
were parsed using the script blastx_hits.pl (parameters: id_cut=40, len_cut=40, 
len2=900, dist_limit=100, met_range=20, max_overlap=200).  Both 
hmmer_3frames.pl and blastx_hits.pl output a predicted ‘VSG translation’ for 
each NTD based on the region of each translation frame used to annotate the 
NTD. 
2.1.3 Sequence comparisons and analyses 
2.1.3.1 Phylogenetic analysis 
The chromosomes were concatenated for each strain and all ten possible 
pairings of the full genomes were aligned using MUMmer (version 3.23) to find 
maximal unique matches (MUMs), using the script make_coords_tbrucei.sh, 
which was based on a script provided by Dr Nick Dickens. Using the script 
mums2distance_tbrucei.pl, also based on a script provided by Dr Nick Dickens, a 
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distance matrix was constructed for each genome pair A and B using the formula 
–log(((fraction of genome A covered by MUMs to genome B) + (fraction of genome 
B covered by MUMs to genome A))/(length of A + length of B)). A neighbour-
joining tree was generated using BIONJ and visualised in Dendroscope. 
2.1.3.2 Global SNP annotation 
Putative SNPs were called from the mapped .bam files using SAMTools. The 
command samtools mpileup was used to parse the .bam file to extract 
information on base and mapping quality and compute SNP likelihoods, with 
filters for base quality and downgrading of reads containing excessive 
mismatches (command line: ‘samtools mpileup -g -Q 23 -C 10 -f <.fasta file> 
<.bam file>), which generated a raw .bcf file. This was followed by calling SNPs 
and filtering using bcftools view and vcfutils varFilter from the SAMTools 
package (commands: ‘bcftools view -bcgv <raw.bcf>’; ‘bcftools view 
<unfiltered.bcf> | vcfutils.pl varFilter -D 300). The resulting .vcf file was 
filtered further for minimum and maximum depth and to remove SNPs with 
multiple alternative alleles using the script vcf_filter.pl (parameters: 
dp4_min=10, dp4_max=200). Plots of SNPs for each contig for each set of 
mapped reads were generated with the script snps_plot.pl. Finally, the script 
compare_snps.pl was used to find positions in the contig where a SNP had been 
called using one set of mapped reads, but not the other, to check that the 
position had sufficient coverage with both sets for a SNP to be called, and to 
generate a plot of the resulting EATRO 3-EATRO 2340 SNPs. 
2.1.3.3 Identification of gene pairs 
Initial pairings were made by querying a nucleotide BLAST database of the 
contigs from one genome (Genome A), with the NTDs annotated from the other 
genome (Genome B), using BLASTX. The best hit or set of hits was identified 
based on score, length and pairwise identity, using the script find_homologues.pl 
(parameters: dis_limit=400, max_overlap=200). The sequence of the best hit was 
extracted from Genome A using hits_for_reblast.pl, with any gaps represented 
by a single ‘N’, and was used to query a database Genome B. The script 
reciprocal_blast.pl (reciprocal_blast_anygene.pl for core genes) was used to 
check whether the best hit for these sequences was the gene in Genome B that 
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hit them in the first step; if not, the gene in Genome B was excluded from the 
analysis. 
Genes with a hit with at least 95% identity and 95% coverage were extracted 
from the results. For the core genes, because only EATRO 2340 queries were 
used, the gene partner was simply taken as the best hit in EATRO 3 (if any met 
the identity and coverage thresholds), translations were those of frame 1, and 
no further processing was carried out. For the VSG NTDs, instances where the 
high-identity hit corresponded to a previously annotated NTD were identified for 
each set of NTD queries using the script find_shared_orfs.pl, and the reciprocity 
of gene pairings was checked with check_pairings.pl, and any that were not 
reciprocal pairs were manually checked. The scripts orf_covered_part.pl and 
full_orf_hit.pl were used to find if there was any sequence at the end of the 
query gene that was not matched to any sequence in the hit, and then to extend 
the co-ordinates of the ‘hits’ to compensate for this; for example, if a hit 
covered positions 5-1000 of an NTD that was 1005 bp long, the hit was extended 
by 4 bp at the start and 5 bp at the end. For ‘hits’ that comprised several BLAST 
high-scoring segment pairs (HSP), this process was done manually. Finally, to 
annotate new genes from the BLAST hits, the sequences of hits that did not 
correspond to previously annotated NTDs were extracted and their co-ordinates 
noted. Hits containing internal gaps were excluded and hits beginning or 
terminating in gaps were cropped to remove the gap, and the co-ordinates 
adjusted accordingly using the scripts seqs_without_ns.pl, trim_off_ns.pl and 
fix_ns_coords.pl. To predict ‘VSG translations’, the new genes were used in 
BLASTX to query a BLASTP database constructed from all the NTDs annotated 
previous to this step. The BLASTX hits were filtered so that each new NTD only 
had hits to the gene that had been used to annotate it originally, then the script 
blastx_hits_rehits.pl was used to predict the VSG translations based on which 
frames the BLASTX hits were in. 
2.1.3.4 SNP cataloguing and processing 
For ease of data handling and analysis, a set of Perl object classes was created. 
The packages containing methods used by these classes are contained in 
Appendix E1 as the files <class name>.pm. The class ORFPair handled paired-up 
sequences, containing information like the co-ordinates and sequence of each 
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partner and their pairwise identity (and used the class ORFs, which contained 
simple details of the origin and co-ordinates of each NTD). ORFPair objects were 
generated from paired NTDs by the script seq_pair_object.pl. The script 
align_orfpairs.pl then worked on these objects to produce a pairwise alignment 
with ClustalW2 (non-default parameter: -pwgapopen=4). Alignments of gene 
pairs where the hit had been pieced together from multiple adjacent hits were 
manually inspected, and if necessary corrected using Jalview. For core genes, 
the alignments were not manually checked, and the script cds_alns.pl was used 
to generate ORFPair objects from paired sequences. 
For cataloguing SNPs, the classes Singlediffs, Plotdiffs and Changes were used, 
for raw and confirmed SNPs respectively. For Method 1 (data not used for final 
analysis), SNPs were catalogued with the scripts orfs_alns.pl (to find differences 
in the alignments, to make Singlediffs objects), check_snps.pl (to check whether 
either position already had a SNP called in the SNP plot), and class_snps.pl (to 
make Changes objects), using SNP plots generated as described in section 
2.1.3.2. For Method 2, snps_from_plots.pl found SNPs in the gene in either 
genome using the SNP plots; singlediffs_from_plots.pl discarded SNPs where 
there was a SNP at the same position in the alignment in both genomes, and 
generated Plotdiffs objects; and class_snps_fromplots.pl made Changes objects. 
The objects and classes described above were used for the SNP analysis. 
Substitution type and strand bias were examined using the scripts class_subs.pl, 
and composition.pl. The effect on predicted protein sequence was examined 
with the script synon_subs_sitetypes.pl and the numbers of each type of site 
(synonymous/non-synonymous) were counted with synon_sites.pl and 
synon_sites_sepgenomes.pl. The distribution of SNPs was examined with 
sub_pos.pl and sub_relative2cys.pl. Clustering was examined with Permute III, 
provided by Prof Dan Haydon, which uses random permutation to find windows 
with significantly higher or lower numbers of events than expected, with window 
sizes of 10 and then 30-600 bp at 30 bp intervals, using 1000 permutations with a 
confidence level of 0.01. Secondary structure prediction was carried out with 
the Jpred 3 server, and the structures extracted from the output with 
jpred_parse.pl. Statistical analyses were carried out in R using the MASS library. 
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2.1.3.5 Archive analyses 
The class NTDs was created to handle and access attributes of the NTDs, 
including their sequences, locations, pseudogene status, method of annotation 
and which regions were used to make the translation. NTDs objects were 
created with the scripts ntds_objects.pl and ntds_objects2.pl. The functionality 
of each NTD was predicted with the script functional_genes.pl, with CTD 
positions used from the SVM predictions. NTDs predicted to be intact were 
tested for signal sequences using SignalP with the settings ‘eukaryote’ and ‘do 
not include TM regions’. 
For analysis of subfamilies, a BLAST protein database was generated from 
predicted VSG translations and queried with the same sequences using default 
settings. Pairs with higher identity than 50% were identified, aligned and 
grouped into subfamilies with the script families.pl. 
2.1.4 Other programs 
Searches with BLAST were carried out with programs from the command line 
suite BLAST 2.2.25+. Common subroutines for custom Perl scripts are given in 
the file SequenceHandling.pm in Appendix E1. The BioPerl version used was 
BioPerl-1.6.901. The R version was R 2.15.1 GUI; models were fitted with glm 
(for Poisson distributions) and glm.nb from the library MASS (for negative 
binomial distributions). 
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2.1.5 Glossary of software 
Program Full name Function (in this work) Reference 
ABACAS 
Algorithm-
Based 
Automatic 
Contiguation of 
Assembled 
Sequences 
Aligns de novo assembled contigs to 
reference genome Assefa et al, 2009 
ACT 
Artemis 
Comparison 
Tool 
Tool for viewing pairwise 
comparisons of DNA sequences Carver et al, 2005 
Artemis - Sequence and annotation viewing tool Rutherford et al, 2000 
BAMview 
Binary 
Alignment/Map 
viewer 
Viewing of BAM files in Artemis Carver et al, 2010 
BIONJ - Generates neighbour-joining phylogenetic trees Gascuel, 1997 
BioPerl - Perl code modules for biology Stajich et al, 2002 
BLAST 
Basic Local 
Alignment 
Search Tool 
Aligning sequences and finding 
homologues 
Altschul et al, 1990; 
Camacho et al, 2009 
BWA 
Burrows-
Wheeler 
Aligner 
Mapping of Illumina reads to 
assembled genome Li & Durbin, 2009 
Celera 
Assembler - 
De novo assembler of short 
sequencing reads 
http://sourceforge.net/ap
ps/mediawiki/wgs-
assembler/index.php?titl
e=Main_Page 
Clustalw1.8 - Aligning sequences (version built into BioPerl) Thompson et al, 1994 
clustalw2 - Aligning sequence; this version used unless version 1.8 is specified Larkin et al, 2007 
Dendroscope - Tree viewer Huson & Scornavacca, 2012 
HMMer - 
Searches sequences for 
homologues using hidden Markov 
models 
Eddy, 2011 
IMAGE 
Iterative 
Mapping and 
Assembly for 
Gap 
Elimination 
Targeted reassembly of sequencing 
reads to fill gaps in assembly Tsai et al, 2010 
Jalview - Alignment viewing and editing Waterhouse et al, 2009 
Jpred 3 - Prediction of secondary structure from amino acid sequences Cole et al, 2008 
MUMmer 
Maximal 
Unique 
Matcher 
Sequence aligner Kurtz et al, 2004 
Newbler - De novo assembler of 454 sequencing reads 
http://www.454.com/prod
ucts/analysis-
software/index.asp 
RATT 
Rapid 
Annotation 
Transfer Tool 
Automatic transferral of annotations 
from reference genome Otto et al, 2011 
Table 2-1 – Glossary of software used in the project. 
Continued on next page. 
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Program Full name Function (in this work) Reference 
SAMTools 
Sequence 
Alignment/Map 
Tools 
Processing of BWA output, SNP 
calling and filtering Li et al, 2009 
SGA String Graph Assembler 
Trimming of poor-quality bases from 
ends of Illumina reads Simpson & Durbin, 2012 
SignalP - Predicts signal peptide (cleavage sites) in amino acid sequences Petersen et al, 2011 
Velvet 
Columbus - 
Short sequencing read assembly 
using reference genome as a guide, 
followed by de novo assembly of 
reads that don't assemble to 
reference 
Zerbino & Birney, 2008; 
http://www.ebi.ac.uk/~zer
bino/velvet/Columbus_m
anual.pdf 
SVM-VSG 
Support Vector 
Machine for 
VSG 
Identification of sequence likely to 
contain VSG, by support vector 
machine learning 
Jon Wilkes, unpublished 
Table 2-1 continued. 
 
2.2 Molecular biology methods 
All procedures were carried out at room temperature (approximately 25ºC) 
unless otherwise specified. 
2.2.1 High-throughput sequencing 
Purified DNA was prepared for sequencing by standard library methods, or by a 
PCR-free approach (Kozarewa et al, 2009), as indicated in Table 2-2. Sequence 
sets 5-7, 13 and 14 (see Table 3-1) were generated by Illumina sequencing, and 
sequence sets 15 and 16 were generated by 454 Titanium sequencing, both at 
the Sanger Institute (collaboration, Dr Matt Berriman). Sequence sets 1-3, and 8-
11 were generated by 454 Titanium sequencing at the University of Liverpool; 
and sequence sets 4 and 12 were generated by 454 Titanium sequencing at the 
University of Nottingham (collaboration, Prof Ed Louis). 
2.2.2 Growth and manipulation of trypanosomes 
2.2.2.1 Trypanosome strains 
For in vitro analysis of pol κ, BSF Lister 427 90:13 was used (Wirtz et al, 1999). 
EATRO 3 was grown in mice from a stabilate of the original ETat 1.2 clone, 
derived from the original EATRO 3 isolate by 32 passages, mainly through mice 
(McNeillage et al, 1969; Lumsden & Herbert, 1975; in both of these papers ETat 
1.2 is referred to as ETat 2). EATRO 2340 was grown from a stabilate of a clonal, 
fly-passaged line derived from the original EATRO 2340 isolate, stock F described 
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by Barry and colleagues (Barry et al, 1983); the stabilate was first inoculated 
into an immunosuppressed mouse, then passaged into a second mouse, then 
extracted into procyclic form culture. 
2.2.2.2 In vitro trypanosome culture 
BSF Lister 427 90:13 parasites and their derivatives were grown in HMI-9 growth 
medium (Hirumi & Hirumi, 1989) supplemented with 20% (v/v) heat-inactivated 
foetal calf serum (FCS, Sigma) and 1% (v/v) penicillin/streptomycin mix (Sigma), 
in a humidified 5% CO2 incubator at 37ºC. Cell lines were maintained in 2 ml 
cultures in 24-well tissue culture plates, and were passaged three times a week 
by transferring 20 µl culture into fresh media. Drugs used were phleomycin (2 
µg/ml), neomycin (2.5 µg/ml), hygromycin (5 µg/ml) and tetracycline (2 µg/ml). 
Lister 427 90:13 required neomycin and hygromycin for maintenance, 
phleomycin was used as the selective drug for parasites transfected with 
overexpression constructs, and tetracycline was used to induce overexpression. 
2.2.2.3 Parasite density and growth curves 
Parasite density in cultures was estimated using an Improved Neubauer 
haemocytometer (Hawksley) by taking a 10 µl sample, counting the number of 
cells in several 1 mm2 fields (0.1 µl volume) culture and calculating the mean 
number of cells/ml in the fields. If the number of cells was low, the mean of 
four fields was used, otherwise the mean of two was used. For growth curves, 
parasites were counted then diluted to approximately 2×105 cells/ml in 4 ml 
cultures in 6-well tissue culture plates. If necessary, appropriate volumes of 
tetracycline (5 mg/ml in 50% ethanol) and/or hydrogen peroxide (3% solution in 
sterile, deionised water (dH2O)) were added. 
2.2.2.4 Growth of trypanosomes in mice 
This work was carried out by Alana Hamilton. ICR mice (Charles River) were 
immunosuppressed by intraperitoneal injection of 200 µl of 31.25 mg/ml 
cyclophosphamide solution, 24 h before inoculation with parasites. Parasites 
were prepared for injection by placing a blood straw into 250 µl CBSS (0.023 M 
HEPES, pH 7.4, 0.12 M NaCl, 5.41 mM KCl, 0.4 mM MgSO4, 5.6 mM Na2PO4, 0.035 
M glucose, 0.05 mM phenol red) containing 10000 U/l heparin, and the whole 
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volume of CBSS/blood mixture was injected into one mouse. After 3 days, the 
mice were euthanised and infected blood from each mouse was harvested by 
cardiac puncture into 200 µl CBSS with 10000 U/l heparin. 
2.2.2.5 Transfection of trypanosomes 
Parasite transfections were carried out using the Amaxa Nucleofector apparatus 
(Lonza). Approximately 3×107 BSF parasites were harvested by centrifugation at 
460×g for 10 min and resuspended in 100 ml Amaxa T-cell solution (Lonza) at 
4ºC. Linearised plasmid DNA dissolved in dH2O (10 µg DNA in a maximum volume 
of 15 µl) was added to a cuvette, followed by the resuspended cells, and the 
parasites were transfected using program X-001. The transfected cells were 
immediately transferred to 30 ml HMI-9 containing drugs appropriate to growth 
of the parental strain (but not the selective drug) and mixed. Three ml of this 
resuspension was transferred to 27 ml HMI-9 containing parental strain drugs. 
The contents of each tube was aliquoted into a 24-well tissue culture plate, 1 ml 
per well. The plates were incubated at 37ºC for 18 h. Media was prepared by 
supplementing HMI-9 with the parental strain drugs, and the selective drug at 
twice its required concentration. One ml of this was added to each well of 
transfected cells. Plates were inspected for growth of transfectants after 5 days. 
Transfectants were transferred to culture plates and cultured as normal. 
2.2.2.6 Isolation of genomic DNA from trypanosomes 
For small amounts of genomic DNA, the DNeasy Blood and Tissue kit (Qiagen) 
was used. For BSF parasites grown in culture, approximately 5×106 cells were 
harvested by centrifugation at 460×g for 10 min and washed twice with 1 ml ice-
cold, filter-sterilised phosphate-buffered saline (cfPBS). The cells were 
resuspended in 200 µl PBS and processed according to the manufacturer’s 
protocol for animal blood or cells. To extract DNA from parasites grown in mice, 
aliquots of blood from infected mice extracted into anticoagulant were 
centrifuged at 1620×g for 10 min at 25ºC, which separated the blood into several 
layers, with the trypanosomes present in the ‘buffy coat’ layer on top of lysed 
blood cells. The buffy coat was transferred to a new Eppendorf tube and 
resuspended in 200 µl PBS per 200 µl original sample, then processed according 
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to the manufacturer’s protocol for animal blood or cells using one column for 
each 200 µl resuspended cells. 
2.2.3 Basic laboratory procedures 
2.2.3.1 Polymerase chain reaction (PCR) 
For routine PCRs, Taq DNA polymerase (New England Biolabs, NEB) was used. 
Reactions contained template, 0.1 mM each deoxyribonucleotide triphosphate 
(dNTP), 0.5 µM each primer, 1X Thermopol buffer (supplied with enzyme) and 
0.5 U Taq enzyme in a total volume of 20 µl, made up with dH2O. Template was 
either approximately 10 ng genomic DNA, 1 ng plasmid DNA, or an Escherichia 
coli colony picked from a plate and resuspended in 20 µl dH2O, in which case 
5 µl of the resuspension was used. Standard cycling conditions were 5 min at 
95ºC, followed by 30 cycles of 30 s at 95ºC, 30 s at the annealing temperature 
(Table 2-2) and 1 min/kb of product at 72ºC, followed by a final extension step 
of 5 min at 72ºC. 
For PCRs where maximum accuracy was required (in production of vectors that 
would be expressed in E. coli or in T. brucei, and for amplification of VSG genes 
for sequencing), a proof-reading polymerase was used, either Herculase II Fusion 
DNA polymerase (Agilent Technologies) or Phusion High-Fidelity DNA polymerase 
(NEB) if amplification with Herculase was unsuccessful. Herculase reactions 
contained 10 ng plasmid DNA or 160 ng genomic DNA, 1 mM each dNTP, 0.25 µM 
each primer, 1X Herculase reaction buffer (supplied with enzyme) and 1 µl 
Herculase enzyme (from kit, catalogue #600675, concentration not available) in 
a total volume of 50 µl, made up with dH2O. Standard cycling conditions for 
Herculase were 5 min at 95ºC, followed by 30 cycles of 15 s at 95ºC, 30 s at the 
annealing temperature (Table 2-2) and 30 s/kb of product at 72ºC, followed by a 
final extension step of 5 min at 72ºC. Phusion reactions contained 10 ng plasmid 
DNA, 1 mM each dNTP, 0.5 µM each primer, 1X Phusion HF reaction buffer 
(supplied with enzyme) and 1 U Phusion enzyme in a total volume of 50 µl, made 
up with dH2O. Standard cycling conditions for Phusion were 30 s at 98ºC, 
followed by 30 cycles of 10 s at 98ºC, 30 s at the annealing temperature (Table 
2-2) and 30 s/kb of product at 72ºC, followed by a final extension step of 10 min 
at 72ºC. 
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All oligonucleotides were synthesised by Eurofins MWG Operon, and sequences 
are given in Table 2-2. 
2.2.3.2 Agarose gel electrophoresis and gel extraction 
DNA separation was usually performed by electrophoresis in gels consisting of 1% 
(w/v) agarose in 1X Tris-acetate-EDTA (TAE) buffer (40 mM Tris pH 8.0, 19 mM 
acetic acid, 1 mM ethylenediaminetetraacetic acid (EDTA)) with 1X SYBR-Safe 
DNA gel stain (Invitrogen). Loading buffer (0.25% bromophenol blue, 40% sucrose 
in dH2O) was added to DNA samples (1 volume buffer to 9 volumes sample) 
before loading on to the gel. Gels were run at 100 V in 1X TAE buffer, typically 
for 40 min. DNA size standards (1 kb Plus DNA ladder, Invitrogen) were resolved 
alongside sample DNA. Stained DNA in the gels was visualised in a GelDoc, and 
images captured with Quantity One software (BioRad). Apparatus was supplied 
by BioRad. 
Where required, DNA bands were excised from the gel using a sterile scalpel 
blade. DNA was extracted from the excised agarose using a Qiaquick Gel 
Extraction kit (Qiagen), according to the manufacturer’s instructions. DNA was 
quantified using a Nanodrop 1000 spectrophotometer (Nanodrop). 
2.2.3.3 Restriction digests 
Enzymes and buffers for restriction digests were supplied by NEB. Reactions 
were carried out with approximately 10 units of enzyme per 1 µg DNA, and 
incubated at 37ºC for 1 h (diagnostic digests), 3 h (preparation of DNA for 
ligation) or overnight (linearisation of DNA for transfection into parasites). 
2.2.3.4 Transformation and growth of E. coli 
Where home-made competent cells were used (see section 2.2.3.5), 
approximately 10 ng of purified plasmid or 10 µl ligation (see section 2.2.3.6) 
were added to 100 µl competent cells. The cells were incubated on ice for 5-10 
min then heat-shocked at 42ºC for 45 s and returned to ice to 10-15 min. Next, 
250 µl SOC (20 g/l tryptone, 5 g/l yeast extract, 0.5 g/l NaCl, 10 mM MgCl2, 10 
mM MgSO4 and 20 mM glucose) was added and the transformations were 
incubated for 1 h at 37ºC with shaking. The transformations were then spread on 
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LB agar plates containing the appropriate antibiotics and incubated at 37ºC 
overnight. For transformations with ligations, typically 200 µl of transformation 
per plate was used; for transformations with purified plasmid, typically 20 µl per 
plate was used. For transformation using commercial competent cells, 
transformation was carried out according to the manufacturer’s instructions. 
Colonies that grew were picked from plates, if necessary checked by colony PCR, 
and then used to inoculate 5 ml of LB with appropriate antibiotics, which was 
then incubated overnight at 37ºC with shaking. 
Stabilates were optionally prepared from overnight cultures by adding 500 µl 
culture to 1 ml 2% tryptone, 40% glycerol in dH2O. Plasmids were purified from 
overnight cultures using the Qiaprep Spin Miniprep kit (Qiagen). All sequencing 
was done using plasmids prepared from transformed E. coli by overnight culture 
and miniprep, by Eurofins MWG Operon. 
2.2.3.5 Preparation of competent cells 
A colony was picked from a fresh overnight plate of the relevant strain and used 
to inoculate 100 ml LB in a 500 ml flask, then incubated at 37ºC with shaking 
until the culture reached an OD600 of 0.35. Next, 50 ml of this culture was cooled 
on ice then centrifuged at 2100×g for 20 min at 4ºC. The supernatant was 
discarded and the cells drained, then resuspended in 30 ml ice-cold filtered 80 
mM MgCl2, 20 mM CaCl2 in dH2O, centrifuged as before, resuspended in 2 ml ice-
cold filtered 0.1 M CaCl2 in dH2O and used directly for transformation. 
2.2.3.6 Cloning 
Gel-purified PCR product (insert) and miniprep of plasmid DNA (vector) were 
treated with the appropriate restriction enzymes. Enzyme was removed from 
digested insert using Qiaquick PCR purification kit (Qiagen), and the appropriate 
part of the digested vector was isolated and purified by gel extraction. A 
standard ligation reaction used approximately 150 ng of insert and a 5:1 
insert:vector molar ratio with 400 U T4 DNA ligase (NEB) in the supplied reaction 
buffer, in a volume of 20 µl, for 3-4 h at 25ºC. 
PCR products for sequencing were cloned into pCR4-TOPO using the TOPO TA 
Cloning Kit for sequencing (Invitrogen). PCR products of the correct size were 
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purified by gel extraction and A-tailed: 8.7 µl of gel-extracted PCR product 
(approximately 200 ng DNA) was incubated in 1X Thermopol buffer (NEB), 0.5 U 
Taq enzyme and 0.2 mM each dNTP in a total volume of 10 µl for 20 min at 72ºC. 
4 µl of the A-tailing reaction was used directly for the ligation reaction and then 
this was transformed into One Shot TOP10 competent cells, both according to 
the manufacturers’ instructions. 
2.2.3.7 Protein electrophoresis 
Protein separation was performed by polyacrylamide gel electrophoresis (PAGE) 
in NuPAGE Novex 10% Bis-Tris polyacrylamide gels (Invitrogen). Protein samples 
were prepared by adding NuPAGE LDS Sample Buffer (Invitrogen) to 1X 
concentration, and heating at 100ºC, 10 min. Gels were run at 200 V in 1X MOPS 
SDS running buffer (Invitrogen). Apparatus was supplied by Invitrogen. To 
visualise protein, gels were stained with Coomassie stain solution (2.5 g/l 
Coomassie brilliant blue R (Sigma) in 45% methanol, 45% dH2O, 10% glacial acetic 
acid, (v/v)) for 1.5 to 3 h, then washed overnight in destaining solution (10% 
glacial acetic acid, 40% methanol, 50% dH2O). To produce figures, gels were 
dried in a gel dryer (BioRad) and scanned. 
2.2.3.8 Western blotting 
Proteins were transferred from polyacrylamide gels to Hybond ECL nitrocellulose 
membrane (Amersham) using Xcell blotting apparatus (Invitrogen). Gel, 
membrane, filter paper and sponges were equilibrated in 1X NuPAGE transfer 
buffer (Invitrogen) before being assembled in the apparatus according to the 
manufacturer’s instructions. Transfer was carried out at 30 V for 1 h. 
2.2.3.9 Probing of western blots 
Nitrocellulose membranes to which protein had been transferred were incubated 
in blocking buffer (5% milk powder (w/v, Marvel), 0.1% Tween 20 in PBS) 
overnight at 4ºC. Membranes were rinsed in PBS-T (0.1% Tween 20 in PBS), then 
incubated for 1 h in blocking buffer containing the primary antibody. The 
primary antibodies used were rabbit polyclonal anti-GFP (Abcam), used at a 
dilution of 1:1000; and mouse monoclonal anti-MYC (Sigma), used at a dilution of 
1:7000. The membranes were washed in PBS-T for 15 minutes followed by two 
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five-minute washes, then incubated for 1 h in blocking buffer containing goat 
anti-rabbit or anti-mouse antibody conjugated to horseradish peroxidase 
(Molecular Probes) at a dilution of 1:5000. Membranes were washed three times 
in PBS-T as before. SuperSignal West Pico Chemiluminescent Substrate (Pierce) 
was applied to the membrane (2 ml per blot) and incubated for five minutes and 
placing the membrane in the dark. Signal from the reaction was detected by 
exposing the membrane to X-ray film (Kodak) for 5 s to 4 h. X-ray films were 
developed in a Kodak M35M Xomat processor. 
2.2.3.10 Site-directed mutagenesis 
Site-directed mutagenesis of pol κ was carried out with the QuikChange II XL 
mutagenesis kit (Agilent Technologies). The reactions were carried out according 
to the manufacturer’s instructions, using 10 ng plasmid DNA as a template. The 
mutant strand synthesis reaction conditions were 1 min at 95ºC followed by 18 
cycles of 50 s at 95ºC, 50 s at 60ºC and 8.5 min at 68ºC, then a final extension 
step of 7 min at 68ºC. Mutants were screened by sequencing with P74, P78, T7 
and T7term. 
2.2.4 Protein production and purification 
2.2.4.1 Production of recombinant protein in E. coli 
A glycerol stock of Rosetta2 E. coli cells that had been transformed with pMAL-
K10 or pMAL-K001 was used to inoculate 10 ml LB containing 34 µg/ml 
chloramphenicol and 100 µg/ml ampicillin, and grown at 37ºC overnight. This 
overnight culture was used to inoculate 50-200 ml LB supplemented with 2 g/l 
glucose and containing 34 µg/ml chloramphenicol and 100 µg/ml ampicillin, 
using 1 ml overnight culture per 100 ml LB. The new culture was incubated at 
37ºC until the culture gave an absorbance at 600 nm of approximately 0.5 U, 
usually around 3 h. Expression of the fusion protein was induced by adding 
isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration of 0.3 mM. 
The culture was grown at 37ºC for 2 h, or at 15ºC overnight, or at 30ºC for 4 h, 
then cells were harvested by centrifugation at 2100×g for 20 min at 4ºC. 
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2.2.4.2 Amylose affinity chromatography 
Harvested cells were resuspended in 40 ml column buffer (20 mM Tris, pH 7.5, 
200 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol (DTT)) per 1 l original culture and 
frozen at least overnight at -20ºC. The cell suspension was then thawed on ice 
and sonicated on ice with 6 cycles of 16 s on followed by 10 s off. Insoluble 
material was removed by centrifugation at 3275×g for 30 min. The soluble 
material was retained and diluted 1:5 in column buffer. 
Purification columns were prepared by placing a filter into a 2.5×10 cm plastic 
column (Pierce), pouring 10 ml amylose resin (NEB) per 1 l original cell culture 
(usually 4 ml) and placing a second filter on top of the resin. The resin was 
equilibrated by washing with 8 column volumes (CV) of column buffer. Cell 
lysate was loaded onto the column, then washed with at least 15 CV column 
buffer plus 0.1 mM maltose. Fusion protein was eluted from the column with 
column buffer plus 10 mM maltose. If only one round of purification was carried 
out, eluted protein was collected as 10×1 ml fractions and one 5 ml fraction. If a 
second round was to be carried out, the protein was eluted in 4 CV and the 
maltose was removed as far as possible by reducing the eluate volume to 
approximately 500 µl in a Vivaspin 20 centrifugal concentrator with a 30 kDa 
molecular weight cut-off (Sartorius), then making up to 20 ml with column 
buffer (no maltose). The volume reduction was repeated twice more, making the 
volume up to 50 ml after the final reduction. The amylose column was 
regenerated according to the manufacturer’s protocol, with 3 CV dH2O, 3 CV 
0.1% sodium dodecyl sulphate (SDS), 2 CV dH2O and 3 CV column buffer. 
For a second round of purification, the regenerated column was equilibrated 
with 20 ml column buffer and the first-round eluate loaded on to it, washed as 
before, eluted with column buffer plus 10 mM maltose and collected as 10×1 ml 
fractions and one 5 ml fraction. The concentration of protein was determined 
with a Nanodrop 1000 spectrophotometer (Nanodrop). Fractions containing 
protein were pooled and concentrated as far as possible with a Vivaspin 20 
centrifugal concentrator with a 30 kDa molecular weight cut-off. 
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2.2.4.3 Inclusion body purification 
MBP-polκ protein was produced in a 200 ml culture by induction at 37ºC and 
harvested by centrifugation as described. The supernatant was removed and the 
mass of the cell pellet determined, and the pellet was resuspended in 3 ml cell 
lysis buffer I (50 mM Tris-Cl, pH 8.0, 1 mM EDTA, 100 mM NaCl) per 1 g of pellet. 
Protease inhibitor cocktail (20X stock made by dissolving one tablet of Complete 
EDTA protease inhibitor (Roche) in 2 ml dH2O) was added to 1X concentration, 
followed by 80 µl of 10 mg/ml lysozyme (Sigma) per 1 g of pellet, and the 
suspension was stirred for 20 min at 4ºC. The lysate was then transferred to 37ºC 
and stirred occasionally until it became viscous. To digest DNA, approximately 
2.5 U DNase I (amplification grade, Invitrogen) was added per 1 g pellet, and the 
lysate was stirred at 25ºC until it was no longer viscous. 
The lysate was centrifuged at 21000×g for 15 min at 4ºC to pellet insoluble 
material. The supernatant was removed and the pellet was resuspended in 9 
volumes of cell lysis buffer II (50 mM Tris-Cl pH 8.0, 10 mM EDTA, 100 mM NaCl, 
0.5% Triton X-100, 5 mM DTT), and incubated at 25ºC for 5 min. The suspension 
was centrifuged, resuspended and centrifuged as before, and the supernatant 
was removed. The pellet was resuspended in 9 volumes 50 mM Tris, pH 8.0, 
10 mM EDTA and transferred to a tube of known weight, then centrifuged as 
before. The supernatant was removed and the pellet dried as completely as 
possible, then the weight of the inclusion body was determined and it was stored 
at -70ºC. 
2.2.4.4 Inclusion body solubilisation and refolding 
Inclusion bodies were solubilised by resuspending in a small volume of 50 mM 
Tris pH 8.0, then adding appropriate volumes of the other components of the 
solubilisation buffer (7 M guanidine hydrochloride (Pierce), 50 mM Tris pH 8.0, 
5 mM DTT), using a total of 1 ml solubilisation buffer per 40 mg inclusion body, 
then incubating overnight at 4ºC. The solubilised protein was then centrifuged at 
21000×g for 15 min at 4ºC to pellet any remaining insoluble matter, and the 
supernatant retained. This yielded a protein solution of approximately 
20 mg/ml. For low protein concentration refolding experiments, a 1 mg/ml 
solution was prepared by dilution in solubilisation buffer. 
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For each refolding condition, 950 µl of a 1.1X refolding buffer was prepared at 
4ºC. Solubilised protein was added as 5×10 µl aliquots, with mixing by pipetting 
between each addition. When all 50 µl had been added, the solutions were 
vortexed then incubated at 4ºC for 18-24 h. After this time, the solutions were 
centrifuged at 21000×g for 15 min at 4ºC to pellet any aggregated protein. To 
remove chaotropic agents that might be artificially keeping unfolded protein in 
solution, and would interfere with downstream analyses, 100 µl of each refolding 
reaction was dialysed into column buffer using Slide-a-Lyzer mini dialysis cups 
(Pierce), for 2 h at 4ºC in 1 l buffer per 8 cups. Dialysed refolded protein was 
stored at 4ºC. 
2.2.5 Assays 
2.2.5.1 Growth of M13 bacteriophage 
To produce M13mp18 double-stranded DNA (dsDNA), 0.02 ng M13mp18 RF1 DNA 
(NEB) or the product of the gap-filling assay was used to transform MAX 
Efficiency DH5αF′IQ competent cells (Invitrogen), according to the 
manufacturer’s instructions, except that the volumes of competent cells and 
SOC media used were reduced to one-quarter of that specified. After 
transformation, 200 µl transformed cells were added to 3 ml aliquots of 2X YT 
(16 g/l tryptone, 10 g/l yeast extract, 5 g/l NaCl) top agar (7 g/l agar) at 45ºC 
containing 0.03% 5-bromo-4-chloro-indolyl-β-D-galactopyranoside (X-Gal) and 
3.3mM IPTG, followed by 100 µl DH5αF'IQ lawn cells (Invitrogen). The top agar 
was poured on top of 2X YT agar plates (15 g/l agar) and the plate incubated at 
37ºC overnight. 
To grow larger amounts of M13mp18 dsDNA, DH5αF'IQ lawn cells were grown 
overnight in 2X YT broth, and 5 ml of this culture was used to inoculate 500 ml 
2X YT broth. A blue plaque was picked from a plate containing cells transformed 
with M13mp18 and added to this broth, and the culture was grown at 37ºC 
overnight. The cells were harvested by centrifugation at 2100×g for 20 min at 
4ºC, and M13mp18 dsDNA was extracted using a Genelute HP maxiprep kit 
(Sigma), according to the manufacturer’s instructions, using two columns. 
Smaller amounts were produced by inoculating a 6 h culture of lawn cells grown 
in LB with cells picked from a white plaque, incubating the culture at 37ºC 
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overnight and extracting M13mp18 dsDNA using a Qiaprep Spin Miniprep kit 
(Qiagen). 
2.2.5.2 Construction of gapped M13 DNA substrate 
To construct the template for the gap-filling assay (Bebenek & Kunkel, 1995), 
M13mp18 double-stranded DNA was digested to completion with KasI and PvuI, 
giving two restriction fragments of 407 bp and 6848 bp. The 6848 bp fragment 
was purified by agarose gel electrophoresis and gel extraction, followed by 
dilution of the DNA 1:10 in dH2O to decrease the salt concentration as far as 
possible. The DNA was heated at 70ºC for 5 min to denature strands. This low 
temperature, low salt concentration denaturation temperature was developed 
and validated in the original paper (Bebenek & Kunkel, 1995), and was used to 
avoid heat-induced DNA damage to the substrate. Next, sufficient M13mp18 
single-stranded circular DNA (NEB) was added to produce a 1:1 molar ratio of 
minus strand, 6848-bp fragment to circular DNA. The hybridisation reaction was 
incubated on ice for 5 min, then 20X saline-sodium citrate buffer (SSC, 3 M NaCl, 
300 mM sodium citrate) was added to a final concentration of 2X SSC. The 
reaction was heated at 60ºC for 5 min then placed on ice. The hybridised DNA 
was cleaned up using a QiaQuick PCR purification kit (Qiagen), and analysed by 
agarose gel electrophoresis to check the size of the product. 
2.2.5.3 Gap-filling assay 
The reaction conditions for the gap-filling reaction were 50 mM NaCl, 10 mM 
Tris-HCl, pH 7.9, 10 mM MgCl2, 1 mM DTT, 200 µg/ml BSA, approximately 300 ng 
of polymerase and approximately 40 ng of gapped substrate, in a total volume of 
25 µl. Reactions were incubated at 37ºC for 2 to 3 h, then stopped by the 
addition of EDTA to a final concentration of 15 mM. Agarose gel electrophoresis 
was used to analyse 20 µl of the reaction mixture. A 1:50 dilution of reaction 
mixture in dH2O was used to transform MAX Efficiency DH5αF′IQ competent cells 
(Invitrogen), and grown as for DNA production (section 2.2.5.1). 
2.2.5.4 Primer extension assays 
Substrates and assays were based on the assay of Rajão and colleagues (Rajão et 
al, 2009). The bipartite primer-template consisted of fluorescein-labelled M13 
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primer and unlabelled DloopF (template) oligonucleotides. The tripartite 
substrate for the strand displacement assay consisted of the same primer and 
template plus the unlabelled oligonucleotide PL3. The substrates were produced 
by annealing the oligonucleotides in 50 mM Tris (pH 7.5) and 100 mM NaCl in a 
volume of 10-50 µl; 0.5 µM primer and 0.8 µM template, with 0.8 µM PL3 for the 
tripartite substrate, were heated to 80ºC for 5 min, then cooled slowly to 25ºC. 
For both assays, DNA polymerase (approximately 1 µg) was incubated with 50 nM 
substrate for 2 h at 37ºC, in a 10 µl reaction. Reaction conditions were 10 mM 
Tris, pH 7.9, 10 mM MgCl2, 50 mM NaCl, 5 mM DTT, 100 µg/ml BSA and 200 µM 
each dNTP. Reactions were stopped by addition of Novex TBE-urea sample buffer 
(Invitrogen) to 1X concentration and incubation at 70ºC for 3 min. Products were 
analysed by electrophoresis on 15% Novex TBE-Urea polyacrylamide gels 
(Invitrogen), and fluorescein signal detected using a Typhoon 8610 imager. 
2.2.5.5 Reversion assay 
This assay was based on an assay described by Osheroff and colleagues (Osheroff 
et al, 1999). M13Stop was incubated with Nb.BbvCI for 2 h at 37ºC to generate 
the nicked template, checked for cutting by agarose gel electrophoresis, then 
the enzyme and buffer were removed using a Qiaquick PCR purification kit 
(Qiagen). The reaction conditions for the DNA synthesis reaction were 50 mM 
NaCl, 10 mM Tris-HCl, pH 7.9, 10 mM MgCl2, 1 mM DTT, 200 µg/ml BSA, 
approximately 400 ng of polymerase and 250 ng of nicked template, in a total 
volume of 20 µl. Reactions were incubated for 3 h at 37ºC, then stopped by the 
addition of EDTA to a final concentration of 15 mM. The reaction mix was diluted 
1:20 in dH2O and 1 µl of this was used to transform MAX Efficiency DH5αF′IQ as in 
the gap filling assay. Plates were incubated at 37ºC overnight then at 4ºC for 2-
4 h to allow the blue colour of the plaques to develop, then the number of blue 
and white plaques on each plate was counted. 
2.2.5.6 Tet repressor escape assay 
The MG1655 cI-Tet cell line (full genotype: MG1655 attλ::cI (Ind-) λpR tetA 
Δara::FRT ΔmetRE::FRT; (Bjedov et al, 2007)) was provided by Dr Ivan Matic 
(Pasteur Institute). Competent cells prepared from the cell line were 
transformed with pMAL-K10 plasmid. A glycerol stock of transformed cells was 
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used to inoculate 100 ml LB with 100 µg/ml ampicillin, and this was incubated at 
37ºC with shaking for 4 h. The density of the culture was then estimated using a 
spectrophotometer and the volume corresponding (very approximately) to 100 
cells was used to inoculate 10 ml LB containing 100 µg/ml ampicillin and various 
concentrations of IPTG. The new cultures were incubated overnight at 37ºC with 
shaking. An aliquot of 500 µl was removed for analysis by SDS-PAGE, centrifuged 
at 17900×g, resuspended in 100 µl loading buffer, and approximately 1×108 cells 
were analysed by SDS-PAGE. The overnight cultures were serially diluted in LB, 
and 200 µl aliquots of 1:10, 1:100, 1:1000, 1:104, 1:105 and 1:106 dilutions and 
20 µl of 1:106 dilution were spread on LB plates containing either 100 µg/ml 
ampicillin and 12.5 µg/ml tetracycline or only ampicillin, to allow estimation of 
the total number of cells plated. Plates were incubated for 24 h at 37ºC then the 
resulting colonies counted for each plate. 
2.2.6 Microscopy 
2.2.6.1 Preparation of slides and fixation 
BSF parasites were grown to a density of between 5×105 and 1×106 cells/ml and 
were harvested by centrifugation at 460×g for 10 min. Cell pellets were washed 
twice with 1 ml cfPBS then resuspended in a small volume of cfPBS to an 
approximate density of 2×107 cells/ml. For live cell microscopy with parasites 
expressing enhanced green fluorescent protein (eGFP)-labelled protein,10 µl 
resuspended cells were pipetted onto a clean glass slide, then a cover slip was 
placed on top and the cells used immediately for microscopy.  
For methanol fixation, one spot of 5 µl resuspended cells was spread onto a 
clean glass slide, then the density of parasites in the spot was checked with a 
low-power light microscope (Leitz) to ensure the cells were neither too dense 
nor too sparse. If either was the case, the volume of resuspended cells was 
adjusted by 1 µl down or up respectively for a further one or two spots. The 
slides were allowed to air dry in a laminar flow hood for at least 15 min. Dried 
slides were immersed in methanol for 20 min, then washed in cfPBS twice for 
5 min. 
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For formaldehyde fixation, an equal volume of 4% formaldehyde in cfPBS was 
added to the resuspended parasites. The parasites were incubated for 10 min, 
then washed twice with PBS and resuspended to a density of approximately 
1×107 cells/ml. Next, 100 µl of resuspended cells were spotted on to a silanised 
glass slide and allowed to settle by gravity for 15 min. Slides were then washed 
four times in cfPBS for 5 min. Fixed parasites on slides were permeabilised by 
placing 1 ml 0.2% NP40 in cfPBS on to the slide and incubating for 5 min at 25ºC, 
then rinsing the slide three times in cfPBS. Slides were air-dried and then 
proceeded to antibody incubation. For refixation after incubation with antibody 
(see below), 100 µl 3% formaldehyde in cfPBS was pipetted onto each cell spot 
and incubated for 10 min. Slides were rinsed in cfPBS then washed three times 
for 5 min in cfPBS and air-dried. 
2.2.6.2 Immunofluorescence (IF): blocking and antibody hybridisation 
Slides with fixed parasites were incubated in blocking buffer (10% FCS, cfPBS) for 
1 h at 4ºC. A primary antibody diluted in blocking buffer was spotted onto the 
slides and these were incubated for 1 h. Slides were washed twice for 5 min in 
blocking buffer, then incubated with secondary antibody diluted in blocking 
buffer for 1 h in the dark. For MYC-tagged protein, the primary antibody was 
mouse monoclonal anti-MYC antibody (Sigma), diluted 1:7000 and the secondary 
antibody was Alexa594-conjugated anti-mouse antibody (Invitrogen), diluted 
1:5000; for eGFP-tagged protein, the primary antibody was rabbit polyclonal 
anti-GFP (Abcam), used at a dilution of 1:1000, and the secondary antibody was 
Alexa488-conjugated anti-rabbit antibody (Invitrogen), diluted 1:5000. For IF 
alone, after incubation with secondary antibody, slides were washed for 5 min in 
blocking buffer, blotted dry, then a drop of Vectashield mounting medium with 
DAPI (Vector Laboratories), and a coverslip was placed on top and sealed with 
nail varnish. For IF with fluorescence in-situ hybridisation (FISH), slides were 
either used directly for FISH (see below) or re-fixed before proceeding to FISH. 
2.2.6.3 FISH 
For FISH, 25 µl plastic frames (Geneframe, Thermo scientific) were applied to 
slides with fixed parasites, each one surrounding a spot of cells. A volume of 
15 µl peptide nucleic acid (PNA) probe complementary to telomere repeats and 
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conjugated to Cy5 (Cambridge Research Biochemicals), at a concentration of 
800 ng/µl in hybridisation buffer (10 mM NaHPO4, 10 mM NaCl, 20 mM Tris, pH 
7.5, 70% formamide) was applied to each parasite spot and the frames sealed 
with coverslips, after which the slides were kept in the dark. The slides with 
probe were incubated on an in-situ block (Eppendorf) at 85ºC for 5 min (probe 
and cell DNA denaturation) followed by slow cooling to 25ºC for 2 h 
(hybridisation). The coverslips and frames were then removed and the slides 
were washed in 0.1% Tween-20 in filtered PBS for 20 min at 50ºC in a 
hybridisation oven, followed by a wash of 1 min in 2X SSC at room temperature 
on a rolling shaker. The slides were then air-dried, mounted with Vectashield 
mounting medium with DAPI, covered with a coverslip and sealed with nail 
varnish. 
2.2.6.4 Protocols and visualisation 
Several combinations of the procedures described below were used. 
Fluorescence from eGFP-tagged parasites was visualised directly by live cell 
microscopy using an Axioskop 2 fluorescence microscope (Zeiss) or from 
methanol-fixed parasites, using either an Axioskop 2 or DeltaVision (Applied 
Precision) fluorescence microscope. In the latter case, the images were 
deconvoluted using Softworx software. Both eGFP and 12MYC tags were 
visualised by IF, with or without FISH, and imaged using an Axioskop 2. 
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2.2.7 Details of oligonucleotides 
Name Sequence (5′ to 3′) Annealing temp (˚C) To amplify 
DLoopF CTTCTCATCTCTCGGTCGTGACTGGGAAAACAAGTGGTCAGTGGT NA NA 
LEWSEQ1 CAGTGATAGAGATCCCTGAG 50 pB2X-GFP 
LEWSEQ2 CACCCTTAATGAGCGCTTTCG 50 pB2X-GFP 
M13 primer GTTTTCCCAGTCACGAC NA NA 
M13 rev (-29) CAGGAAACAGCTATGACC seq various 
M13 uni (-21) TGTAAAACGACGGCCAGT seq various 
P73 TGTCCCATCATCGACAGAGC 50 K10 
P74 AGCCCCCTCACAATTCTCGG 50 K001 
P76 GCTCTGTCGATGATGGGACA 50 K10 
P77 CCGAGAATTGTGAGGGGGCT 50 K001 
P78 GGTCGTCAGACTGTCGATGAAGCC seq pMAL constructs 
P79 ACGTTGTAAAACGACGGCCAGTG 52 pMAL constructs 
P86 TGCCAAGCTTACTAGTAATTATGGTAAC 50 pMAL-K10 and -K001 
P95 TCAGAATTCAAGCTTATGTGTGGGGGAG 50 pMAL‑K10 and -K001 
PL1 GATTACGAATTCGAGCTGAGGATCGGTACCCGGGGATCC 52 M13mp18 LacZα 
PL2 TTTGAGAGATCTACAAAGGCTATC 52 M13mp18 LacZα 
PL3 CGAGAGATGAGAAG NA NA 
PL4 GATCTTATGCGAGAAACTAGTGAACA 65 12MYC 
PL5 CAGTGACTCGAGGTCCGCGTGGATCCTCAC 65 12MYC 
PL8 AAGCTTGATCTTATGCGAGAATCTAGAGAACA 65 12MYC 
PL9 GATATCCTCGAGGTCCGCGTGGATCCTCAC 65 12MYC 
PL12 CAGTGAAAGCTTGATATCATGTGTGGGGGAGAAGAG 50 K10 and K001 
PL13 CAGTGATCTAGAAATTATGGTAACTTCCCTC 50 K10 and K001 
PL15 CATCAGCTTTGGTTTGGCCGAACTGACCCTTGAGG 60 K10 mutagenesis 
PL16 CCTCAAGGGTCAGTTCGGCCAAACCAAAGCTGATG 60 K10 mutagenesis 
PL17 ATTACATAGTTGTTGGTTTGGCCGACTTTACTCTCGAAGTAAGTG 60 K001 mutagenesis 
PL18 CACTTACTTCGAGAGTAAAGTCGGCCAAACCAACAACTATGTAAT 60 K001 mutagenesis 
PL19 CATCAGCTTTGGTTTGGCC 52 mutant K10 
PL21 CATAGTTGTTGGTTTGGCC 52 mutant K001 
PL33 CTTTGTCTTTGCCTCTAAAAG 50 E2340_ORF312 
PL34 ATGGCAAACTACAACACTCTTC 50 E2340_ORF312 
PL35 GAACCAAGCAAGCCCCTCTTGC 50 E2340_ORF312 
Table 2-2 – Details of oligonucleotides. 
NA = not applicable (primer was for polymerase primer extension assay); seq = annealing 
temperature determined by sequencing provider; * = no product was obtained. Continued 
on next page. 
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Name Sequence Annealing temp (˚C) To amplify 
PL38 GAGCAGAAAACAGGCTGCGATG 55 E3_ORF250 
PL39 TACTTTGGGTTGGTGCCGGCTG 55 E3_ORF250 
PL40 GCGCAGAGGCCAGACCTCGATG 55 E3_ORF250 
PL41 TATTAAAGACGCGGAATGATG 52 E3_NTD0250 
PL42 ATGAGCTTCTATATCCTTGATG 52 E3_NTD0250 
PL43 ATGAAAGCGCTTAGACAAGG 50 E3_NTD0866 
PL44 CCTTTCTCGTTGTTTCGATTG 50 E3_NTD0866 
PL45 CCTTTCTCATTGCTTCGATTG 50 E3_NTD0866 
PL46 ATAAAAATGAAGAATAAACTAG 50 E3_ORF328 
PL47 TTCTTGTTCCTGTTTCTGGAC 50 E3_ORF328 
PL48 ATGGAACACAAAATTCTGC 52 E3_ORF189 
PL50 CATCAGTTCCCTCTTTGTTGC 52 E3_ORF189 
PL51 ACAAGAGGGGTGGAGGGC 50 E2340_NTD1110 
PL52 GTTCAAAAGGCTTTGAATTATC 50 E2340_NTD1110 
PL53 ATGAAAAGAGGTTTCGCCGT 50 E2340_NTD1104 
PL54 GTTGGCTGCTGTAGGCGATG 50 E2340_NTD1104 
PL55 ATGGCGGTAACTTTTTTTATAGC 50* E2340_NTD1648 
PL56 CCGGTGCCGACGCTATAAAAC 50* E2340_NTD1648 
PL57 ATGATTACCGGTAACGTCATA 50 E2340_NTD1861 
PL58 GGTTGAGGCCTTGGAGTTCTG 50 E2340_NTD1861 
PL62 CAGATGAGGGTCAGTTTATTC 55 E2340_NTD1171 
PL63 TGGCGTTGTTGTTACTTGTG 55 E2340_NTD1171 
PL64 ATGATAAAGAAACCGCGGTTTTG 55 E2340_NTD0947 
PL65 GGCGGTCTTTTTGCGATCGTAG 55 E2340_NTD0947 
PL66 AGCATGACGCAGCAAGCGGTC 50 E3_NTD0529 
PL67 TATTTCTGCTTTGTAGAGCTC 50 E3_NTD0529 
PL68 AGCAGGTCAAAGAACACGACC 50 E3_NTD0529 
PL69 ACAATGATCACAAGAAATAGC 52 E2340_NTD0451 
PL70 TTGGCCTGTAGTTGGTGCTGG 52 E2340_NTD0451 
PL71 GTCTGCAATACGCTATTGGC 50* E3_NTD0257 
PL72 CAGCTACCGTTCACGATATT 50* E3_NTD0257 
PL73 ATGCACAGGACGCTTCTTAAG 50 E2340_NTD0909 
PL74 ATCTCCAATCCAAAGAAAAGCC 50 E2340_NTD0909 
T7 TAATACGACTCACTATAGGG seq various 
T7term CTAGTTATTGCTCAGCGGT seq various 
Table 2-2 continued. 
 
 
 
 
 
 
Chapter 3: Assembly and global 
comparison of EATRO 3 and 
EATRO 2340 genomes 
  
Chapter 3 79 
3 Assembly and global comparison of EATRO 3 
and EATRO 2340 genomes 
3.1 Introduction 
Previous studies of the evolution of subtelomeres and subtelomeric genes have 
been based on a single, haploid, assembled genome and have studied the 
differences between related genes and chromosome segments within that 
genome to deduce changes that have occurred (Marcello & Barry, 2007b; 
Linardopoulou et al, 2005). This type of approach can provide valuable 
information. However, it is limited by several factors: it relies on duplications 
within the genome; it is very difficult to estimate the divergence time of 
duplicated genes; and the divergence time between genes studied may be 
sufficiently great that separating two overlaid mutational events is very 
challenging. This project, therefore, aimed to study changes in the subtelomeres 
by sequencing two time-separated isolates of the same trypanosome strain, 
effectively sequencing the same genome twice, but with sufficient time 
between sampling for changes to occur. After assembly, the goal was to find 
novel and previously identified subtelomeric genes, and to identify the same 
gene in both genomes, so that the changes in these genes could be analysed. 
Identifying the changes would then allow patterns of mutation at the levels of 
individual genes and of the whole genome to be considered. As described in the 
Introduction, the subtelomeric antigen gene family of VSGs is enormous, highly 
variable and crucial to the survival of the parasite in its mammalian host, and I 
therefore focused on VSG genes in this study. 
The aims of the work described in this chapter were to generate draft-quality 
genome assemblies for the two T. b. rhodesiense isolates, to assess the quality 
of these assemblies, and to determine the overall mutation rates in the 
chromosome cores and in the subtelomeres. The overall goals were to provide 
sequence data from which VSG genes could be annotated and compared 
between isolates; and to ensure that this analysis would be likely to provide 
insights into the mutational processes in subtelomeres by checking that they 
had, as hypothesised, a higher rate of mutation than the chromosome cores. 
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3.1.1 Isolates used in study 
The two isolates used in the study were from a T. b. rhodesiense sleeping 
sickness focus in south-east Uganda, close to Lake Victoria, which appeared in 
1940 (Robertson & Baker, 1958). Samples were taken from this disease focus 
every few years, and in this longitudinal set of samples we can follow the 
evolution of the causative strain. EATRO 3 (East African Trypanosomiasis 
Research Organisation isolate 3) was isolated in 1960 from flies or a fly in Busoga 
(Lumsden & Herbert, 1975), and EATRO 2340 was isolated in 1977 from a human 
in Samia (stock F in Barry et al, 1983; J.D. Barry, pers. comm.). The two isolates 
have been shown serologically to share a VSG set (Barry et al, 1983), and they 
belong to a set of isolates that have been indicated by population genetic 
analysis to have propagated clonally in the field (Tait et al, 1985; Hide et al, 
1991). The clonal relationship has been confirmed by microsatellite and 
minisatellite genotyping with Genescan (L. Morrison and A. MacLeod, 
unpublished): out of six markers examined, five (JS2, 18, 5L5, 5 and m12) were 
identical between the two isolates, and for the other marker (PLC), one allele 
was different. Four other isolates from the same focus were examined in the 
same set of experiments, and all of these isolates had an identical genotype to 
EATRO 3, indicating that all six isolates are from the same clonal lineage. Details 
of the serology and marker genotypes of the isolates are given in Appendix 1. 
The serological and genotypic similarity of the EATRO 3 and EATRO 2340 isolates 
makes them ideal for the purpose of following VSG evolution, as we are likely to 
be able to identify the same VSG genes in both genomes. 
Our knowledge of the relationship between the strains means that the 
approximate number of generations separating them (in the sense of cell 
divisions rather than complete life cycles) can be estimated (Figure 3-1). These 
estimates were obtained by assuming a doubling time of approximately 6 h 
through most of the life cycle; although this assumption ignores the time spent 
in non-proliferative life-cycle stages, it should provide a reasonable figure on 
which to base a conservative estimate of mutation rate (Turner et al, 1995; van 
den Abbeele et al, 1999; Salmon et al, 2005; Koffi et al, 2009). 
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Figure 3-1 – Range of possible relationships between isolates EATRO 3 and EATRO 2340. 
In both cases, the origin of the disease focus is shown in 1940. In the upper panel, the 
relationship is shown where EATRO 2340 is the direct clonal descendant of EATRO 3, and 
hence the separation between the two is the time interval from 1960 to 1977 (17 years). In 
the lower panel, the maximum expected separation is shown, where the EATRO 3 and 
EATRO 2340 lineages diverged at the beginning of the disease outbreak, and hence 
differences have accumulated in the 20 years from 1940 to 1960 and the 37 years from 1940 
to 1977. 
The sizes of chromosomes 1 to 6 of EATRO 2340 have been analysed by pulsed-
field gel electrophoresis, as have those from EATRO 795, a 1964 isolate from the 
same disease focus and isolate sequence, and from TREU 927, the strain used for 
genome sequencing (Melville et al, 1998; and S. Melville, unpublished). The sizes 
estimated for the TREU 927 chromosomes in the pulsed-field gel experiment 
corresponded well with the sizes found when its genome was sequenced 
(Berriman et al, 2005). As mentioned above, TREU 927 has relatively short 
subtelomeres, and both EATRO 2340 and EATRO 795 were shown to have several 
Mb more sequence in their subtelomeres, despite only the six smallest 
chromosome pairs being considered. In the chromosomes examined, these 
isolates had a total of 11.12 Mb and 8.96 Mb respectively of subtelomeric 
sequence, compared with 4.83 Mb in the same subtelomeres of TREU 927. The 
difference in subtelomere size even between EATRO 2340 and EATRO 795 
demonstrates the dynamism of these genome regions, which evidently can 
change size dramatically even as the repertoire of expressed VSGs remains 
substantially the same, as judged from serological analyses (Barry et al, 1983). 
3.1.1.1 Note on subspecies classification 
There has been some discussion over the classification of EATRO 2340 as 
T. b. rhodesiense, due to an apparent lack of the rhodesiense-defining gene SRA 
in a derivative of the isolate used to study BESs (Young et al, 2008b). However, 
since the original isolate was from a human, we consider that EATRO 2340 should 
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not be considered as T. b. brucei; and the classification of the disease focus as 
caused by T. b. rhodesiense is well-established. Further, microsatellite analysis 
has confirmed that the parasite line used in the Young et al study, which was 
considerably more passages removed from the original isolate than the 
EATRO 2340 cell line used in this study, differs from other EATRO 2340 lines, and 
thus it is most likely that the Young et al strain is not EATRO 2340 (A. MacLeod, 
M. Turner, G. Rudenko and K. Matthews, pers. comm.). The EATRO 2340 used in 
this work was the original line cloned from the EATRO 2340 stabilate in our 
laboratory (Barry et al, 1983) and, having been derived from a human, is T. b. 
rhodesiense. The EATRO 3 clone used here is infective to humans (Herbert et al, 
1980) and is the strain from which SRA was initially characterised (De Greef & 
Hamers, 1994), so it certainly is T. b. rhodesiense. The presence of SRA in the 
genome is examined in section 3.2.4.4. 
3.2 Assembly of genomes 
3.2.1 Assembly strategy 
The work in this section was performed in collaboration with Dr Thomas Otto 
(Sanger Institute), who carried out or directed the majority of the assembly 
steps; Dr Matt Berriman (Sanger Institute), who provided Illumina and 454 
sequencing data; and Prof Ed Louis (University of Nottingham), who provided 454 
sequencing data. I began to work on the project after the sequence data had 
been generated, and worked on the assembly steps under the direction of Dr 
Otto. After the steps detailed in this section I took over full control of the data 
and analysis. A glossary of the software used in assembly is given in Table 2-1 
(which also includes details of other programs used in the project). DNA was 
prepared from BSF EATRO 3 and a culture of procyclic form EATRO 2340 
parasites. Sequence data were obtained from DNA of both isolates by Illumina 
sequencing and 454 sequencing (Table 3-1 , read sets 1-14). Separate de novo 
assemblies were attempted with the Newbler assembler from each isolate’s 454 
data sets. The EATRO 2340 assembly was the more successful, and to improve 
this assembly a further two 454 data sets were generated (Table 3-1, read sets 
15 and 16). A new set of de novo contiguous DNA sequences (contigs) was 
generated from the five EATRO 2340 454 data sets using Celera Assembler, a 
newer program. To produce assembled chromosomes, the EATRO 2340 de novo 
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contigs were aligned to a reference genome, T. b. gambiense strain DAL 972 
(Jackson et al, 2010), using ABACAS. This reference genome was chosen because 
the assembled chromosomes contain very little subtelomeric sequence. Because 
subtelomeric sequence changes rapidly at both small and larger scales, these 
regions vary considerably between parasite strains (Melville et al, 2000), so it 
was not appropriate to use the subtelomeres of another parasite strain as a 
template for contig ordering. After ordering, the three 8 kb 454 libraries were 
mapped to the new assembly, and a plot was generated of the coverage of mate 
pairs that were mapped at the correct distance apart. Contigs were broken at 
points where the paired read coverage was below three, i.e. at likely 
misassembled points. Finally, gaps in the assembly were filled, as far as 
possible, by targeted reassembly with IMAGE in contigs longer than 15 kb, which 
closed 1210 gaps. 
Set Isolate Technology Type 
Insert/ 
fragment 
size 
No. reads Total read length (bp) 
Mean read 
length (bp) 
1* EATRO 2340 454 PEL 2 kb 347728 63397799 182 
2* EATRO 2340 454 PEL 2 kb 896497 168031785 187 
3* EATRO 2340 454 PEL 3 kb 983398 201707497 205 
4* EATRO 2340 454 PEL 8 kb 1146306 189307841 165 
5* EATRO 2340 Illumina PEP 300 bp 48192764 3662650064 76 
6 EATRO 2340 Illumina PEL 3 kb 11028950 838200200 76 
7 EATRO 2340 Illumina PEL 3 kb 18420270 1399940520 76 
8 EATRO 3 454 PEL 2.5 kb 729630 172417460 236 
9 EATRO 3 454 PEL 3 kb 589856 154717106 262 
10 EATRO 3 454 R - 515398 164008964 318 
11 EATRO 3 454 R - 512420 178841313 349 
12 EATRO 3 454 PEL 3 kb 746428 261645469 351 
13* EATRO 3 Illumina PEP 300 bp 37446496 2845933696 76 
14* EATRO 3 Illumina PEL 3 kb 23514048 1787067648 76 
15* EATRO 2340 454 PEL 8 kb 1138453 241502445 212 
16* EATRO 2340 454 PEL 8 kb 1223578 225366130 184 
Table 3-1 – Sequencing data sets generated for the project. 
* denotes sequence sets that were used in the final draft assemblies. PEL = paired-end 
library; PEP = paired-end PCR free sequencing; R = random sequencing. 
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As the two genomes were expected to be very similar, the EATRO 2340 assembly 
was used as a reference to produce an EATRO 3 genome assembly. Illumina reads 
generated from PCR-free and 3 kb libraries of EATRO 3 DNA were trimmed to 
remove poor-quality bases at the ends of reads, using SGA. The trimmed reads 
were then used for assembly with Velvet Columbus. This program initially used 
the EATRO 2340 assembly (chromosomes and unmapped contigs) as a guide for 
assembly, then did de novo assembly to generate contigs from reads that could 
not be mapped to the reference. In the part of the EATRO 3 assembly that had 
been assembled to EATRO 2340, any position that was not covered by at least 
two reads was considered to be poorly supported and the base called was 
changed to an N to indicate ambiguity. The resulting contigs were ordered using 
ABACAS, to the EATRO 2340 chromosomes1. Finally, IMAGE was used to fill, as far 
as possible, gaps in contigs longer than 15 kb, resulting in the closure of 5751 
gaps. The assembly strategy is summarised in Figure 3-2. 
                                                
1 In the actual ABACAS run, the EATRO 2340 full assembly was used as a reference; 
however, mappings to EATRO 2340 bin contigs were then ignored. 
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Figure 3-2 – Strategy used to generate EATRO 3 and EATRO 2340 genome assemblies. 
Software used at each step is described beside the arrows representing the appropriate 
step(s), see also Table 2-1. Red boxes show draft genomes used in the further analyses 
described below. 
3.2.2 Summary statistics of assembled genomes 
The assembly steps produced an EATRO 2340 assembly consisting of 11 
chromosomes and 831 unmapped (‘bin’) contigs, and an EATRO 3 assembly of 11 
chromosomes and 5122 bin contigs (Table 3-2). These assemblies both contained 
a large number of very short contigs. To simplify downstream analyses, I 
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excluded contigs smaller than 1000 bases (excluding gaps), producing the full 
draft genome versions for EATRO 2340 and EATRO 3. 
Assembly No. contigs 
Total length 
(bp) N50 (bp) N90 (bp) 
No. 
gaps 
EATRO 2340 all contigs and 
chromosomes 842 38008219 1247284 30262 4178 
EATRO 2340 chromosomes 11 22490340 2065168 1131951 1130 
EATRO 2340 contigs ≥ 1 kb 550 15342690 71827 19729 3045 
EATRO 2340 final draft assembly 
(chromosomes plus contigs ≥ 1 kb) 561 37833030 1247284 31106 4175 
EATRO 3 all contigs and 
chromosomes 5133 36968657 1171069 3636 13944 
EATRO 3 chromosomes 11 20510521 1917240 1171069 3359 
EATRO 3 contigs ≥ 1 kb 1702 14774087 31683 2706 9438 
EATRO 3 final draft assembly 
(chromosomes plus contigs ≥ 1 kb) 1713 35284608 1278464 9274 12797 
Table 3-2 – Summary statistics of the assemblies generated for EATRO 3 and EATRO 2340. 
90% of sequence is in contigs of the N90 length or greater; similarly 50% of sequence is in 
contigs of the N50 length or greater. 
3.2.3 Annotation of genomes 
3.2.3.1 Annotation of boundaries of chromosome cores 
Although the T. brucei reference genome (strain TREU 927) has been extensively 
annotated (Berriman et al, 2005; Marcello & Barry, 2007b; Kolev et al, 2010), 
there is no readily available description of the boundaries of the chromosome 
cores. Therefore, in order to define the chromosome cores and subtelomeres in 
EATRO 3 and EATRO 2340, I first annotated the core boundaries in TREU 927. I 
used TriTrypDB (Aslett et al, 2010) to compare each chromosome from TREU 927 
and T. b. gambiense strain DAL 972 (Jackson et al, 2010), and define the core 
boundaries by the first and the last genes that 1) were syntenic between the two 
genomes and 2) were neither typical subtelomeric genes such as VSG genes, 
expression-site associated genes and retrotransposon hot spot protein genes, nor 
unlikely hypothetical genes (Table 3-3). This annotation used the most up-to-
date versions of the TREU 927 chromosomes available on TriTrypDB at the time: 
version five of chromosome 10, and version four of all other chromosomes. 
To find the core boundaries in EATRO 3 and EATRO 2340, I aligned each 
chromosome to its homologue in TREU 927 using BLAST, and viewed alignments 
of at least 90% identity using ACT. Using these alignments, I defined the 
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chromosome cores by identifying the EATRO 3 or EATRO 2340 copies of the genes 
defining the chromosome cores in TREU 927. If the gene could not be found, or 
was poorly assembled, the core boundary was taken to be the point where the 
EATRO chromosome started to have high (at least 90%) identity to TREU 927. The 
lengths of chromosome cores and subtelomeres defined by this annotation 
process are shown in Table 3-3. 
3.2.3.2 Automated transfer of core annotations 
To annotate individual genes in the chromosome cores, I used RATT, which uses 
the MUMmer alignment algorithm to identify regions of synteny and 
automatically transfer annotations between a reference and a related genome. 
The reference genome was the TREU 927 chromosome cores only. Of 8508 coding 
sequences in TREU 927 cores, 6253 were transferred to both EATRO 3 and 
EATRO 2340; a further 1408 were transferred to EATRO 2340 but not to EATRO 3, 
and 337 were transferred to EATRO 3 but not to EATRO 2340. 
3.2.4 Assessment of quality of genomes 
3.2.4.1 Length of sequence and coverage of reference genome 
The assemblies contained 19.11 Mb of EATRO 3 and 20.44 Mb of EATRO 2340 core 
sequence, which is 88% and 94% respectively of the TREU 927 core sequence. To 
check how similar the EATRO assemblies were to TREU 927, I used NUCmer from 
the MUMmer suite of programs to align the chromosomes of each isolate with the 
TREU 927 core sequences. When a 90% identity cut-off was used, 82% of the 
TREU 927 core sequence was contained in alignments to the EATRO 3 
chromosomes, and 92% to the EATRO 2340 chromosomes. These figures imply 
that most of the core sequence that could be assembled in the EATRO isolates 
had high identity to the reference genome. 
Chapter 3 88 
To
ta
l c
hr
om
os
om
e 
le
ng
th
 
EA
TR
O
 
23
40
 
76
09
95
 
78
86
20
 
19
68
40
1 
14
15
95
1 
12
47
28
4 
11
31
95
1 
20
65
16
8 
19
88
80
4 
25
00
27
8 
38
54
75
0 
47
68
13
8 
22
49
03
40
 
EA
TR
O
 
3 
69
00
46
 
79
09
75
 
20
39
57
5 
14
51
24
3 
11
71
06
9 
12
78
46
4 
19
17
24
0 
20
08
84
2 
19
09
13
5 
35
65
63
4 
40
97
35
1 
20
91
95
74
 
TR
EU
 
92
7 
10
64
67
2 
11
93
94
8 
16
53
22
5 
15
90
43
2 
16
08
19
8 
16
18
91
5 
22
05
23
3 
24
81
19
0 
30
57
54
7 
41
44
37
5 
49
77
08
2 
25
59
48
17
 
To
ta
l s
ub
te
lo
m
er
e 
le
ng
th
 
EA
TR
O
 
23
40
 
71
15
3 
49
17
3 
48
79
73
 
11
96
66
 
13
14
90
 
21
75
8 
16
79
66
 
54
35
4 
70
04
22
 
49
67
6 
19
36
00
 
20
47
23
1 
EA
TR
O
 
3 41
54
5 
83
12
5 
84
36
80
 
63
81
9 
10
65
01
 
99
04
 
73
53
5 
15
49
2 
39
04
50
 
49
29
9 
13
13
92
 
18
08
74
2 
TR
EU
 
92
7 
28
39
19
 
33
97
10
 
21
84
15
 
20
61
75
 
43
96
31
 
38
10
66
 
89
92
6 
13
56
94
 
90
18
65
 
23
88
22
 
52
67
75
 
37
61
99
8 
Su
bt
el
om
er
e 
af
te
r c
or
e 
EA
TR
O
 
23
40
 
65
04
1 
40
38
0 
12
92
6 
10
97
25
 
39
78
4 
15
83
5 
42
65
4 
15
94
3 
22
06
95
 
10
54
5 
16
15
93
 
73
51
21
 
EA
TR
O
 
3 
38
45
1 
78
14
0 
42
18
40
 
63
81
9 
26
86
5 
77
27
 
35
45
3 
60
78
 
14
69
50
 
15
21
5 
86
18
9 
92
67
27
 
TR
EU
 
92
7 
80
72
4 
33
04
0 
71
35
2 
12
52
95
 
27
75
42
 
20
53
82
 
62
85
5 2 
57
55
15
 
17
02
20
 
49
49
39
 
20
96
86
6 
C
or
e 
EA
TR
O
 
23
40
 
68
98
42
 
73
94
47
 
14
80
42
8 
12
96
28
5 
11
15
79
4 
11
10
19
3 
18
97
20
2 
19
34
45
0 
17
99
85
6 
38
05
07
4 
45
74
53
8 
20
44
31
09
 
EA
TR
O
 
3 
64
85
01
 
70
78
50
 
11
95
89
5 
13
87
42
4 
10
64
56
8 
12
68
56
0 
18
43
70
5 
19
93
35
0 
15
18
68
5 
35
16
33
5 
39
65
95
9 
19
11
08
32
 
TR
EU
 
92
7 
78
07
53
 
85
42
38
 
14
34
81
0 
13
84
25
7 
11
68
56
7 
12
37
84
9 
21
15
30
7 
23
45
49
6 
21
55
68
2 
39
05
55
3 
44
50
30
7 
21
83
28
19
 
Su
bt
el
om
er
e 
be
fo
re
 c
or
e 
EA
TR
O
 
23
40
 
61
12
 
87
93
 
47
50
47
 
99
41
 
91
70
6 
59
23
 
12
53
12
 
38
41
1 
47
97
27
 
39
13
1 
32
00
7 
13
12
11
0 
EA
TR
O
 
3 30
94
 
49
85
 
42
18
40
 0 
79
63
6 
21
77
 
38
08
2 
94
14
 
24
35
00
 
34
08
4 
45
20
3 
88
20
15
 
TR
EU
 
92
7 
20
31
95
 
30
66
70
 
14
70
63
 
80
88
0 
16
20
89
 
17
56
84
 
27
07
1 
13
56
92
 
32
63
50
 
68
60
2 
31
83
6 
16
65
13
2 
Chromosome 1 2 3 4 5 6 7 8 9 10
 
11
 
A
ll 
Table 3-3 – Core and subtelomere lengths in bp for the three genomes annotated. 
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The assembled chromosomes contained 1.81 Mb of subtelomeric sequence in 
EATRO 3 and 2.05 Mb in EATRO 2340, compared with 3.76 Mb of subtelomeres in 
TREU 927. However, due to the contigs being aligned to strain DAL 972, which 
has minimal subtelomeric sequence, this low coverage was expected. Much of 
the subtelomeric sequence was likely to be on contigs that were not mapped on 
to reference chromosomes. Such sequence totalled 14.77 Mb in EATRO 3 and 
15.34 Mb in EATRO 2340. Some of these ‘bin’ contigs probably corresponded to 
the homologous partners of sequence already assembled into chromosomes, 
where the two homologues were different enough to be seen as two separate 
sequences by the assembly algorithm, but this possibility was not examined in 
detail. 
3.2.4.2 Read coverage 
In order to assess the depth of coverage in the assemblies, I mapped each set of 
paired-end Illumina reads to the corresponding genome using BWA, using as a 
reference all the chromosomes and bin contigs available for each genome (Table 
3-2, rows 1 and 5). I then calculated the mean coverage with good-quality 
sequence (Phred-scaled base quality score of at least 23) for all bases in the 
chromosomes and the final set of bin contigs over 1 kb (Table 3-2, rows 4 and 8). 
This self-mapping gave a mean coverage of 25-fold for EATRO 3 and 54-fold for 
EATRO 2340, with 92.4% and 97.3% of bases respectively having a coverage with 
good-quality sequence in at least eight reads, demonstrating that the genomes 
were well-supported. To call SNPs and heterozygosities (see below) I used more 
stringent coverage thresholds, requiring good-quality coverage between 10 and 
200 inclusive. Using these thresholds, 89.1% of EATRO 3 and 96.9% of 
EATRO 2340 positions had coverage suitable for calling SNPs, so most of both the 
genomes could be examined for differences between the isolates. The 
difference in coverage between the two strains was partly due to the difference 
in the amount and quality of sequence obtained from each experiment: 24 
million pairs were generated from the EATRO 2340 PCR-free sequencing 
experiment compared with 18 million pairs of reads from EATRO 3. Further, 
while 88% of forward reads and 71% of reverse reads from EATRO 2340 contained 
more than 80% good-quality bases, these figures were only 80% and 60% 
respectively for EATRO 3. 
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When I performed mappings of the EATRO 2340 reads to the EATRO 3 genome, 
and the EATRO 3 reads to the EATRO 2340 genome, the mean coverages were 
46-fold and 28-fold respectively. These figures are somewhat counterintuitive 
when compared with the results for the self-mapping, but are explicable. The 
EATRO 2340 reads gave higher coverage of the EATRO 3 genome than did the 
EATRO 3 reads: this was likely due to the previously discussed better quality and 
number of EATRO 2340 reads compared with the EATRO 3 reads. The EATRO 3 
reads mapped with higher coverage to the EATRO 2340 genome than they did to 
the EATRO 3 genome: this was probably due to the read coverage tending to 
drop off at the ends of contigs and towards gaps, because reads where only part 
of the sequence is present will usually not be aligned. The EATRO 3 genome was 
more fragmented than the EATRO 2340 genome, i.e. more sequence was in the 
bin contigs than for EATRO 2340; the bin sequence was spread over 1702 contigs 
with an N50 of 32 kb, compared with 550 contigs with an N50 of 72 kb; and there 
were nearly 13000 gaps compared with 4000 in EATRO 2340.  
3.2.4.3 Coverage of previously sequenced telomeric and subtelomeric 
genes 
The related strain EATRO 795 has been used extensively in work characterising 
various aspects of the biology of VSGs, as result of which the sequences of a 
number of telomere-proximal VSG genes from the EATRO lineage are available 
(Miller & Turner, 1981; Robinson et al, 1999). In order to assess the coverage of 
the VSG repertoire by the genome sequences, I used BLASTN to query the 
EATRO 3 and EATRO 2340 genomes with 16 ILTat genes. Of these 16 ILTat genes, 
good matches for nine were found in EATRO 3 and for eight in EATRO 2340 
(Table 3-4). This represents a good level of coverage, given that in EATRO 795 
some of these genes had only telomere-proximal copies (Robinson et al, 1999), 
which means that they were in one of the most difficult regions of the genome 
to assemble. It would be expected that EATRO 3 (isolated four years before 
EATRO 795) would share more of these genes with EATRO 795 than would 
EATRO 2340 (isolated 13 years later), and it is encouraging to see this reflected 
somewhat in the assembled genomes despite less EATRO 3 than EATRO 2340 
sequence having been assembled. 
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Table 3-4 – Quality of matches to VSG genes previously characterised in the parasite 
lineage. 
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Table 3-4 continued. In the ‘Gap?’ column, a ‘yes’ indicates that the hit was interrupted or 
truncated by an assembly gap. Data on EATRO 795 are from Robinson et al, 1999. 
MC = minichromosomal, T = telomeric, I = internal (most likely in subtelomere arrays), 
nd = not done 
3.2.4.4 SRA 
As described above, the history of both EATRO 3 and EATRO 2340 predicts that 
they contain the T. b. rhodesiense-defining gene SRA. I therefore used BLASTN 
to query both genomes with four published sequences of SRA: Z37159, the 
original SRA sequence, from EATRO 3 (De Greef & Hamers, 1994); AF097331 from 
a Ugandan isolate (Milner & Hajduk, 1999); AJ345057 from a Kenyan isolate and 
AJ345058 from a Zambian isolate (Gibson et al, 2002). Despite their widely 
separated geographic origins, the minimum pairwise identity between these 
published SRA sequences is 97.8% (once the sequences have been truncated so 
that they all start and end at the same point as the shortest sequences, 
AJ345057 and AJ345058), reflecting the high level of conservation of SRA. In 
EATRO 2340, all four gave good hits to a sequence close to the end of a short 
(15 kb) bin contig. In the new genomes, finding SRA would likely present a 
challenge because the gene is in a BES in all trypanosomes examined, and hence 
in one of the most difficult regions to assemble. The EATRO 2340 hit was 
truncated by 97 bp at the 3′ end compared with the shortest published 
sequence, but had a minimum pairwise identity of 97.8% in the region that was 
present in all five sequences. EATRO 3 did not have such good hits, even to 
Z37159. I therefore checked whether the SRA homologue in EATRO 2340 was 
well-covered by the BWA-mapped EATRO 3 PCR-free sequence reads described in 
section 3.2.4.2. This proved to be the case, indicating that the EATRO 3 DNA 
sequence did indeed contain the SRA gene, as expected (Figure 3-3). There was 
only one likely EATRO 3-EATRO 2340 SNP in the SRA sequence (see section 
3.4.1), indicating that the EATRO 3 SRA gene was also very highly conserved. 
Because no EATRO 3 SRA gene was assembled from this analysis, a comparison 
with the previously reported SRA from EATRO 3 (Z37159) was not possible, but 
the comparison with EATRO 2340 indicated that the two versions of the gene 
from EATRO 3 shared at least the 99% level of identity that was found between 
the assembled EATRO 2340 SRA and Z37159. 
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Figure 3-3 – EATRO 3 PCR-free sequence reads mapped with BWA to EATRO 2340 SRA 
homologue confirm the presence of SRA in the EATRO 3 genome sequenced. 
BLAST queries with SRA genes showed a homologue in EATRO 2340 contig249, which 
contig is shown in part (bottom), visualised with Artemis, with the likely SRA gene shown by 
a green box. The scale is bp from the start of contig249. PCR-free reads from EATRO 3 
mapped to this region are shown (top plot) as blue (forward orientation) or green (reverse) 
horizontal bars. The reads were mapped with good coverage (middle plot, reads per base in 
non-overlapping 8 bp windows, scale is from 0 to 27.8), and few SNPs (red strokes in top 
plot), indicating that SRA was present in the EATRO 3 genome sequenced. 
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3.3 Comparison of EATRO genomes and reference 
strains 
3.3.1 Pairwise identities of coding sequences in EATRO 3, 
EATRO 2340 and T. b. brucei TREU 927 
As described above, I used automatic annotation transfer to annotate coding 
sequences in EATRO 3 and EATRO 2340 chromosome cores. This approach yielded 
6253 genes that had been annotated in both EATRO 3 and EATRO 2340. For each 
of these, I performed three pairwise alignments: EATRO 3 vs EATRO 2340, 
EATRO 3 vs TREU 927 and EATRO 2340 vs TREU 927 (Figure 3-4). In the EATRO 3 
vs EATRO 2340 comparisons, around half of the coding genes examined (2982) 
were identical, and 96.7% had at least 99% identity. However, between 
TREU 927 and each EATRO genome, only around 5% were identical, and 86% 
(EATRO 3) and 87% (EATRO 2340) had at least 99% identity. This is consistent 
with EATRO 3 and EATRO 2340 being more closely related to each other than 
either is to TREU 927. 
 
Figure 3-4 – Pairwise comparisons of all coding sequences annotated in EATRO 3, 
EATRO 2340 and TREU 927. 
RATT was used to transfer annotations automatically from TREU 927 to EATRO 3 and 
EATRO 2340. Genes containing gaps and those less than 50% of the TREU 927 length were 
excluded, as were genes that had been transferred successfully to only one genome. 
Pairwise alignments were done for each gene for all three possible pairings, as shown in 
the key, using Clustalw1.8. 
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3.3.2 Comparison with other reference genomes 
I decided to use the EATRO sequences to perform inference of the relationships 
between these isolates and other sequenced T. brucei strains, to test whether 
EATRO 3 and EATRO 2340 grouped closely, as expected. For this analysis, I used 
the publicly-available genomes of T. b. brucei strains TREU 927 (Berriman et al, 
2005) and Lister 427 (downloaded from TriTrypDB), and T. b. gambiense strain 
DAL 972 (Jackson et al, 2010). My first strategy was to attempt to create 
alignments of genes that had been used previously to study phylogeny within 
Trypanosoma (Alvarez et al, 1996; Stevens & Gibson, 1999; Hamilton et al, 
2004), but this approach was not successful. In some cases, for example 
phosphoglycerate kinase and various rRNA subunits, the genes were unusable 
because they were not properly assembled in one or both EATRO genomes, most 
likely because the genes are found in tandem arrays, which makes them difficult 
to assemble. In other cases, for example trypanothione reductase and heat-
shock protein 70, there were only one or two differences within the five-genome 
alignment, which meant the alignments were unlikely to be reliable bases for 
trees. 
Instead, I used a whole-genome comparison approach to generate a tree of the 
relationships between strains. This approach involved finding maximal unique 
matches (MUMs) between the concatenated genomes of each pair of strains using 
MUMmer, and estimating phylogenetic distances between two strains based on 
the fraction of each sequence that was covered by MUMs, scaled logarithmically. 
The analysis used 25.6 Mb of sequence in TREU 927, 25.6 Mb in Lister 427, 
22.1 Mb in DAL 972, 21.5 Mb in EATRO 3 and 23.6 Mb in EATRO 2340. This 
approach generated a well-separated tree that was consistent with the expected 
relationships between the strains (Figure 3-5). 
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Figure 3-5 – Unrooted tree showing relationships between five T. brucei whole genomes 
using new EATRO 3 and EATRO 2340 genome assemblies. 
The chromosomes were concatenated for each strain and MUMs for all ten possible 
pairings of the full genomes were found using MUMmer. A distance matrix was constructed 
by calculating, for each pair of sequences A and B, –log((fraction of genome A covered by 
MUMs to genome B) + (fraction of genome B covered by MUMs to genome A)/(length of A + 
length of B)). A neighbour-joining tree was generated using BIONJ and visualised in 
Dendroscope. The scale bar represents 0.1 distance units. 
The strategy of using MUMs has several limitations, but is sufficient to give a 
general impression of the relationships. One limitation is caused by the fact that 
the genomes vary in length and in assembled subtelomere content, which means 
that the longest genome may have contained unmatched sequence that had 
simply not been assembled in the others; and that the genome with the highest 
assembled subtelomere content will have appeared to contain a higher 
proportion of sequence that is not found in the others. Both of these 
complications would have artificially inflated the distance of the genome in 
question from the others, and are probably at least partially responsible for the 
long branch length separating the best-assembled genome, TREU 927, from the 
others. A second caveat is that it is possible that the distance between EATRO 3 
and EATRO 2340 was under-estimated somewhat, because EATRO 3 used 
EATRO 2340 as a reference for assembly. However, to produce any topology 
other than what is seen here, this bias would have to be considerably more than 
seems likely. 
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3.4 Comparison of EATRO 3 and EATRO 2340 genomes 
3.4.1 Calling of mutations, and quality control 
To look at mutations across the genome, I used EATRO 2340 as the reference 
sequence because this genome was better assembled than EATRO 3. I used BWA 
to map PCR-free, paired-end Illumina sequencing reads from both EATRO 2340 
and EATRO 3 on to the EATRO 2340 genome assembly (including bin contigs), 
which gave mean coverages with good-quality reads of 54-fold and 28-fold 
respectively. I used the program SAMTools to locate single-nucleotide 
differences (either SNPs or indels) between the reference genome and the 
aligned reads, and to filter these differences to exclude any where the read 
coverage was unusually high (above 200), or too low to be confident of the call 
(below 10). For the EATRO 2340 to EATRO 2340 mapping, 96.9% of positions had 
appropriate coverage for SNP calling; this figure was 92.5% for the EATRO 3 to 
EATRO 2340 mapping. SAMTools identified 176334 ‘good quality’ differences 
using the EATRO 3 reads and 184161 using the EATRO 2340 reads, of which 34982 
and 41497 respectively were indels. I also used the information from SAMTools to 
classify substitutions into homozygous differences, where all (or almost all) 
reads differed from the reference, and likely heterozygosities, where the 
numbers of reads identical to the reference and reads that differed were 
consistent with two alleles being present. This analysis found that the majority 
of differences called as substitutions were likely to be due to heterozygosities: 
137964 out of 141352 (97.6%) with EATRO 3 reads and 139234 out of 142664 
(97.6%) for EATRO 2340. 
I then developed a Perl script to identify differences that were present either 
when comparing the EATRO 2340 genome and the EATRO 3 reads, or when 
comparing the EATRO 2340 genome and the EATRO 2340 reads, but not in both. 
This step was to discard differences that were called either due to errors in the 
EATRO 2340 genome assembly, or due to heterozygosities that were present in 
both genomes. As a further check, if there was a SNP called in only one genome, 
the script also tested whether coverage in the other genome was sufficient for a 
SNP to have been called; if not, the SNP was discarded, as I could not be 
confident that there was not a SNP in both genomes. 
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Of the putative differences between EATRO 3 and EATRO 2340, 146433 were 
discarded due to there being a SNP in both isolates, and 11769 were discarded 
because coverage was insufficient in one or other genome for a SNP to be called. 
This analysis yielded 55860 likely EATRO 3-EATRO 2340 SNPs, of which 9596 were 
indels, 45608 were heterozygous substitutions (i.e. the genome with a new allele 
at the SNP position probably also contained the old allele) and 656 were 
homozygous substitutions. 
I used this approach to generate a plot of differences for every EATRO 2340 
chromosome and contig. The distributions of differences for each chromosome 
are shown in Figure 3-6, plotted on an ACT view showing hits of at least 90% 
identity in BLAST alignments of the EATRO 3 and EATRO 2340 chromosomes. 
From these plots it can be seen that, in general, there were many more 
differences between isolates in the subtelomeres than in the chromosome cores. 
There were some regions within the cores that showed a greater difference 
between the isolates than would be expected. One of the most obvious of these 
is on chromosome 4, where there were many differences along the chromosome, 
approximately from the homologue of Tb927.4.3760 to the end of the 
chromosome core after Tb927.4.5380. This region corresponds quite well with a 
region of the chromosome that is a segmental duplication shared with 
chromosome 8, between Tb927.4.3860 and Tb927.4.5390 (Jackson, 2007a). 
Although the corresponding region on chromosome 8 was assembled, it did not 
show a similarly high number of SNPs; however, it seems likely that the 
apparently anomalously high rate of mutation on chromosome four is due to 
misassemblies or misalignments caused by this duplication. This possibility is not 
of particular concern to the main analysis, which will concentrate on the genes 
in the subtelomeres. 
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Figure 3-6 – Distribution of differences between EATRO 3 and EATRO 2340. Continued on 
next pages. 
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Figure 3-6 continued. 
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Figure 3-6 continued. 
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Figure 3-6 continued. 
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Figure 3-6 (previous four pages). Chromosomes were aligned by BLASTN, and hits of at 
least 90% identity were visualised using ACT, showing hits between the EATRO 3 
chromosome (top set of grey bars) and the EATRO 2340 chromosome (bottom set) 
connected by red (hit in the same orientation) and blue (reverse orientation) bars. The scale 
bars in each chromosome indicate the distance along it in bp. Chromosomes are shown at 
the same scale, except for chromosomes 10 and 11, which are shown at smaller scales to 
enable each to fit on to one page. Subtelomeres are shown as yellow boxes on both the 
forward and reverse strand for each isolate and chromosome. Validated differences 
between EATRO 2340 and EATRO 3, annotated using PCR-free reads as described in the 
text, are plotted on the bottom graph, relative to the EATRO 2340 chromosome. These plots 
show the number of differences per base in non-overlapping 100 bp windows along the 
chromosome, with minimum 0 and maximum as shown on the right-hand end of each plot. 
3.4.2 Comparison of mutation rates in cores and subtelomeres 
From these SNP plots I calculated the overall mutation frequency in chromosome 
cores, subtelomeres and bin contigs (Table 3-5). Because the approximate 
relationship between the two isolates is known (see Figure 3-1), it was also 
possible to estimate upper and lower bounds for per-generation mutation rates. 
The mutation frequency in subtelomeres (2.4×10-3 SNPs/base) was 2.9-fold 
higher than in the chromosome cores, with a similar difference (2.7-fold) 
between the bin contigs and chromosome cores. 
Genome 
region 
Total 
length 
(bp) 
Total 
SNPs 
SNPs/base SNPs/base/generation 
Mean 99% CI lower 
99% CI 
upper Min Max 
Core 20443109 16817 0.00082 0.00081 0.00084 9.7×10-9 3.3×10-8 
ST 2047231 4935 0.00241 0.00233 0.00249 28.4×10-9 9.6×10-8 
Bin 15342690 34108 0.00222 0.00220 0.00225 26.1×10-9 8.9×10-8 
Table 3-5 – Overall mutation frequencies and likely range of mutation rates in cores, 
subtelomeres and bin contigs. 
CI = confidence interval: 99% confidence intervals were calculated assuming a binomial 
distribution. ST = subtelomeres 
To further examine the difference, I calculated the mutation frequency in 10 kb 
windows across each chromosome core and each subtelomere (Figure 3-7). To 
simplify analysis I only considered full-length windows, e.g. if a contig was 
65000 bp long, I examined only the first six windows. This meant that some 
sequence was ignored from the ends of each region: 63109 bp from the cores, 
117231 bp from assembled subtelomeres and 1942690 bp from bin contigs. I used 
R to model the mutation frequency using a negative binomial distribution, and to 
test whether genome region made a significant difference to mutation frequency 
in this model. For this analysis I considered assembled subtelomeres and bin 
contigs as a single subtelomere region. For the model, the residual deviance was 
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4044.0 on 3569 degrees of freedom, which indicates that the model described 
the data reasonably well. The analysis found that genome region (subtelomere 
or core) was a significant determinant of mutation frequency in a window, and 
that subtelomeres had a significantly higher mutation rate than cores 
(p < 0.0001). The variation in the mutation frequency was considerably higher in 
subtelomeres and bin contigs than in the cores, with an interquartile range of 
2.2×10-3 SNPs/base compared with 8×10-4 SNPs/base for cores. 
 
Figure 3-7 – Box plot of mutation frequencies in 10 kb windows across cores, assembled 
subtelomeres and bin contigs. 
The x-axis shows the number of mutations per bp in 10 kb windows across the indicated 
regions. Boxes enclose values between Q1 and Q3; dotted lines indicate the median value; 
the whiskers extend to the maximum and minimum values. Subtelomere (combined 
assembled subtelomeres and bin contigs) mutation frequency was significantly higher than 
core mutation frequency (p < 0.0001). 
3.4.3 Distribution of new mutations 
As described above, new mutations were annotated by identifying SNP positions 
where one isolate had an allele that was not present in the other. Most of these 
positions were homozygous in one isolate, and in the second were heterozygous, 
with one new allele and one allele the same as in the first isolate. Hence, the 
lineage in which the new mutation arose can be deduced with high probability. 
The distribution of such new mutations between EATRO 3 and EATRO 2340 can 
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be used to inform the estimate of the relationship between the two isolates. For 
example, if EATRO 2340 is indeed a direct clonal descendant of EATRO 3, then 
EATRO 2340 would already contain all alleles that had been present in EATRO 3, 
and so any new alleles should only have been found in EATRO 2340. In any case, 
the ratio of the number of new mutations in EATRO 2340 to the number in 
EATRO 3 should be approximately proportional to the ratio of the time from 
each to their most recent common ancestor (MRCA). I therefore determined the 
distribution between the two isolates of annotated new mutations (Table 3-6). 
This analysis was performed on only substitution mutations, because the calling 
of indel mutations was likely to be less reliable. 
Chromosome 
Core Subtelomere 
EATRO 3 EATRO 2340 EATRO 3 EATRO 2340 
1 71 70 61 100 
2 125 175 64 70 
3 306 538 354 525 
4 1224 153 254 42 
* 4 minus anomalous regions 54 112 19 13 
5 201 273 46 70 
6 187 365 19 21 
7 140 286 136 143 
8 331 446 45 55 
9 188 352 853 959 
10 2787 527 58 58 
* 10 minus anomalous regions 186 503 58 58 
11 628 1265 197 231 
Bin contigs NA NA 14807 15921 
Initial total 6188 4450 16894 18195 
Initial EATRO 2340:EATRO 3 
ratio 0.72 1.08 
* Total minus anomalous 
regions 2417 4385 16659 18166 
* Revised EATRO 2340:EATRO 
3 ratio 1.81 1.09 
Table 3-6 – Distribution of new mutations between EATRO 3 and EATRO 2340 lineages. 
Lines marked with asterisks are those referred to in the text. 
The distribution was initially somewhat surprising, because in the chromosome 
cores there were considerably more new mutations annotated in EATRO 3 than 
in EATRO 2340 (6188 compared with 4485). On inspection of the distribution on 
each chromosome, it became apparent that this unexpected result was 
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dominated by the values for two chromosomes, 4 and 10 (lines five and 12, 
Table 3-6), where the number of mutations in EATRO 3 far exceeded the number 
in EATRO 2340. To examine these anomalous results further, I plotted the 
distribution of new EATRO 3 and new EATRO 2340 alleles along these 
chromosomes (Figure 3-8). This analysis revealed that on each of these two 
chromosomes there was one large region where the number of EATRO 3 
mutations suddenly increased, and there were very few EATRO 2340 mutations. 
In chromosome 10, this observation was reminiscent of a phenomenon observed 
in other T. brucei strains: loss of heterozygosity (LOH) in large regions of 
chromosome 10 (A. Cooper, PhD thesis, 2009). LOH was observed in multiple cell 
lines from several strains that were being maintained in cell culture (seven lines 
from three strains and a fourth strain that was a cross of two of the independent 
strains), and was associated with an increased growth rate compared with wild-
type. It was hypothesised that this loss had occurred on multiple independent 
occasions because one of the chromosome 10 haplotypes contains a dispersed 
combination of alleles that together confer a growth advantage, and that 
converting both chromosomes to this haplotype would give an even greater 
growth advantage. Therefore, LOH in one direction would be selected for (A. 
Cooper, PhD thesis, 2009). If such a LOH event had occurred in EATRO 2340, 
heterozygosities that had been present in the ancestor of both isolates would be 
removed, and the allele that had been lost from EATRO 2340 would appear to be 
a new mutation in EATRO 3. Furthermore, EATRO 2340 would be expected to be 
homozygous throughout this region, or at least nearly so, since it possible that 
some new mutations could have arisen in one or other homologue since the loss 
of heterozygosity event. I therefore examined the number of heterozygous 
positions in the core region of EATRO 2340 chromosome 10 (i.e. the number of 
positions where a heterozygous SNP had been called in the EATRO 2340 reads 
mapped to the EATRO 2340 genome). This analysis revealed that there were 
indeed far fewer heterozygous SNPs called across the putative LOH region, with 
more than 17-fold higher density in the core sequence outside the anomalous 
region than within it: 0.00019 heterozygous SNPs/base inside the anomalous 
region compared with 0.00326 heterozygous SNPs/base outside it. 
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Figure 3-8 – Anomalous regions of new mutation distribution in A) chromosome 4 and B) 
chromosome 10. 
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Figure 3-8 continued. Plots are of the number of new mutations per base in 100 bp windows 
in EATRO 3 (top plots) and EATRO 2340 (bottom plots). Red boxes approximately indicate 
the anomalous regions described in the text. Yellow boxes below the scale bar indicate 
subtelomeres, as in Figure 3-6. 
The anomalous region of EATRO 2340 chromosome 10 extended approximately 
from positions 915900 to 2204700, including the genes from Tb927.10.3680 to 
Tb927.10.9100 inclusive. The region between these genes in TREU 927 
chromosome 10 (version 5) is positions 958508 to 2258748. The LOH region 
previously observed has been characterised in four cell lines, and was found to 
extend from at least the first genetic marker on the chromosome (at position 
91140 in the current TREU 927 assembly), to a varying end position between 50% 
and 70% of the way along the chromosome. The end position was determined at 
high resolution for only one strain, and the estimated boundaries of the losses of 
heterozygosity ranged from approximately positions 2250000 to 3195925 in the 
current assembly (A. Cooper, PhD thesis, 2009). The potential LOH region in 
EATRO 2340, therefore, was consistent in its end point with previously 
characterised occurrences. The start point was considerably further from the 
beginning of the chromosome than in previously described LOH events, where it 
is likely LOH extended to the start of the chromosome. It was suggested that the 
LOH occurred by break-induced replication (A. Cooper, PhD thesis, 2009). 
Meiotic exchange was not considered since in several of the cell lines the event 
could only have occurred in culture, and trypanosome mating takes place in the 
tsetse fly (MacLeod et al, 2005). Break-induced replication would usually be 
expected to proceed from the break event to the end of the chromosome 
(Paques & Haber, 1999), which is consistent with what has been seen previously, 
but not with the apparently internal conversion in EATRO 2340 chromosome 10. 
However, it is possible that template switching from the homologous partner to 
the sister chromatid, or disengagement of the repair machinery, could have 
ended the LOH (Smith et al, 2007); that some other mechanism operated, for 
example two mitotic crossover events; or that heterozygosity was restored in 
some way and subsequently selected for. It is not possible to distinguish 
between these possibilities with the data available. 
In general, a LOH event in part of chromosome 10 would explain the 
observations of the distributions of new mutations between isolates on this 
chromosome, and the plausibility of this explanation is supported by previous 
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observations in other strains. This finding implies that apparent new mutations 
in this region should perhaps not be considered in further analyses of mutation 
rate and profile. 
For chromosome 4 the anomalous region extended from approximately position 
896500 (just upstream of Tb927.4.3770) until the end of the chromosome 
(including the subtelomere). As has already been noted, in TREU 927 there is a 
segmental duplication on chromosome 4 shared with chromosome 8, which 
begins around Tb927.4.3860 and extends into the subtelomere, and there was an 
apparent increase in the number of EATRO 3–EATRO 2340 mutations across this 
region compared with the rest of the chromosome. It therefore seems likely that 
the anomaly in ‘new mutation’ distribution is connected with this duplication, 
and is perhaps due to misassemblies or misalignments caused by it. An 
alternative is that a LOH event similar to that hypothesised in chromosome 10 
has occurred in chromosome 4, in a region that, by its segmental duplication, 
has already shown itself to be prone to rearrangement. (In fact, the approximate 
start of the anomalous region is in a region of repeats.) The excess of apparent 
new mutations in EATRO 3 in this region, therefore, is not of undue concern to 
the main analysis, although again it is implied that apparent new mutations in 
this region should perhaps not be considered in further analyses. 
The observations in both chromosomes 4 and 10 could be explained by the 
physical loss of part of one chromosome from each homologous pair in 
EATRO 2340. However, there was little difference in read coverage of 
EATRO 2340 between the anomalous and normal regions of both chromosomes, 
which makes this explanation unlikely. In both cases, it remains possible that 
meiotic recombination is the explanation for the anomalous distributions of new 
mutations. However, it seems highly unlikely that mating with another strain has 
occurred, since genetic analysis has strongly suggested that expansion has been 
clonal, and inter-strain mating in one of the lineages would have produced a far 
higher number of new alleles than was observed. A second possibility is that 
mating between two individuals from the same clonal lineage could occur, i.e. 
inbreeding. Given that in general there is a reasonable level of heterozygosity in 
both isolates, it is unlikely that inbreeding mating has been a common 
occurrence. However, meiotic exchange followed by mating would result in 
partial LOH in all offspring (unless the relevant chromosome had had an 
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exchange event at exactly the same place in both parents), and could produce a 
phenotype such as is seen in chromosomes 4 and 10. However, examination of 
the plots of distribution of new mutations in the other chromosomes did not 
reveal any other substantial regions of this nature, which are unlikely to be 
absent if an inbreeding mating event had occurred. Furthermore, it is striking 
that the only anomalous regions should be those where previously reported 
phenomena could provide an alternative explanation to meiotic exchange. 
If these anomalous regions on chromosomes 4 and 10 are removed, the 
distribution of new mutations between EATRO 3 and EATRO 2340 is more in line 
with what might be expected (Table 3-6, asterisked lines), with an EATRO 2340 
to EATRO 3 ratio of 1.8:1 in the chromosome cores. This core ratio implies that 
the time from the MRCA to EATRO 2340 is 1.8-fold that of the time for EATRO 3, 
i.e. the time since the MRCA is approximately 21 years for EATRO 3 and 38 years 
for EATRO 2340 with a divergence date of 1939. The minimum expected ratio, 
given the range of genealogies outlined in Figure 3-1, would be 1.9:1 (37 
years:20 years). This result therefore implies that the separation between the 
two isolates is around the maximum expected from their known history. Using a 
divergence date of 1939 implies that the mutations observed have accumulated 
over 59 years, which corresponds to approximately 86000 generations and yields 
mutation rate estimates of 4.22×10-9 mutations/base/generation for the 
chromosome cores and  2.34×10-8  mutations/base/generation for the 
subtelomeres and bin contigs combined. 
The ratio from the assembled subtelomeres and bin contigs combined (1:1.1) is 
somewhat lower than both the core ratio and minimum expected ratio2. 
However, because of the haploid nature of these regions, and probable high 
level of ectopic recombination, it is not surprising that the apparent distribution 
is not straightforward. Moreover, this global analysis was intended only to give 
an initial approximation of the mutations occurring in EATRO 3 and EATRO 2340. 
In particular, it is possible that there were more false positive new mutations 
called in EATRO 3 than in EATRO 2340, especially in the subtelomeres, since the 
                                                
2 The subtelomeres of chromosome 4 initally had a large deviation from this average, with 
a ratio of 6.0:1. However when the anomalous regions of chromosome 4 were removed 
as described above, many subtelomeric EATRO 3 mutations were removed, giving a less 
unusual ratio of 1.5:1 (19 EATRO 3 to 13 EATRO 2340, Table 3-6). 
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quality of reads was somewhat lower for EATRO 3. This caveat also applies to 
the estimates of mutation rates calculated above from the core ratio. A more 
careful and rigorous mutation rate determination and comparison will be 
described in Chapter 5. 
3.4.4 Kinetoplast DNA 
The initial BLAST searches described in this section were carried out by Prof 
Dave Barry. BLASTN was used to query both genomes with the sequence of the 
coding region of the kinetoplast maxicircle of T. brucei Lister 427 (GenBank 
reference M94286). This search identified one contig of 31 kb in the EATRO 3 
genome that contained the coding region of the maxicircle, with 99% identity to 
the Lister 427 sequence, and some sequence matching the repetitive region 
between the end of the coding region and the replication origins. The contig 
appears to be composed of the 3′ two-thirds of the coding region, followed by a 
poorly assembled version of the repetitive region, followed by a second copy of 
most of the coding region (Figure 3-9). This assembly is likely due to the fact 
that kinetoplast DNA (kDNA) exists in circular form, but the assembly algorithm 
is designed for linear DNA, and has assembled one-and-a-half rounds of the 
circle. 
No contig corresponding to the maxicircle was identifiable in the EATRO 2340, 
although one EATRO 2340 contig of 1033 bp was 99.32% identical to part of the 
EATRO 3 contig, containing part of ND1 and part of MURF1. I therefore examined 
the data generated from mapping the PCR-free sequencing reads to the EATRO 3 
contig. The contig had high mean good-quality read coverage with both EATRO 3 
(206-fold) and EATRO 2340 reads (456-fold) , indicating, unsurprisingly, that the 
maxicircle was present in EATRO 2340. No SNPs had been called in the EATRO 3 
PCR-free reads mapped to the contig. One SNP had been called in the 
EATRO 2340 PCR-free reads, but the SNP was caused by a length difference in a 
homopolymeric adenosine tract following a gap, and so was unlikely to be 
genuine. There may be other SNPs that were not called, but in general, this 
analysis indicated that there was very little difference between the kDNA of the 
two isolates. 
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Figure 3-9 – EATRO 3 contig containing kDNA maxicircle. 
The EATRO 3 contig was identified by BLASTN with the kDNA maxicircle of Lister 427, then 
aligned with the maxicircle sequence using NUCmer and the alignment visualised with 
MUMmerplot. The Lister 427 kDNA is on the x-axis and the EATRO 3 contig is on the y-axis, 
with the scale indicating the distance in bp along each. Where the sequence could be 
aligned, a red line is drawn, with dots marking the start and end of the alignment. 
3.5 Summary 
In this chapter, I have described the assembly, annotation and comparison of 
two new T. brucei genomes, from very closely related isolates of T. b. 
rhodesiense. These genomes were of draft quality with many gaps, and a large 
amount of the assembled sequence could not be mapped onto chromosomes. 
However, there was a large amount of sequence present; the genomes had high 
mean coverage depths; and most annotated TREU 927 coding genes could be 
transferred to both genomes. These metrics demonstrated that the genomes 
were of sufficiently high quality for further study. The assemblies did not 
contain every gene that would be expected in the isolates’ genomes. However, 
the coverage of known genes was sufficiently high that it seemed reasonable to 
expect to find a substantial proportion of the isolates’ VSG genes in the 
assemblies. 
Comparison of the conserved chromosome cores with other trypanosome 
genomes confirmed that EATRO 3 and EATRO 2340 are extremely closely related. 
This analysis supported the presumed relationship between the two isolates, 
which was derived from the provenance of the original parasites and from 
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serology. Despite this close relationship, however, comparison of the two 
genomes uncovered numerous differences between the isolates. Previous 
observations led us to predict that trypanosome subtelomeres are subject to an 
elevated rate of mutation, and indeed, in these genomes the subtelomeres had a 
significantly higher mutation rate than the cores. 
Confirmation both of the close relationship and the presence of difference 
between the two genomes gave me confidence that a comparison of EATRO 3 
and EATRO 2340 would yield fruitful insights into VSG evolution: the isolates 
appeared to be similar enough that it would be possible to identify the same VSG 
gene in both genomes, but different enough that there would be changes 
apparent in many genes. Further, at a first approximation, the way that 
mutation proceeds was quantifiably different between cores and subtelomeres, 
which suggested that closer analysis would be able to uncover any more detailed 
quantitative and qualitative differences. I therefore proceeded with analysis of 
the VSG archives within and between the two isolates.
 
 
 
 
 
Chapter 4: The VSG archive of EATRO 3 
and EATRO 2340 
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4 The VSG archive of EATRO 3 and EATRO 2340 
4.1 Introduction 
Chapter 3 described the assembly of two new trypanosome genomes, those of 
T. b. rhodesiense isolates EATRO 3 and EATRO 2340. These assemblies 
substantially increased the number of sequence data available for a range of 
genomic studies in T. brucei. However, the primary purpose of the genome 
sequencing was to provide new subtelomeric sequence in which a new set of VSG 
genes could be annotated. The first use of these data was to compare the VSG 
genes between the two isolates in order to gain insight into the detailed 
processes of subtelomere evolution. A second outcome was the availability of a 
new data set that could be compared with previously described archives to study 
the VSG archive more generally. 
In this chapter I will first describe the annotation of sequences encoding VSG 
NTDs in both genomes, a non-trivial process due to the considerable variability 
inherent in VSGs; the identification of sequences that corresponded to the same 
gene in the two genomes; and the cataloguing of the substitution mutations that 
had occurred in the VSG NTDs and in the core genes. I will then present a 
detailed comparison of mutation in the subtelomeric VSG NTDs with that 
occurring in chromosome core genes, and with that occurring across 
subtelomeres as a whole. The aims of the analysis were to test in detail the 
hypothesis (already supported tentatively by the analyses described in Chapter 
3) that mutation in the subtelomeric genes is a different, more rapid process 
from what occurs in core genes; to examine the effect of mutations on the 
subtelomeric antigen genes; and, if this first hypothesis was supported, to test 
the hypothesis that the elevated mutation rate of VSG NTDs applies across the 
subtelomeres rather than being gene-specific. The project focused on evolution 
of VSG genes but the chapter also contains a brief analysis of substructuring and 
pseudogenicity in the newly annotated EATRO 3-EATRO 2340 VSG archive. 
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4.2 Annotation of VSG NTDs 
4.2.1 Support vector machine-based VSG prediction 
Because the sequences of VSG and VSG genes are so diverse, and because genes 
often include frameshifts, annotation approaches based solely on sequence 
similarity will give an incomplete picture. Therefore, to aid my annotation of 
VSGs I used a support vector machine-based prediction program (SVM-VSG), 
developed by Dr Jon Wilkes. This program examines DNA sequence in 
overlapping 1000 bp windows, and decides for each window whether it is likely 
to contain VSG domain sequence, with separate analyses for NTDs and CTDs. It 
can therefore be used to query whether a particular sequence is likely to be a 
VSG gene, and de novo to find windows of sequence that likely contain VSG 
sequence. 
4.2.2 Full-length, potentially intact genes 
I began annotation by looking for VSGs that were encoded by a complete ORF. 
Examination of previously annotated full-length VSG genes in VSGdb (Marcello et 
al, 2007) gave a range of 1317 to 1623 bp for this type of gene; I therefore used 
a range of 1290 to 1650 bp for my search. I used Artemis to find all ORFs above 
1290 bp in every subtelomere and bin contig for both genomes. I then extracted 
the sequences for the ORFs and used a Perl script to trim them to the first in-
frame ATG, remove any that contained assembly gaps, and filter the final 
sequences for maximum and minimum length. These sequences were analysed 
with the SVM-VSG program, and a sequence was retained as a likely full-length 
VSG if both an NTD and a CTD were predicted within the ORF. 
Within the ORFs, the NTD-CTD boundaries were annotated using HMMs. HMMs for 
the A- and B-type NTDs and for the CTD were provided by Dr Bill Wickstead 
(University of Nottingham). The ORFs were translated, and then queried with 
the NTD HMMs using hmmsearch from the HMMer suite of programs. If either 
type of NTD was found, the domain boundary was defined after the last residue 
of this domain, and the NTD type was defined according to which HMM had a hit. 
If no NTD was found, the ORF was queried with the CTD HMM, and the DNA 
sequence of the CTD hit was manually examined to locate the conserved pattern 
of cysteines. The domain boundary was defined as 50 residues upstream of the 
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first conserved cysteine, and the NTD type was defined as ‘unknown’. This 
approach identified 280 VSGs in EATRO 3 and 348 in EATRO 2340. 
4.2.3 Pseudogenes 
To extend the analysis, I used the SVM-VSG program to locate windows of 
sequence containing likely NTDs in the chromosomes and in the contigs longer 
than 10 kb (the VSG-SVM program could not analyse shorter contigs). After 
excluding windows containing assembly gaps, this yielded 883 NTD windows in 
EATRO 3 and 2179 in EATRO 2340. In order to define the VSG NTDs within these 
sequences, I used a combination of HMMer and BLASTX. I produced translations 
of all three frames of the NTD windows, and queried these with the NTD HMMs. 
When the HMM had a near full-length hit, this single hit was used to define the 
boundary of the domain. For those that did not have a near full-length hit but 
did hit adjacent fragments of NTDs in different frames, I developed a script to 
piece hits together where possible to give a near full-length domain. For all 
HMM-defined NTDs, I developed another script to check the start of the domain: 
if the sequence did not begin with a methionine (ATG) codon, the sequence 
immediately 5′ was scanned for a suitable start codon. If a start codon was 
found, the sequence was extended to include it; if not, the original start 
position was retained. This approach delineated 421 NTDs in EATRO 3 and 1077 
in EATRO 2340. 
There remained a large number of NTD windows where an NTD could not be 
found using HMMer. I generated protein BLAST databases from all the NTDs I had 
earlier annotated in both genomes, and used BLASTX to query the EATRO 3 
database with the remaining unannotated EATRO 3 NTD windows, and the 
EATRO 2340 database with the remaining EATRO 2340 windows. Again, any near 
full-length BLASTX hits were used, where possible, to define the boundaries of 
the domains; then for NTD windows without near full-length hits, adjacent 
fragments found in different frames were used, where possible, to delineate 
domain boundaries. I then used the script developed for use with HMMer results 
to check the start positions of these domains. NTD windows for which it was not 
possible to annotate domain boundaries by either the HMMer or the BLASTX 
approach were not considered further (393 SVM windows in EATRO 3, 860 for 
EATRO 2340). 
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Finally, I checked all the genes annotated in each genome to ensure that they 
were all non-overlapping, so that no part of the genome was considered twice. 
This resulted in five genes being discarded from EATRO 3 and nine from 
EATRO 2340. The final data from the annotation process in these two sections 
are summarised in Table 4-1. The larger number of genes in EATRO 2340 was to 
be expected, given that the EATRO 2340 genome assembly was both larger and 
of better quality than the EATRO 3 assembly, as discussed in Chapter 4. Given 
that the length of assembled subtelomeric sequence was less than the 
subtelomere lengths of these parasite strains, determined from molecular 
karyotypes, neither annotated gene set was likely to represent the full VSG NTD 
archive existing in the genome. 
Genome EATRO 3 EATRO 2340 
Full-length ORFs 279 348 
SVM NTD windows 883 2179 
HMMer 
From single hit 286 657 
From several hits 132 411 
BLASTX 
From single hit 43 125 
From several hits 29 126 
Initial annotation total 769 1667 
BLASTN from other genome 341 130 
Total VSG NTDs 1110 1797 
Table 4-1 – VSG NTD coding sequences annotated in EATRO 3 and EATRO 2340 genomes. 
 
Although many of the NTDs contained probable frameshift mutations, it was 
possible to predict the most likely protein sequence, i.e. the sequence that 
looked most like it could form part of a functional VSG, for almost all the genes. 
For NTDs that were annotated as full-length ORFs, I simply took the translation 
of the NTD part of the ORF. For NTDs that were annotated by searches with 
HMMer or BLASTX, I used the positions of the HMM or protein sequence hits to 
annotate where the reading frame shifted, and used the translation of several 
frames. If stop codons remained in the translated sequence, they were assumed 
to be the result of substitution mutations, and there was no way of determining 
the original sequence, so they were allowed to remain in the sequence. 
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4.3 Gene pairs: identifying and comparing the same NTD 
gene in the two genomes 
4.3.1 Identifying gene pairs 
The analysis described above generated a set of 769 VSG NTDs in EATRO 3 and a 
set of 1667 NTDs in EATRO 2340. For each NTD in EATRO 3, I attempted to 
identify the same gene in EATRO 2340, and vice versa. I used BLASTN to query a 
database of the EATRO 2340 genome with the EATRO 3 NTDs. I used the highest-
scoring hit for each NTD to define the region of the EATRO 2340 most likely to 
correspond to the same gene. In some cases, several adjacent hits on the same 
EATRO 2340 contig could be concatenated together to give sequence that was a 
better match for the NTD than any single hit, for example if the EATRO 2340 
sequence was interrupted by a gap. In these cases I took all the sequence 
between the start of the first hit and the end of the last hit. I then repeated this 
process with the EATRO 2340 NTDs and an EATRO 3 genome sequence database. 
Gene pairs were classified by quality, according to what percentage of the 
original NTD was covered by its hit, and to the degree of identity of the aligned 
sequence. 
In pairing genes by this method, it is possible that gene pairs that appeared to 
be high quality were not in fact true pairs, for example if more than one NTD 
was paired with the same sequence in the opposite genome. In order to reduce 
the likelihood of such false pairings, I carried out reciprocal BLASTN searches. I 
extracted from the EATRO 2340 genome the sequences that had been defined as 
the partners of EATRO 3 NTDs, and used these EATRO 2340 sequences to query 
the EATRO 3 database. When the best hit for the EATRO 2340 sequence 
corresponded to the EATRO 3 NTD with which it was paired, I accepted the 
pairing. If not, the pairing was discarded and the EATRO 3 NTD was classed as 
having ‘Poor or no hit’. I checked the EATRO 2340 NTD pairings in a similar way 
(Figure 4-1A and B). This approach led to the rejection of 28 pairings from the 
EATRO 3 NTDs and 431 from the EATRO 2340 NTDs. Most of the pairs excluded 
had an identity below 90% (334 out of 459 genes excluded). I repeated this 
process to identify how many EATRO 3 and EATRO 2340 NTDs had identifiable 
counterparts in TREU 927, which is from a distinct lineage: far fewer had good 
hits, or indeed any hits at all (Figure 4-1C and D). 
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Figure 4-1 – Results of pairing by BLASTN searches with VSG NTDs, after checking pairings 
by reciprocal BLASTN. 
Results for all queries are shown, classified by percentage identity of the hit (% ID) and by 
the percentage of the query covered by the hit (% coverage). A) EATRO 3 NTDs queried 
against EATRO 2340 genome. B) EATRO 2340 NTDs queried against EATRO 3 genome. C) 
EATRO 3 NTDs queried against TREU 927 genome. D) EATRO 2340 NTDs queried against 
TREU 927 genome. The areas of the pies are approximately proportional to the relative 
number of query sequences used in each comparison. The number of NTDs in each 
category is indicated in the appropriate segment. ‘Poor-quality’ hits had either less than 
70% coverage, less than 90% ID, or both. 
4.3.2 Pairwise identities of gene pairs 
Where 95% or more of the sequence of an NTD was contained in its assigned 
partner (described hereafter as at least ‘95% coverage’), and reciprocal BLASTN 
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confirmed the pairing, it seemed plausible that the two sequences genuinely 
represented the same gene in the two genomes. When considering the 
percentage sequence identity of such high-coverage sequence pairs (Figure 4-2), 
it became apparent that the vast majority of pairs had high identity: in EATRO 3, 
96% of high-coverage pairs had identity of at least 95%, and in EATRO 2340 this 
figure was 95%. This observation suggests that the mutation processes acting on 
these genes are mainly small-scale, for example base substitution or short 
indels. (However, it should be noted that it is possible that larger-scale 
mutations had also taken place, but that genes in which these occurred had had 
their sequence changed to such an extent that they were excluded from this 
analysis by the thresholds used.) 
In order to be most confident about the gene pairings, I took sequence pairs with 
at least 95% coverage and 95% identity for further analysis as ‘gene pairs’. It 
seemed likely that there would be a large degree of overlap between the 
annotated EATRO 3 and EATRO 2340 NTDs. I therefore checked the gene pairs to 
see whether the hit of an EATRO 3 NTD in EATRO 2340 had already been 
annotated as an NTD, and vice versa. If this was the case, I excluded from 
further analysis whichever NTD was shorter; or, if the two were the same length, 
I excluded the EATRO 2340 NTD. This step removed 489 duplicates from the 
analysis, 90 from EATRO 3 and 399 from EATRO 2340. There were also four cases 
where the hit from one gene of the pair fitted the criteria for a ‘high-quality 
match’, but the other did not, and so only one gene from the pair had been 
included in the analysis anyway. In all four cases the asymmetry was the result 
of the first gene being shorter than the second, leading to the percentage 
coverage differing although the length of sequence matched was approximately 
the same. In these cases, the pairing was retained and only the shorter gene was 
included in the analysis. These filtering steps left 1030 pairs that were unique in 
the analysis, with 493 of these matched with an already-annotated gene. 
Next, for each gene pair that had less than 100% coverage, I extended the start 
and/or end of the hit so that, as far as possible, each position in the query NTD 
had a corresponding base in the hit. For example, if a hit covered positions 5-
1000 of an NTD that was 1005 bp long, I extended the hit by 4 bp at the start 
and 5 bp at the end. This step was so that mutations at the very ends of genes, 
which would have caused the BLAST hits to be truncated, would not be missed. 
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Figure 4-2 – Percentage identities of query-hit pairs for which the best BLAST hit covered at 
least 95% of the query NTD sequence. 
A) EATRO 3 NTDs queried against the EATRO 2340 genome. B) EATRO 2340 NTDs queried 
against the EATRO 3 genome. The percentage identity is shown in bins of 1%. 
In cases where there was a high-identity match, but the gene had been 
annotated in only one genome using the HMMer and BLASTX annotation approach 
described in section 4.2, I used the hit information to annotate new NTDs. If a 
gene had a region with an internal gap, this region was not annotated as a new 
gene; if one end of the hit was truncated by an assembly gap then the region 
was annotated as a gene, but its possible incompleteness was noted for 
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downstream analyses. I then double-checked that the ‘new’ genes did not 
overlap with each other or with any previously annotated genes. This annotation 
gave 341 new genes in EATRO 3 and 130 in EATRO 2340, bringing the total 
number of annotated genes to 1110 in EATRO 3 and 1797 in EATRO 2340, with 
964 paired up between the genomes. There were a further 66 genes that had a 
good BLAST hit in the other genome (13 from EATRO 3 and 53 from EATRO 2340), 
but the hit sequence was interrupted by an assembly gap. These pairs were 
considered in the SNP analysis, but the gapped hit sequences were not 
annotated as new genes. 
I classified all NTDs into A-type and B-type according to the type of sequence 
used to annotate them. In EATRO 3, there were 519 A-type NTDs, 560 B-type, 
and 31 that could not be classified. In EATRO 2340, there were 843 A-type NTDs, 
921 B-type, and 33 that could not be classified. 
4.4 Detecting changes in VSG NTDs 
4.4.1 Core gene pairs 
As described in Chapter 3, I used an automatic annotation program to transfer 
core gene annotations to both genomes, and many genes were annotated in 
both. However, to produce a set of control gene pairs where the method of 
pairing of sequences was more comparable with that of the VSG NTD gene pairs, 
I used a similar BLASTN analysis to produce a set of pairs. This set of pairings 
would allow comparison of the mutations in VSG genes with those in core genes. 
Using the 7605 coding sequences automatically annotated in the EATRO 2340 
chromosome cores, I repeated the steps of BLASTN, finding of the best hit, and 
checking by reciprocal BLASTN to generate a set of gene pairs. A far higher 
proportion of the original genes could be paired with high confidence than was 
the case for VSG NTDs (Figure 4-3A). I applied the same filters to these gene 
pairs (at least 95% identity and at least 95% coverage) as to the VSG NTD gene 
pairs, to give a comparable set of genes. Some 97% of the gene pairs with at 
least 95% coverage had 99% pairwise identity or above (Figure 4-3B), compared 
with 85% for VSG NTDs originally annotated in EATRO 3 and 82% for NTDs from 
EATRO 2340. 
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Figure 4-3 – Gene pairing with chromosome core genes. 
A) Results of BLASTN search of EATRO 3 genome with coding sequences annotated in the 
EATRO 2340 chromosome cores. B) Percentage identities of gene-hit pairs with at least 95% 
coverage of the query by the best BLAST hit. Analyses were carried out as in Figure 4-1 
(part A) or Figure 4-2 (part B). The pairwise percentage identity in B is shown in bins of 1%. 
4.4.2 Cataloguing of changes 
Initially, I catalogued EATRO 3-EATRO 2340 SNPs by aligning and comparing the 
sequences of VSG NTDs paired up by BLAST (Method 1). I attempted to minimise 
the number of false SNPs by checking each position that differed to see if the 
apparent difference could be attributed to an error or ambiguity in the assembly 
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in both sequences. For each potential change, I therefore checked to see if a 
‘self-mapping SNP’ had been called at this position when PCR-free sequencing 
reads were mapped back to the genome from which they came (e.g. EATRO 2340 
reads to the EATRO 2340 genome), and discarded the EATRO 3-EATRO 2340 SNP 
if a self-mapping SNP had been called in both genomes. 
In order to check the reliability of the SNP calling and genome assembly, I 
selected 16 pairs of genes, exhibiting a range of different types of change, for 
resequencing. For templates, I purified genomic DNA from EATRO 3 parasites 
grown in mice (by Alana Hamilton), and obtained genomic DNA from cultured 
procyclic form EATRO 2340 parasites (cells grown by Dr Barbara Marchetti and 
DNA extracted by Jamie Hall by phenol/chloroform extraction). I designed 
primers to each gene (sequences given in Table 2-2), and used them for de novo 
PCR with EATRO 3 or EATRO 2340 genomic DNA as a template, cloned gel-
purified PCR products into the sequencing vector pCR4-TOPO and had the inserts 
sequenced by capillary Sanger sequencing with the primers M13 uni and M13 rev. 
Two pairs of genes failed to amplify in PCR, but in both cases there was no 
product from either genomic DNA template, implying that the failure was due to 
the PCR primers or conditions rather than the gene being absent from the 
genome. 
Three clones from each successful PCR were sequenced. However, many of the 
sequences obtained differed greatly from the expected sequence, in one 
instance having only 33% identity. In these cases, it seems likely that due to the 
relatively low annealing temperature used in PCR (50-55ºC), the products were 
from mis-primed PCRs. Additionally, the primers were designed to bind to 
sequence at or just beyond the ends of the NTDs, so they might contain 
sequence complementary to conserved flanks or conserved sequence in adjacent 
CTDs, making mis-priming more likely. Unfortunately, time did not permit the 
repetition of these experiments with more stringent reaction conditions. 
Of the 28 genes examined, only six had PCR products that were identical to the 
expected sequence. Two of these genes also yielded PCR products with over 100 
differences from the expected sequence. A further eight each gave products 
with over 100 differences from the expected sequence, with no products similar 
to what was expected. In the remaining genes, there were between two and 41 
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differences between the recovered sequence and the expected sequence. The 
differences between the recovered and the expected sequence often coincided 
with positions annotated as EATRO 3-EATRO 2340 SNPs. However, if a SNP 
coincided with a difference it does not necessarily mean that the SNP was 
invalid: for example, consider a gene that has two copies in each genome, only 
one of which had been assembled in each. If position 10 in copy two had 
changed from A to G in EATRO 2340, then position 10 in the composite gene may 
be A or G in the EATRO 2340 assembly, but only A in the EATRO 3 assembly. If 
the position had been called as G in EATRO 2340, it would have been annotated 
as an EATRO 3-EATRO 2340 SNP. The described experiment could recover a 
sequence with A instead of G at this position in EATRO 2340, but it does not 
follow that the A to G change did not happen. In resequenced genes with 
reasonably good matches to the reference, such a scenario could have occurred 
in approximately half of the SNPs predicted; in the other half, both isolates 
contained both possible alleles. Therefore, the resequencing experiments were 
not as informative as had been expected, but where the results could be used to 
check SNP calls, it appeared that in many cases the apparent SNPs were not in 
fact true differences between isolate genomes. 
The results of the PCR resequencing cast some doubt on the reliability of the 
SNPs annotated by comparing the two sequences, and implied that the archive is 
more complex than was suggested by the assembled genome. That is not to say 
that there was any substantial problem with the VSG genes that were 
assembled: it was possible to recover some of the expected sequences from an 
experiment with low-stringency PCR conditions; and, more convincingly, out of 
around 1800 NTDs annotated in EATRO 2340, around 670 had matches with at 
least 99.9% identity in the EATRO 3 genome — neither of which is likely to have 
happened if the genes had been primarily assembly artefacts. 
I examined in more detail the SNPs called in the whole-genome comparison, 
where the PCR-free reads mapped to the EATRO 2340 genome had a SNP called 
in one genome but not the other (see previous chapter), and found that the vast 
majority of these (139234 out of 142664, 97.6%) had been called as heterozygous 
rather than homozygous SNPs. This heterozygosity implied that in most cases 
where there was a SNP, the sequence in which it was found was present in two 
copies, that only one copy had been assembled for EATRO 2340, and that one 
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copy differed at the SNP position between EATRO 3 and EATRO 2340. 
Heterozygosity would be expected from the core sequences, which are diploid, 
but would not necessarily be expected for the subtelomeric VSG genes: as 
indicated by the variation in subtelomere size between homologous 
chromosomes, subtelomeres can be considered as effectively haploid, and 
previous studies have shown haploidy (Melville et al, 1999; Callejas et al, 2006; 
Hutchinson et al, 2007). However, the preponderance of heterozygous SNPs in 
the subtelomeres indicated that most genes (or at least most genes that change) 
had a partner somewhere in the archive of sufficient similarity that the two 
genes could not be separated from each other by the assembly algorithms. In 
this case, it was quite likely that if there were more than one difference 
between the partners, and the differences were widely separated (such that 
they would not be connected by the fragment size used in the assembly), the 
gene in the assembly would have been a composite of both partners, not 
absolutely identical to either. 
The possibility of composite assembled genes represents a complication that 
must be considered in analysis of the VSG archive. However, if the sequences 
are sufficiently similar to be conflated by the assembler, then using the 
composite gene in the analysis will give a reasonable general idea of the archive, 
though we must be careful when focusing on specifics. Additionally, for almost 
every SNP called there were only two variants, and the alleles were predicted to 
be in approximately a 1:1 ratio3. These data suggest that almost all composite 
assembled genes represented only two genes, which makes comparison with the 
diploid core valid when looking at SNPs called from reads, as it removes the 
possibility that more SNPs were called in a same-sized window in the 
subtelomeres than the cores solely because the subtelomere window actually 
sampled more genes. 
                                                
3 SNPs that had more than two variants, or where the alleles were predicted to be present 
in a different ratio noticeably different from 1:1, were excluded early in the SNP 
processing procedure, so there are no data for how many of SNPs with these 
characteristics would have passed all the filters, and none were present in the final 
EATRO 3-EATRO 2340 SNP data set. However, before those SNPs that were present in 
both genomes were excluded, there were 184358 SNPs with appropriate coverage called 
from mapping EATRO 2340 reads to the EATRO 2340 genome, and 176579 SNPs called 
from mapping EATRO 3 reads to the EATRO 2340 genome; 77 and 103 respectively had 
more than two alleles called; 120 and 142 respectively had only two alleles called but the 
frequency of the alternative allele was not predicted to be between 0.4 and 0.6. 
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The results of the PCR resequencing experiments suggested that there was more 
variation in both genomes than had been captured in the genome assemblies, 
but that I could use the data from mapping the PCR-free reads to each genome 
to try to find a more reliable method of annotating SNPs in the VSG. I therefore 
developed a second strategy for SNP annotation, Method 2. The EATRO 2340 
PCR-free Illumina sequencing reads were used only in the gap-filling step of the 
EATRO 2340 assembly, although the EATRO 3 PCR-free reads were used to 
assemble the EATRO 3 genome. Both sets of PCR-free sequencing reads had 
already been mapped to the EATRO 2340 genome, and SNPs called. For the 
EATRO 2340 half of each high-identity pair of VSG genes, I compared the SNPs 
called from mapping the EATRO 3 reads and from mapping the EATRO 2340 
reads. For positions where a SNP had been called in only one set of reads, I 
checked that the coverage of these positions with the other set was sufficient 
that, if a SNP were present, it would likely have been called. If this were the 
case, I annotated the position as a putative SNP. I then carried out the 
reciprocal process of mapping both sets to the EATRO 3 genome assembly and 
calling putative SNPs for the EATRO 3 half of each pair. I then compared the 
putative SNPs called in both genes of the pair, and annotated a SNP only if an 
identical SNP had been called at the equivalent position in both. This last step 
gave a further advantage to Method 2 over Method 1 because the step would 
reduce the number of SNPs called due to incorrect pairing of EATRO 3 and 
EATRO 2340 genes: the method required a SNP to be called at the same place in 
both genes of the pair, and this is unlikely to have happened if the genes being 
compared were not truly the same gene. 
This analysis yielded 446 substitutions in 136 pairs, compared with 2213 
substitutions in 203 pairs from the first analysis, with Method 1. This second, 
more stringent analysis was intended to decrease the chance of SNPs being 
called in regions that were different due to misassembly (and hence the quality 
of mapping not being sufficient to call SNPs), and generally to provide an extra 
layer of quality control. The new analysis predicted the genotype of each isolate 
at the SNP position, usually with one being a heterozygote and the other 
homozygous for a reference allele, and this genotype prediction could be tested 
by looking at the sequences recovered. Within the 14 resequenced gene pairs, 
this analysis called 18 SNPs, allowing 28 genotype predictions to be tested (eight 
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predictions were in a gene that had no resemblance to the expected sequence). 
Ten of these predicted genotypes were homozygous: in nine cases only the 
predicted allele was found, but in one a second allele was found that matched 
the ‘SNP’ predicted at that position in the other genome. The remaining 18 were 
heterozygous: in five cases, both predicted alleles were found; in eight cases (all 
in the same gene), only one of the predicted alleles was found, but it was the 
one not already represented in the reference gene; in five cases, only the allele 
in the reference gene was found. The results from Method 2, therefore, gave 
SNP predictions that had a reasonable degree of support from the data, although 
these predictions were not 100% correct. 
The Method 2 results were not directly comparable with the results of the first 
attempt at cataloguing SNPs by directly comparing the assembled sequences of 
the genes in each genome (Method 1), as the outputs were different. 
Additionally, the resequencing experiments, designed to test the results from 
Method 1, did not provide many data to test Method 2. However, comparison of 
the results from Method 2 with the available resequencing data indicated that 
looking for SNPs in paired genes was a more reliable method than simply looking 
at the assembled sequence as in Method 1, although neither method was without 
false positives. The strategy in Method 2 has certain limitations: the program 
used to annotate SNPs from the read data is unreliable at calling indels, so 
Method 2 can only be used to study substitutions; and Method 2 will also be poor 
at detecting segmental conversions donated by less closely-related genes, 
because the mapping algorithm will discard a read that contains more than a 
certain number of differences from the reference, and so no SNPs will be called 
in the converted sequence. However, this second point could potentially be 
addressed to some extent by looking for regions that show considerably 
decreased coverage compared with the rest of the sequence. In general, Method 
2 will probably generate more false negatives than the assembled sequence-
based approach in Method 1, because of the described problems calling indels 
and segmental conversions, and because the more stringent filters will likely 
exclude more true SNPs than Method 1. 
In summary, there appeared to be considerably more diversity within each 
genome than initially appeared from the assembly, which made detection of 
changes from EATRO 3 to EATRO 2340 more difficult. Without substantial further 
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resequencing, which was not feasible in this project, it was not possible to fully 
evaluate different strategies for analysing SNPs, or to find a completely reliable 
method. However, I developed a strategy (Method 2, Figure 4-4) involving 
finding SNPs in the annotated genes using PCR-free reads, which appeared to 
have reasonable reliability. I therefore used this strategy to annotate SNPs to 
provide data for more detailed analysis of the substitutions that occur in VSG 
genes, with the caveat that there may be some incorrectly annotated SNPs. 
 
Figure 4-4 – Outline of steps in SNP annotation Method 2, showing the order of steps, the 
input data, and the number of SNPs remaining at each step. 
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4.4.3 Mutation analysis pipeline 
In order to process a large number of gene pairs, I developed an object-oriented 
Perl pipeline. This set of programs extracted the sequences of each gene in the 
pair and aligned them for use with the SNP-finding strategies described in the 
previous section. A final step grouped together single-base changes if they 
seemed likely to represent a single mutation event (e.g. substitution of multiple 
adjacent bases simultaneously), to allow later estimation of the frequency of 
mutational events as well as the frequency of mutated bases. 
4.5 Substitution mutations in VSG evolution 
4.5.1 Mutation frequency 
I used the strategy described above to search for substitution mutations in the 
VSG NTDs and in the control core genes, and detected 446 substituted bases in 
the VSG NTDs and 1781 in the core genes. Some substituted bases were 
immediately adjacent to each other and so were grouped together as being 
likely to represent a single mutation event (four pairs in the VSG and 12 pairs in 
the core genes), giving a total of 431 mutations in the NTDs and 1769 in the core 
genes. These data yield a mutation frequency of 3.97×10-4 mutations/base in the 
VSG NTDs and 1.67×10-4 mutations/base in the core genes, which indicates a 2.4-
fold higher mutation rate in VSG NTDs than in core genes; and the difference 
was significant (p < 0.001), assuming a straightforward binomial distribution. 
These numbers were calculated by dividing the number of SNPs by the total 
length of the genes in gene pairs; however, not every base was suitable for 
calling SNPs, for example due to low coverage. I therefore determined the 
number of bases in total that were suitable for calling SNPs, i.e. the coverage 
with all four genome-read pairings was at least 10 and not greater than 200 
reads with good-quality bases. When the frequencies were calculated based on 
the number of SNPs per base suitable for SNP calling, the frequencies were 
4.79×10-4 mutations/base in the VSG and 1.69×10-4 mutations/base in the core 
genes, a ratio of 2.8 (Table 4-2). 
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Region 
Total 
positions 
changed 
Total no. 
changes 
Total gene 
length (bp) 
Substitutions 
per base 
Substitutions/base/ 
generation 
Min Max 
Core 1781 1769 10581389 0.000167 2.0x10-9 6.7x10-9 
VSG NTD 446 442 1112229 0.000397 4.7x10-9 1.6x10-8 
Table 4-2 – Mutation frequencies and rates in VSG NTDs and in core genes. 
 
When I examined the number of substituted bases per gene in VSG NTDs, it 
seemed possible that there were more genes with no substitutions than would be 
predicted from the mutation frequency if the occurrence of every substitution 
were random (i.e. the data were overdispersed) (Figure 4-5). 
 
Figure 4-5 – Number of SNPs per gene in VSG NTDs. 
The data are overdispersed, i.e. there were more NTDs with no new mutations than would 
have been expected if the occurrence of mutations was random. 
I therefore used R to model the data of number of SNPs per gene to two 
distributions, a Poisson and a negative binomial distribution. The models also 
incorporated length, because the number of mutations in a gene would be 
expected to depend on the number of nucleotides in a gene as well as the 
mutation rate (i.e. SNPs depends on number of bases as well as SNPs/base). The 
log likelihood of the Poisson model was -1287, whereas the log likelihood of the 
negative binomial model was -665, indicating that the negative binomial model 
described the data much better than did the Poisson model, and that the 
assumptions of the Poisson distribution likely did not hold in the process 
producing the data. The most likely reason for these data not fitting the Poisson 
distribution is that the mutations did not occur entirely independently of one 
another. The negative binomial model predicted that the expected number of 
SNPs for a gene of length 1000 bp was 0.56. This length was chosen because it 
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was a typical length for the NTDs examined, and hence the region where the 
model was most likely to be a good reflection of the data. This expected value 
corresponds to 5.6×10-4 mutations/base, which is reasonably close to the value 
of the mean number of 3.97×10-4 mutations/base calculated directly from the 
data. 
Since the negative binomial model described the VSG data reasonably well, I 
used a similar model to test whether the mutation rates in the VSG NTDs and 
core genes differed significantly. I used R to produce a single model of the 
number of SNPs per gene in both regions (subtelomere and core) using a 
negative binomial distribution, again incorporating the length of gene. This 
analysis indicated that the region that a gene came from was a highly significant 
determinant of the number of SNPs it contained (p < 0.0001), after gene length 
had been taken into account. For a gene of length 1000, the expected number of 
SNPs was 0.407 for VSG and 0.180 for core genes, indicating that the mutation 
rate in VSG NTDs was 2.41-fold higher than in cores, which was very close to the 
value of 2.37-fold calculated directly from the data. 
4.5.2 Distribution of mutations between lineages 
The mutations annotated by this approach have been more stringently checked 
than those in the larger set discussed in Chapter 4. The new mutation 
annotations can therefore can be used to obtain a more reliable estimate of the 
relationship between the two isolates, by looking again at the distribution of 
new mutations. For the reasons discussed in section 3.4.3, genes from the 
anomalous regions of chromosomes 4 and 10 were excluded from the analysis. 
Excluding genes from these regions gives mutation frequencies of 3.97×10-4 
substitutions/base in the VSG NTDs and 8.81×10-5 substitutions/base in the core 
genes. The EATRO 2340:EATRO 3 ratio was 3.5 for core genes and 2.8 for VSG 
NTDs (Table 4-3). These values imply approximate times to the MRCA of seven 
years for EATRO 3 and 24 years for EATRO 2340 (using the core genes ratio), or 
nine years for EATRO 3 and 26 years for EATRO 2340 (using the VSG NTDs ratio), 
with divergence dates of 1953 and 1951 respectively. The values for the two 
genome regions therefore seem acceptably similar. Using the divergence date 
estimated for the core genes, the mutations observed have accumulated over 31 
years, which corresponds to approximately 45000 generations and gives mutation 
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rates of 8.82×10-9 substitutions/base/generation for VSG NTDs and 1.96×10-9 
substitutions/base/generation for core genes. This core mutation rate is a 
credible value since it is reasonably consistent with a previously estimated 
minimum mutation rate of approximately 10-9 
substitutions/base/cell/generation (Valdes et al, 1996). 
Region EATRO 3 
EATRO 
2340 
EATRO 2340: 
EATRO 3 ratio 
Total 
subs 
Mutation 
frequency 
(subs/base) 
Mutation rate 
(subs/base/ 
generation) 
Core 188 665 3.54 853 0.000088 1.96×10-9 
VSG NTDs 111 309 2.78 435 0.000397 8.82×10-9 
Table 4-3 – Distribution of new mutations in core genes and VSG NTDs between EATRO 3 
and EATRO 2340 lineages. 
Genes in anomalous regions of chromosomes 4 and 10 have been excluded from the 
analysis. Note that the total number of mutations includes those for which both isolates 
were homozygous and so it could not be determined which lineage the mutation occurred 
in. subs = substitutions. 
It should be noted that excluding genes from the anomalous regions of 
chromosomes 4 and 10 substantially decreased the observed mutation frequency 
of core genes, but had very little effect on VSG NTDs (since only 11 of the latter 
were excluded from the analysis). The estimated VSG NTD substitution 
frequency thus became 4.5-fold higher than the core substitution frequency 
rather than 2.4-fold higher. However, this change does not substantially affect 
the conclusions of the work: the VSG NTD frequency is still higher than the core 
frequency, and the difference between the two regions is still the same order of 
magnitude. Moreover, presumably the excluded mutations from EATRO 3 core 
genes arose largely by the same mutational process which gave rise to all the 
other core gene mutations, albeit over a longer time period than expected, and 
not in the time since the MRCA of the two isolates. Hence, when the mutation 
profiles are compared (see sections below), the comparison is still between a 
sample of mutations in the core genes and a sample of mutations in the VSG 
NTDs; the possibility that each sample was accumulated over a different time 
period is essentially irrelevant. 
4.5.3 Specific base changes 
I counted the number of each type of substitution mutation in the VSG NTDs and 
core genes, taking the base in EATRO 3 as the starting base. Note that although I 
examined the bases in the DNA strand containing the coding sequence, the 
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mutation could have occurred in either strand, e.g. a mutation that appears to 
be from A to G in the VSG coding strand could in fact have come about by a 
mutation from T to C in the complementary strand. For this reason, mutations 
were considered in their complementary pairs. The proportions of each type of 
substitution appeared quite different in the VSG NTD genes from the core genes 
(Figure 4-6). I analysed these results in R using Pearson’s χ2 test of 
independence, which indicated that the distributions were significantly different 
(p < 0.0001). 
 
Figure 4-6 – Proportion of each type of substitution mutation in VSG NTDs and core genes. 
The x-axis shows the type of change: Label ‘A-G’ indicates A in EATRO 3 and G in 
EATRO 2340. Complementary mutations (e.g. A-G and T-C) have been grouped together as 
it was not possible to distinguish between them in the analysis used. VSG NTDs are 
represented in dark grey and core genes in dark grey, as shown in the key. 
Analysis of the raw counts of the number of each type of substitution gave a first 
approximation comparison between the two genome regions, but such an 
analysis may suffer from bias if the regions differ in composition. For example, if 
the coding sequences of one region contained a higher proportion of As than the 
other, then genes in that region would be expected to exhibit a higher 
proportion of A substitutions even if the probability a given A will mutate was 
the same in both regions. The comparison described above also assumed that 
there was no difference between mutations in the coding and the non-coding 
strands. I therefore determined the base composition of the EATRO 3 sequence 
in the coding strand of high-identity pairs of VSG NTDs and core genes (excluding 
pairs where there was a sequencing gap in either genome) (Table 4-4). EATRO 3 
was used to be consistent with the description of each type of substitution as 
‘base in EATRO 3’ to ‘base in EATRO 2340’. The compositions of the coding 
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strands in the two genome regions were revealed to be strikingly different. It 
would be expected that bases which are A or T would be distributed equally 
between A and T (i.e. P(A|(A or T)) = 0.5), and similarly for C and G. In fact, the 
A/T and C/G distributions differed significantly from this expectation (p < 0.001) 
for both core genes and VSG NTDs. However, for all but the VSG A/T 
distribution, the magnitude of the difference from 0.5 was small (<0.05). 
Importantly, there was a significant difference (p < 0.001) between VSG NTDs 
and core genes for both A/T and C/G distributions. The substantial excess of A 
over T bases is consistent with observations in TREU 927 VSG (L. Marcello, PhD 
thesis, 2007). 
Base 
VSG Core 
Count % Count % 
A 381402 34.3 2627855 24.7 
C 289790 26.1 2499189 23.4 
G 270204 24.3 2947698 27.7 
T 169936 15.3 2583071 24.2 
Table 4-4 – Composition of EATRO 3 genes in coding strands of paired VSG NTDs and core 
gene sequence. 
All probabilities were significantly different from 50% (p < 0.001), assuming a binomial 
distribution between A and T for all A/T positions, and C and G for all C/G positions. 
As mentioned above, it was impossible to tell whether (for example) an 
apparent A to G mutation in the coding strand was the result of an actual A to G 
mutation in the coding strand, or the result of a T to C mutation in the non-
coding strand. However, the primary aim of comparing the mutation profiles 
between VSG NTDs and core genes was to determine whether the two profiles 
were different. If the two mutation profiles were identical, and the 
compositions of the two genome regions were the same, then the proportion of 
mutations that were A to G in the coding strand would be expected to be the 
same in both regions, as would the proportion of mutations that are T to C in the 
non-coding strand. Therefore, if the mutations are assumed for simplicity always 
to have taken place in the coding strand, the proportion of apparent A to G 
mutations should be approximately the same between the two genome regions. 
If they are not, it can be concluded that the mutation profiles differ in some 
way, although it will not be possible to tell whether they differ in the A to G 
substitution rate in the coding strand, or the T to C substitution rate in the non-
coding strand, or both. 
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A similar idea can be applied to allow for the possibility that the assumption 
that all mutations are in the EATRO 3 to EATRO 2340 direction was an 
oversimplification. If the MRCA of EATRO 3 and EATRO 2340 was not EATRO 3 
then the reported mutation profile may not be correct, because, for example, 
some of the mutations annotated as A to G may actually be G to A mutations 
that have occurred in the EATRO 3 lineage since the MRCA. However, if the core 
and VSG mutation profiles were identical, the number of each (A to G in the 
MRCA-EATRO 2340 lineage and G to A in the MRCA-EATRO 3 lineage), and hence 
the apparent A to G totals would be expected to be similar in the core genes and 
the VSG NTDs. If the totals are significantly different, again it can be concluded 
that the mutation profiles are not identical, although the specific difference will 
not be clear. 
The concept that allows simplification of the analysis to consider only one strand 
can be extended to allow comparison between the VSG and core substitutions 
with correction for the different compositions of the two regions. The reasoning 
supporting this statement can be expressed as an example with the A to G in the 
coding and T to C in the non-coding strand: 
expected n A to G mutations = AG = P(AG) . nA, where P(AG) is the probability any 
given A will mutate to G, and nA is the number of As in the sequence 
Let c denote a parameter for the coding strand and nc a parameter for the non-coding 
strand. 
apparent AGc = AGc + TCnc 
   = P(AG)c . nAc + P(TC)nc. nTnc 
but nTnc = nAc as the two strands are complementary 
so apparent AGc = nAc ( P(AG)c + P(TC)nc ) 
P(AG)c + P(TC)nc  = (apparent AGc) / nAc 
Hence if (apparent AGc) / nAc for the VSG does not equal (apparent AGc) / nAc for the  
core genes, the VSG and core mutation profiles are different. 
A similar approach was used to generate ‘corrected’ numbers of each type of 
substitution, i.e. the number of each type that would be expected in the VSG 
NTD genes if they had the same base composition as the core genes: 
Using the equation 
P(AG)c + P(TC)nc = (apparent AGc) / nAc 
we can calculate P(AG)c + P(TC)nc from the observed data, and use it in the equation 
apparent AGcoding = nAc ( P(AG)c + P(TC)nc) 
to calculate the expected value of apparent AGc if nAc changes. 
If the VSG sequences had the same base composition as the core sequences 
nAc, VSG / totalVSG = nAc, core / totalcore 
so in this case, for the VSG 
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corrected AGc = ( P(AG)c + P(TC)nc ) . nAc, core / totalcore . totalVSG 
   =  (apparent AGc, VSG) / nAc, VSG . nAc, core / totalcore . totalVSG 
This process allowed the ‘corrected’ numbers to be compared with the observed 
numbers of each type in the core genes using a χ2 test, to determine whether 
there was a significant difference between the mutation profiles of core and 
VSG NTDs. Again, this comparison will not have revealed precisely what the 
differences are. The ‘corrected’ data are given in Table 4-5 and plotted in 
Figure 4-7. I re-analysed these new data in R using Pearson’s χ2 test of 
independence, which again indicated that the distributions were significantly 
different (p < 0.0001). This result implies that mutation is qualitatively as well 
as quantitatively different in VSG NTDs and core genes. 
Base change 
(EATRO 3 to 
EATRO 2340) 
Raw number 
Corrected number 
(to core 
composition) 
Corrected number 
(to equal base 
frequency) 
A-C 45 32 33 
A-G 80 57 58 
A-T 11 8 8 
C-A 56 50 54 
C-G 37 33 35 
C-T 31 28 30 
G-A 73 83 75 
G-C 26 30 27 
G-T 16 18 16 
T-A 17 27 28 
T-C 30 48 49 
T-G 24 38 39 
Table 4-5 – Counts of each mutation type with VSG data adjusted for A-richness. 
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Figure 4-7 – Proportion of each type of substitution mutation in VSG NTDs and core genes 
with VSG data adjusted for A-richness. 
Label ‘A-G’ indicates A in EATRO 3 and G in EATRO 2340 on the coding strand. VSG NTDs 
are represented in dark grey and core genes in dark grey, as shown in the key. 
4.5.3.1 Strand bias 
The asymmetry of composition of VSG genes, as observed previously (L. 
Marcello, PhD thesis, 2007), suggested that there may be a difference between 
the mutation processes that act on the coding and on the non-coding strands. 
Therefore, to examine the VSG NTD mutations for strand bias I generated a 
second set of corrected mutation frequencies, this time assuming that all bases 
occurred with equal frequency (Table 4-5). I then examined the frequency of 
complementary mutations, for example A-G and T-C. If there were no strand 
bias, i.e. both strands had the same probability of each mutation, then 
complementary mutations should be approximately equal: the apparent A-G on 
the coding strand is the sum of the actual A-G on coding strand plus the actual 
T-C on the non-coding strand, and the apparent T-C on the coding strand is the 
sum of the actual T-C on the coding strand plus the actual A-G on the coding 
strand. This was not the case in the mutations found in the VSG genes: there was 
considerable asymmetry in several cases, with a particularly noticeable bias 
towards mutations generating As in the coding strand (Table 4-6). Further, the 
number of mutations generating As was 1.6-fold higher than the number of As 
mutating to other bases, and the of number Ts mutating to other bases was 2.1-
fold higher than the number of mutations generating Ts, an observation that was 
consistent with the A-richness of the coding strand of the VSG NTDs. Some 
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asymmetry was seen in the core gene mutations (which were not corrected, 
because the core gene base composition was approximately even), but not to 
anything like the extent of the VSGs. 
 Change Number Complement Number Ratio 
VS
G
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AC 33 TG 39 0.84 
AG 58 TC 49 1.19 
AT 8 TA 28 0.29 
CA 54 GT 16 3.26 
CG 35 GC 27 1.33 
CT 30 GA 75 0.4 
C
or
e 
ge
ne
s 
AC 63 TG 64 0.98 
AG 368 TC 254 1.45 
AT 38 TA 26 1.46 
CA 79 GT 74 1.07 
CG 64 GC 62 1.03 
CT 316 GA 373 0.85 
Table 4-6 – Frequency of substitutions displayed in pairs corresponding to an identical 
mutation occurring in the coding strand or the non-coding strand. 
 
4.5.4 Effects on predicted protein sequence 
Substitution mutations are presumably only of functional significance to the 
parasite’s antigenic variation if they result in a change to what is presented to 
the immune system, i.e. a different amino acid in an expressed VSG. I therefore 
examined whether the substitution mutations detected would change the 
protein sequence. VSG genes often include frameshifts, an observation which 
was borne out in my data by the fact that it was often necessary to use HMMer 
or BLASTX hits in several frames to annotate a full-length VSG NTD (see section 
4.2). The frequency of frameshifts meant that it was not straightforward to 
predict the ‘translation’ of a gene: we were interested in the amino acid 
sequence that the gene would contribute to a functional VSG, rather than 
necessarily a full translation of the first frame of the gene. A functional VSG can 
be achieved by assembly of a mosaic gene from silent donor VSG genes or 
pseudogenes, and the final polypeptide will not necessarily be the same as the 
amino acid sequence obtained by translating the domain in a single frame from 
start to finish. However, I was able to use the information from HMMer and 
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BLASTX hits during annotation to predict a ‘VSG translation’ for almost every 
NTD, which I then used to examine the effects of substitutions. 
For each gene pair with a substitution mutation, I examined the predicted 
protein sequence of the gene to find the codon affected by the mutation, and 
compared the amino acids encoded by the two alternative codons at this 
position to determine whether the substitution was synonymous or non-
synonymous; and determined the total number of synonymous and non-
synonymous sites in paired VSG NTDs. (The results given were calculated with 
the assumption that EATRO 3 contained the ancestral base, but redoing the 
analysis with the assumption that EATRO 2340 contained the ancestral base 
made very little difference to the results.) I also carried out a similar analysis 
for mutations in the core genes. The results of these analyses (Table 4-7) 
revealed that there were a considerable number of non-synonymous mutations in 
both VSG NTDs and core genes. For both genome regions, I estimated confidence 
intervals (CI) for the number of mutations per site for which every possible 
mutation was non-synonymous (dN3, i.e. 3 mutations are non-synonymous), and 
the number of mutations per site for which every possible mutation was 
synonymous (dS3), because the mutation frequency at both these types of site is 
essentially a binomial distribution. Importantly, dS3 for the VSG (7.9×10-4/site ± 
2.0×10-4, 99.9% CI) was significantly higher (p < 0.001) than dS3 for the core 
genes (3.0×10-4/site ± 4.0×10-5). The mutation rate at fourfold degenerate sites 
(considered here as dN3) is frequently taken as a measure of the background rate 
of mutation. This result therefore strengthened the conclusion that the rate of 
substitution mutation was genuinely higher in VSG NTDs than in core genes, and 
was not just an artefact of relaxed selection on VSGs. The VSG dN3 value was 
also significantly higher than that of the core genes (VSG: 3.0×10-4/site ±  
6.4×10-5, 99.9% CI; core: 1.1×10-4/site ± 1.2×10-5), and in fact the difference 
between the two was greater than for the dS3 values, but the core value may 
have been decreased because of selection acting to remove fatal or strongly 
deleterious mutations, so the significance of these values in terms of differences 
between the mutation processes in core genes and VSG cannot really be 
evaluated. 
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Region VSG Core 
Non-synonymous changes 254 852 
Non-synonymous sites 840942 8169245 
Synonymous changes 189 917 
Synonymous sites 256479 2487988 
Total changes 442 1769 
dN 3.02×10-4 1.04×10-4 
dS 7.37×10-4 3.69×10-4 
dN/dS 0.41 0.28 
Table 4-7 – Synonymous and non-synonymous changes in VSG NTD and core protein 
coding genes. 
Only gene pairs where neither partner contained an assembly gap were considered. Note 
that, as is standard practice, sites where some possible changes are synonymous and 
some are non-synonymous have been counted according to the proportion of each, e.g. if 
one of the possible changes is synonymous and two are non-synonymous, the site will add 
0.33 to the synonymous site total and 0.67 to the non-synonymous site total. 
In studying sequence evolution, it is often useful to consider the ratio between 
dN, the number of non-synonymous mutations per non-synonymous site, and dS, 
the number of synonymous mutations per synonymous site. In the case of the 
VSG NTDs, the dN/dS ratio (based entirely on counting sites and mutations) was 
0.4 (Table 4-7) (and the dS3 was significantly higher than the dN3, p < 0.05). 
Usually such a dN/dS value would be taken to mean that on average the VSG 
genes were under weak purifying selection. Given that the function of VSG 
essentially is to be diverse, this conclusion seems highly unlikely. There are 
several factors that can be considered to explain this anomalous result. Firstly, 
the time-scale under consideration, only a few decades, is very short in 
evolutionary time. Originally, studies of dN/dS were used to detect selection on 
particular nucleotide sites by looking at several species, with the implicit 
assumption that the polymorphisms under consideration had gone to fixation in 
their respective species. Various studies have concluded that dN/dS is not a 
reliable indicator of selection in very closely-related lineages, and has a complex 
and unclear dependence on divergence time as well as direction and strength of 
selection (Rocha et al, 2006; Kryazhimskiy & Plotkin, 2008; Peterson & Masel, 
2009). Secondly, the VSG genes are not considered to be under direct selection 
(Barry et al, 2012), and the effects of the true selective pressure, to have a 
diverse VSG repertoire, would likely be expressed in more subtle ways than a 
high dN/dS ratio. Therefore, the dN/dS ratio is not a particularly relevant statistic 
to VSG evolution, and for this reason, it seems unnecessary to consider more 
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sophisticated approaches to estimate the dN/dS ratio, for example by using 
models that take into account codon bias and transition/transversion bias. 
4.5.5 Distribution 
To examine the distribution of SNPs across the VSG NTDs, I found the position of 
each VSG SNP relative to the first cysteine codon of the gene containing it. 
Figure 4-8A and C show the distribution of SNPs in A-type and B-type NTDs. To 
test for clustering within the gene, I used the program Permute III, provided by 
Prof Dan Haydon, which uses permutation to find windows with significantly 
higher (hot spots) or lower (cold spots) numbers of events than expected. 
Because different genes had different sequence lengths before the first 
cysteine, for the Permute analysis I considered only SNPs after this position. I 
tested for clustering in 10 bp windows and then in windows from 30-600 bp at 
30 bp intervals, using 1000 permutations with a confidence level of 0.01. No hot 
spots or cold spots were found in A-type NTDs using this analysis. In the B-type 
NTDs, there was evidence of clustering: window sizes from 360-570 bp found 
hot-spots centred around positions from 415-520 bp after the cysteine codon, 
with larger window sizes having centres more 5′ in the gene (example in Figure 
4-8E). 
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Figure 4-8 – Distribution of SNPs and predicted secondary structure across VSG NTDs. 
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Figure 4-8 continued. A) SNP positions in A-type NTDs (193 genes, 179 SNPs), showing 
number of SNPs at each relative position, split into 15-bp bins. B) Jpred 3 predicted 
secondary structure in the predicted VSG translations of A-type NTDs, showing number of 
NTDs with each type of structure prediction at each position. As shown by the key, blue 
indicates a predicted stop codon, green indicates an extended (β-sheet) structure, yellow 
indicates no predicted secondary structure, and red indicates α-helical structure. Codon 
positions have been converted to nucleotide positions, so each line is 3 bp wide. C) SNP 
positions in B-type NTDs (162 genes, 157 SNPs), showing number of SNPs at each relative 
position, split into 15-bp bins . D) Jpred 3 predicted secondary structure in the predicted 
VSG translations of B-type NTDs, showing number of NTDs with each type of structure 
prediction at each position, colours as in part B. E) Example screenshot from a run of 
Permute III using a window size of 480 bp, showing clusters of SNPs in B-type NTDs, and 
scaled to approximately match parts A-D. Centres of hot-spot regions are indicated by red 
arrows. In all figures, position 0 corresponds to the first base of the first cysteine codon in 
the translation. Ten genes containing SNPs did not have a cysteine residue with 75 aa of the 
start of the sequence, and so were not considered, and a further 60 genes were of unknown 
type. Note that the plot in the screenshot (E) is of the number of SNPs at each position, 
whereas A and C use the frequency in 15-bp non-overlapping windows, and B and D use the 
frequency in 3-bp overlapping windows (since the structure predictions are converted from 
codon positions). 
To investigate whether the observed region of clustering corresponded to a 
particular structural feature, I used the Jpred 3 server to make secondary 
structure predictions for every A-type and B-type predicted VSG NTD sequence 
that contained a SNP (Figure 4-8B and D). Most regions were either predicted to 
form alpha helix (red in Figure 4-8) or to have no structure (orange in Figure 
4-8). In the A-type NTDs, the location of the predicted helices and loops 
corresponded reasonably well with what would be expected from published VSG 
sequences and structures (Freymann et al, 1990; Blum et al, 1993; Carrington & 
Boothroyd, 1996), with helices predicted at either end of the domain and 
unstructured loops in the middle region. The pattern in B-type NTDs was less 
clear, although this is likely to have been simply because the structures lined up 
less well than the A-type structures, perhaps due to more length variation. In 
any case, there did not appear to be a strong correspondence between higher 
frequency of SNPs (Figure 4-8C) and either secondary structure type. It is 
notable that the A-type NTDs, where regions corresponding to the loops and 
helices were discernible, had no significant clustering of SNPs. It therefore 
seems unlikely that the clustering of SNPs in B-type NTDs, although statistically 
robust, has any particular biological significance. 
4.5.6 Comparison of mutation rate in VSG NTDs with mutation 
rate across the subtelomeres 
To examine whether VSG NTD genes specifically had higher mutation frequencies 
than core genes, or whether an elevated mutation frequency was a general 
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feature of subtelomeres, I compared the mutation frequency in VSG NTDs with 
that across all sequence in the subtelomeres. As described above, for a large 
number of VSG NTDs, the same gene could be identified in both genome 
assemblies. However, it was not possible to repeat that approach to pair up all 
sequences across the subtelomeres. The strategy of double-checking mutations 
in VSG genes by examining SNP calls to the same gene in both genomes could 
therefore not be used for verification of mutations across the subtelomeres. This 
strategy (Method 2 described in section 4.4.2) was used to ensure that the SNPs 
studied in detail were as accurate as possible, and false positives were as few as 
possible. However, to compare the mutation frequency in VSG NTD genes with 
the mutation frequency across the subtelomeres, a less stringent method was 
acceptable, as there was no reason to think that false positive SNPs would be a 
VSG-specific phenomenon. 
I therefore examined the substitution mutation frequencies in the EATRO 2340 
genome assembly using the strategy of considering all good-quality SNPs called 
from mapping reads, as described in section 3.4.1. To calculate the mutation 
frequency, I counted the number of SNPs in the VSG NTD genes, and then in the 
assembled subtelomeres in chromosomes plus all the bin contigs on which VSG 
domains had been annotated. The mutation frequencies in VSG NTD genes and in 
all subtelomere sequence (including VSG) are shown in Table 4-8. The 
frequencies for the two regions were very similar, with the frequency in the 
subtelomeres as a whole being 1.16-fold the VSG frequency. To further examine 
the difference in frequency between VSG NTDs and total subtelomere sequence 
in EATRO 2340, I counted the number of SNPs in 1 kb windows across the 
subtelomeres (i.e. windows approximately the length of a typical NTD), and used 
R to produce a negative binomial model of the number of SNPs in 1 kb windows 
and VSG NTD genes. Although the subtelomere 1 kb windows would have 
included VSG sequence, there were approximately 10 times as many 
‘subtelomere’ windows as annotated VSG NTD genes (17156 compared with 
1858), so considering all the subtelomere sequence windows would give a 
reasonable approximation of the picture in non-VSG subtelomere sequence. 
Testing with this model found that region (VSG or subtelomere) was not a 
significant determinant of mutation SNP count (p > 0.1). These data indicate 
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that the probability of mutation in VSG NTD was no different from anywhere else 
in the subtelomeres. 
Region No. SNPs Length (bp) SNPs/base Ratio to VSG 
EATRO 2340 VSG NTD 3866 2056405 0.00187998 1 
EATRO 2340 all ST 34373 15724393 0.00218596 1.163 
EATRO 2340 ST minus VSG 30507 13667988 0.00223200 1.187 
Table 4-8 – Mutation frequencies in VSG NTDs and in all likely subtelomere sequences. 
ST = subtelomere. 
4.6 Pseudogenes and substructuring of the EATRO 3 and 
EATRO 2340 VSG archive 
4.6.1 Functionality of NTD coding sequences 
I screened each VSG NTD sequence for which a translation could be predicted 
(including those identified only by BLASTN hits) for features likely to render it a 
pseudogene. The pseudogene criteria were considered sequentially in a pipeline 
such that if a gene fitted one criterion this gene was given a pseudogene 
classification and excluded from further checks. The features considered to 
make an NTD likely to be pseudogene were (in the order checked): lack of an 
initial ATG codon; an in-frame stop codon; and a likely frameshift (i.e. any genes 
that required several BLASTX or HMMer hits in different frames in order to 
annotate them). Additionally, NTDs with no CTD predicted by SVM in the near 3′ 
proximity were classed as ‘fragments’; and NTDs with fewer than four cysteines 
in the predicted translation, or for which the NTD type could not be determined, 
were classed as ‘atypical’, following standard practice for VSG (Berriman et al, 
2005; Marcello & Barry, 2007b). I then tested the predicted translations of 
otherwise intact NTDs for the presence of a signal sequence using SignalP, and 
classed as ‘atypical’ any that did not have a signal sequence predicted. Because 
the study did not consider CTDs in detail, and CTD domain boundaries and 
translations were not annotated, the presence of GPI anchor signal sequences 
was not examined, even if there was a CTD predicted by SVM in close proximity 
to the NTD under consideration. The results of the analysis are shown in Figure 
4-9, alongside a similar breakdown of TREU 927 VSG NTDs, using classifications 
from VSGdb (Marcello et al, 2007). 
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Figure 4-9 – Predicted functionality of VSG NTD genes. 
A) EATRO 3. B) EATRO 2340. C) TREU 927 (sequences and classifications from VSGdb). 
Red represents intact NTDs, yellow represents atypical but otherwise intact NTDs, green 
shows fragments, i.e. NTDs for which there is no nearby CTD. In parts A and B, blue 
represents NTDs with no initial ATG, and purple represents NTDs that are pseudogenes due 
to a premature in-frame stop codon or a probable frameshift. In part C, purple represents 
NTDs that are pseudogenes for any reason, including no initial ATG, a premature stop 
codon or a frameshift. Classifications are detailed further in the text. The number of NTDs in 
each category is indicated in the appropriate segment. 
I then checked the high-identity NTD pairs to see whether any had changed 
between being classed as intact and being classed as not intact (including 
atypical NTDs) (Table 4-9). This analysis was intended to give only an idea of the 
dynamics of functionality: given the problems verifying SNPs and the true 
sequence of genes, discussed in section 4.4.2, any specific changes in the 
classification should be treated with caution. I counted separately those gene 
pairs that had changed because one partner was classed as intact but the other 
had no close predicted CTD (‘fragments’ in Figure 4-9). Such changes were quite 
likely to be due to the somewhat more fragmented nature of the EATRO 3 
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genome assembly, rather than to genuine mutations; 7.6% of NTDs in EATRO 3 
were classed as fragments, which was considerably higher than the 
corresponding figure for EATRO 2340, 2.7%. 
Classification in EATRO 3 Classification in EATRO 2340 No. gene pairs 
Intact Intact 192 
Pseudogene Pseudogene 604 
Intact Pseudogene 70 
Pseudogene Intact 27 
Intact Fragment 15 
Fragment Intact 48 
Table 4-9 – Functionality classification of genes with a high-identity partner in the other 
genome. 
 
For most of the gene pairs, either both were intact or both were pseudogenes, 
but there were some pairs where one gene was intact but the other was a 
pseudogene. Some changes from intact to pseudogenes were to be expected, 
given the fact that the parasite can make use of pseudogenes and hence there is 
not strong selection on individual genes to remain intact. However, a change 
from pseudogene to an intact gene was much less likely to have occurred by 
chance, and therefore was of particular interest in this analysis. The gene pairs 
most likely to represent this scenario were those that were annotated as 
pseudogenes in EATRO 3 but were predicted to be intact in EATRO 2340; 
although of course it is possible that in such cases the gene in the common 
ancestor was intact, and had become pseudogenised in EATRO 3 but not 
EATRO 2340. 
Of the 27 gene pairs that changed from pseudogenes in EATRO 3 to intact in 
EATRO 2340, 12 had a premature stop codon, 11 had no start codon and four 
were atypical in EATRO 3. Of these 27 pairs, only four contained validated SNPs. 
In three of these four cases the call as a pseudogene was not due a change 
caused by the SNP, but in fact due to slight differences in the annotated gene 
boundaries (meaning the EATRO 2340 gene contained the ATG, but the EATRO 3 
gene did not, although the same sequence was present in both genomes), or to 
an assembly gap truncating the EATRO 3 gene. In the fourth, changing the allele 
of the SNP would not have changed the pseudogene call. Therefore, it seems 
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that there was no particular evidence that genes which started out as 
pseudogenes in the archive had changed so as to regain function. 
If it is assumed, instead, that all changes are from intact to pseudogene rather 
than vice versa, then the distribution of such changes between the two lineages 
should reflect the time of each since the MRCA of the two isolated (as with 
mutations, as discussed in sections 3.4.3 and 4.5.2). The ratio of the number of 
genes that were intact in EATRO 3 but pseudogenes in EATRO 2340, to the 
number of genes that were intact in EATRO 2340 but pseudogenes in EATRO 3 is 
2.6:1, a value that is similar to the 2.8:1 calculated for VSG NTD substitutions in 
the more stringent gene-based analysis of distribution (Table 4-3). 
4.6.2 VSG gene subfamilies 
A striking finding of the analysis of the TREU 927 VSG archive was that around 
40% of VSG NTDs were in subfamilies, falling into outlier groups comprising two 
or more partners with approximately 50% or greater amino acid sequence 
identity (Marcello & Barry, 2007b). To examine whether such substructuring 
occurred in the EATRO VSG NTDs that I had annotated, I carried out individual 
pairwise amino acid alignments of predicted VSG sequence for all possible 
combinations of NTDs within each archive. The resulting distribution of identities 
indicated that although most pairwise comparisons had low identity, there was 
an outlier group with pairwise peptide identities above approximately 50% 
(Figure 4-10). It is also worth noting that the modal pairwise identity for both 
archives was between 10% and 20%, which is well into the ‘twilight zone’ of 
protein sequence alignment (less than 20-25% pairwise identity), below which 
proteins are usually expected not to be homologous (Rost, 1999). 
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Figure 4-10 – Percentage identities in all pairwise comparisons of predicted NTD 
translations within each VSG archive. 
Dark grey represents comparisons within the EATRO 3 NTD archive, light grey represents 
comparison within the EATRO 2340 NTD archive. Pairwise alignments were carried out with 
ClustalW. The pairwise percentage identity is shown in bins of 1%. The number of 
comparisons for each identity bin is shown on a log scale to allow observation of the low-
frequency outlier group (percentage identities greater than 50). 
To identify subfamilies, I used a combined BLASTP and ClustalW approach. For 
each genome, I first identified candidate pairs by using the full set of predicted 
gene translations of VSG NTDs to query a protein database made from the same 
set of sequences. After removing the trivial matches of genes to themselves, for 
pairs of genes that had a highest-scoring pair with 50% sequence identity I then 
carried out a ClustalW alignment of the full amino acid sequences, and retained 
the two genes as a high-identity pair if this second alignment demonstrated at 
least 50% peptide identity between the two, i.e. if the pair fell in the outlier 
group in Figure 4-10. Pairs of genes were joined together to make larger 
subfamilies when every member of the subfamily had at least 50% identity with 
at least one other member (but not necessarily every other member). The 
revealed subfamilies in each archive are summarised in Table 4-10. 
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Genome Genes with no close relatives 
No. genes in families with … members 
TOTAL 
2 3 4 5 6 7 8 
EATRO 3 622 300 117 44 20 0 0 0 1103 
EATRO 3 % 56.4 27.2 10.6 4 1.8 0 0 0 - 
EATRO 2340 563 502 333 180 110 72 28 8 1796 
EATRO 2340 % 31.3 28 18.5 10 6.1 4 1.6 0.4 - 
Table 4-10 – NTD subfamilies in the EATRO 2340 and EATRO 3 VSG archives. 
Note that the total number of genes considered in this analysis was slightly smaller than the 
total number of genes annotated, because translations could not be predicted for some 
genes. 
Both genomes contained a large number of genes in subfamilies, although they 
differed to some extent in the proportion of genes in subfamilies, and the 
number of genes in each subfamily. Given that we expect EATRO 3 and 
EATRO 2340 to possess essentially the same VSG archive, it was perhaps 
surprising that they appeared to have somewhat different substructures. 
However, the subfamilies were numerous and usually had only a few members, 
and we know that both sets of annotated genes were each likely to be only a 
subset of the full archive. Therefore, we would expect that whichever gene set 
samples the true archive more thoroughly would appear to have a larger 
proportion of its genes in subfamilies, as well as a larger absolute number. This 
is indeed what was seen in the data: only 31% of the EATRO 2340 NTDs had no 
high-identity partner, compared with 56% of EATRO 3 NTDs. By the same token, 
we should be cautious when drawing conclusions about the detailed 
substructuring of the EATRO VSG archive from the annotated EATRO 2340 NTDs, 
because they too represented only a sample of the full data. A further caveat is 
that some of the NTDs in the gene sets were annotated based on similarity to 
the predicted protein sequences of other annotated genes, which would lead us 
to expect the proportion of genes in subfamilies in the samples to be an 
overestimate of the real value for the archive. However, the 69% of annotated 
EATRO 2340 genes that had high-identity partners indicated that this archive has 
a considerable amount of substructuring. In this respect the EATRO 3-
EATRO 2340 archive was similar to the TREU 927 archive. The high mean 
pairwise identity of the subfamilies (72% in EATRO 2340 subfamilies and 69% in 
EATRO 3 subfamilies) is also informative, because it implies that the mechanism 
producing closely related genes, which is presumably gene duplication followed 
by divergence, is ongoing. However, the main point emerging from this work is 
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the large degree of substructuring in the archive, with its implications for the 
ease of segmental conversion and mosaic formation as a fundamental mechanism 
of generating new antigenic variants during infection, as discussed by Marcello 
and Barry (Marcello & Barry, 2007b). 
4.7 Discussion 
In this section I will give an overview and brief discussion of the principal 
findings of the chapter; in Chapter 6, the results will be further evaluated and 
discussed in the wider context of the project and current understanding of 
antigenic variation and subtelomere evolution. 
4.7.1 Gene annotation 
The first outcome of the work described in this chapter was the annotation of 
thousands of VSG NTDs in the subtelomeres of the EATRO 3 and EATRO 2340 
genome assemblies. The annotated gene sequences constituted the raw data 
required for the analyses described in the remainder of the chapter. The genes 
also provide a valuable resource for future studies (some possibilities discussed 
in Chapter 6) of the evolution and properties of the VSG archive in this strain 
and in T. brucei more generally, which were not possible within the scope of this 
project. The conclusions that could be drawn from analysing these data are 
discussed below, but there are two main points that emerged from the initial 
results. Firstly, the success of the annotation demonstrates that it is possible to 
extract a large number of data from the difficult subtelomeric regions even if 
they cannot be assembled into chromosomes, and that sequence that is often 
discarded in assembly efforts can be extremely informative. 
Secondly, when compared by BLASTN, the genes from EATRO 3 had good hits in 
the subtelomeres of EATRO 2340, and vice versa, but neither archive matched 
well to the TREU 927 genome. This result illustrates how similar the two archives 
remain. Further, the lack of similarity with TREU 927 validated the annotation 
approach: because the TREU 927 and the EATRO 3-EATRO 2340 archives differed 
considerably, an annotation approach based solely on sequence similarity to 
previously annotated genes would have missed many VSGs in the EATRO 
genomes. The approach used was also far less time-consuming than annotating 
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VSGs by manual inspection for conserved cysteine patterns, as was used for 
some of the TREU 927 annotation (L. Marcello, PhD thesis, 2007). 
4.7.2 Gene pairing and unpaired genes 
Next, I described the identification of sequences that corresponded to the same 
gene in both genomes, a key step required to be able to follow changes in genes 
between the genomes. The pairing approach used was able to identify 1034 
genes that were likely present in both genome assemblies. In conjunction with 
SNP annotation from PCR-free sequencing reads, this pairing of genes revealed 
the changes that had occurred in each gene between EATRO 3 in 1960 and 
EATRO 2340 in 1977. However, there remained 130 EATRO 3 and 778 EATRO 2340 
VSG NTDs that could not be matched with high confidence to a sequence in the 
other genome. Considering the incomplete nature of both genomes, it is likely 
that many genes were missing partners simply because the partner was not 
assembled. In these cases, it may be speculated that one partner but not the 
other was assembled because the two were in somewhat different genomic 
contexts, but there was not sufficient information to investigate this possibility. 
It is striking that far more EATRO 2340 than EATRO 3 genes were unmatched, 
even when considered as a proportion of the total rather than an absolute count 
(43% of EATRO 2340 compared with 12% of EATRO 3 genes). However, this 
observation can be explained to some extent by the larger amount of sequence 
and smaller number of gaps in EATRO 2340: EATRO 2340 had 2.04 Mb of 
subtelomeric sequence in the assembled chromosomes, and 13.7 Mb of sequence 
on bin contigs containing annotated VSG NTDs; EATRO 3 had 1.81 Mb and 9.7 Mb 
respectively. 
In an important step in pairing genes, a match was excluded because the 
sequence annotated as the partner of a particular gene did not hit that gene 
when it was used as the query in the reciprocal BLAST step. Often, the lack of a 
reciprocal hit was because there were two genes in the query genome that had 
both hit the same, or nearly the same, sequence in the other genome. In this 
case, whichever gene had the higher-identity match was excluded, and the 
other was classed as a ‘poor hit’. However, in 17 cases the gene that had the 
lower-identity match was nonetheless a good hit, and would have been accepted 
as a high-confidence match in the absence of a second hit. In two further 
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instances there were two genes in the same genome that were very similar to 
one another, and had hit nearly the same sequence in the other genome, but 
there was a small difference between the precise limits of the hit that had 
prevented reciprocal BLAST from identifying either pair as invalid. Both of these 
scenarios could have been the result of one of the genes’ partner not being 
assembled. However, the close similarity of all three genes (two in the query 
genome and one in the other genome) means a plausible alternative explanation 
is that there was originally just one gene in each genome, and it was duplicated 
in one genome but not the other. These results therefore provide some evidence 
that gene duplication had occurred in the course of VSG archive evolution in the 
time-scale studied. 
4.7.3 Evolution of VSG NTDs 
The next and principal part of the study described in this chapter was the 
comparison of genes and detection of changes that had occurred in the VSG 
NTDs between EATRO 3 and EATRO 2340, and analysis of what these changes 
could tell us about hyperevolution of VSG genes. One important technical point 
to emerge from the annotation of changes in the genes was that the assembled 
genomes represented only part of the true genomes, such that highly similar 
genes tended to have been conflated into a single gene. Hence, to compare the 
sequence of the assembled genes was over-simplistic. Therefore, such 
approaches should be used with caution, and sequences should be verified as far 
as possible by targeted resequencing. However, this study demonstrated that it 
was possible to gain data with reasonable reliability; albeit with some caveats, 
particularly that of not focusing too closely on specific SNPs. 
An important conclusion obtained from the analysis of gene changes was that 
VSG NTDs accumulated substitution mutations significantly faster than core 
genes, with 2.4-fold higher substitution frequency. This conclusion was 
strengthened by the finding that the frequency of mutations at positions where 
any change was synonymous, a measure that removes the effects of selection, 
was significantly higher in VSG NTDs than in core genes. Substitution mutations 
account for only one of several mutation processes that change the sequence of 
VSG (Marcello & Barry, 2007b), so the substitution rate obtained for VSG NTDs 
(4.7×10-9 to 1.6×10-8 substitutions/base/generation) represents a minimum rate 
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of change of VSG genes, and the overall rate of evolution is likely to be 
substantially higher. Further, it is likely that the figure obtained underestimated 
the difference in substitution frequency: as described above, the method used 
for SNP annotation was likely to have a non-negligible false negative rate. It 
seems probable that there will be more false negatives in the VSGs than in the 
core genes, for reasons that include more uncertainty in the assembly and more 
missing sequence, and that can be summed up as consequences of the VSGs 
being in a genome region that is more complex to assemble. The complexity and 
uncertainty of the subtelomeres’ assembly is particularly relevant because 
successful annotation of SNPs relied on correct alignment of paired genes. This 
reasoning was borne out to some extent by observations of SNP numbers using 
different cataloguing methods: as the filters became more stringent, the number 
of SNPs in VSGs decreased more rapidly than the number of SNPs in core genes. 
Although most of the removed SNPs were likely to have been false positives, it 
does not seem implausible that some true positives were also excluded. This 
work therefore presents a picture of VSG genes evolving rapidly, at several times 
the rate of core genes. 
The analysis also revealed that the substitution mutation profile of VSG NTDs 
was significantly different from that of core genes, even when corrected for the 
A-richness of the VSGs. Further, a preliminary comparison of strand bias in the 
two gene types suggested that the mutations occurring in VSG NTDs had a more 
pronounced strand bias than those in core genes. Taken together with the faster 
rate of change in VSG NTDs, these results supported the hypothesis that 
substitution mutation in VSGs is a process that is distinct from substitution 
mutation in chromosome cores. Such a difference could be produced either by 
different mechanisms acting in each genome region, or by the same basic 
mechanisms combining in different ways. 
Having concluded that substitution in VSG NTDs was different from and faster 
than substitution in core genes, I explored the VSG NTD data further to attempt 
to gain insight into the processes occurring in VSG genes. First, the distribution 
of the number of SNPs per gene was not well described by a Poisson distribution; 
that is, one or more of the assumptions of the Poisson distribution was not true. 
Because of the observed overdispersion of the data, a probable explanation for 
violation of the Poisson distribution assumptions was that the occurrences of 
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SNPs were not independent. In particular, the probability a gene with at least 
one SNP would have more than one SNP (0.61) was considerably greater than the 
probability that any gene would have at least one SNP (0.13, i.e. P(n>1| n>0) > 
P(n>0), where n = number of SNPs in a gene), whereas if SNPs occurred 
completely independently we would expect the two probabilities to be equal. 
One possible explanation for this lack of independence is that despite the 
stringent filters used, in some cases ‘SNPs’ had been annotated which were 
actually due to the existence of two highly similar genes in both genomes that 
had a difference at that position in both genomes. 
However, there are also plausible biological explanations that do not invoke 
technical artefacts. Firstly, multiple SNPs could arise from a single event. For 
example, segmental conversion between two highly similar genes could produce 
the outcomes observed: if a recent duplication event produced two copies of a 
particular gene, point mutations would accumulate independently in both 
daughter copies, and then a single segmental conversion event could copy 
several mutations from one gene to the other. This explanation is probably the 
most likely, because gene duplications, point mutations and segmental 
conversions have been predicted to occur in VSGs (Marcello & Barry, 2007b). A 
related possibility is that such duplication and point mutation do occur, but 
rather than sharing mutations between the two daughter copies, segmental 
conversion has overwritten changes in one copy by converting it to the ancestral 
sequence still present in the other copy. This mechanism would elevate the 
number of genes with no mutations beyond the number that would be expected 
from random mutations. A more speculative explanation is that point mutation 
occurs at random and independently, but only in a subset of genes. Such a 
subset could be created by targeting of mutagenic activity; however, no 
research has been done that could confirm or reject the idea of such targeting 
of mutations within subtelomeres. The observed distribution of the number of 
SNPs per gene therefore most probably resulted from the effects of segmental 
conversions but may well include some effects of sequencing and assembly 
artefacts. 
When the SNPs were examined in the context of predicted protein sequence, a 
substantial number were found to result in an amino acid change, demonstrating 
that the observed mutations had potential to contribute to antigen diversity. 
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The frequency of non-synonymous mutations at non-synonymous sites (dN) was 
higher than the frequency of synonymous mutations at synonymous sites (dS), 
with a dN/dS ratio of 0.4, but as discussed above, this was unlikely to indicate 
purifying selection on the VSG genes. 
On examination of the distribution of SNPs within genes, it appeared that 
distribution was random in type A NTDs but that there was some clustering of 
SNPs in type B NTDs. However, there seemed to be little relationship between 
predicted secondary structure and the region of SNP clustering, so the biological 
significance of the clustering is unclear. It is surprising that the two NTD types 
should differ in their SNP distribution, because there has been no previous 
indication that they evolve by distinct processes, and the genes’ classification is 
based on their lineage rather than any separation of function (Jackson et al, 
2012). Additionally, NTD genes of both types are intermingled in the genome, so 
it is not the case that B-type genes could experience a completely different 
genomic environment from A-type (Berriman et al, 2005; Marcello & Barry, 
2007b). It is possible that aspects of the SNP annotation method biased the 
position of recovered SNPs: specifically, that the central region, which is more 
variable between genes, was more likely to have sequence that was unique to 
each gene and hence to have Illumina reads mapped with high confidence, which 
was necessary for a SNP to be called. Overall, there may be a bias in SNP 
occurrence towards certain parts of the gene, but the bias observed was not 
strong, and the difference between domain types was probably not relevant. 
Importantly, despite a possible bias in B-type VSGs towards the centre of the 
NTD, it was possible for a SNP to occur in any part of the gene. 
Although SNPs may not be distributed at random within VSG sequence, this study 
found no evidence that a SNP was more likely to occur in VSG NTD than in 
subtelomeric sequence that was not annotated as VSG NTD. There was no 
difference in the frequency of substitution mutations in VSG NTDs and in 
subtelomeres generally. Further, any bias introduced by the method of SNP 
calling would be expected to bias the overall subtelomere substitution frequency 
downwards, because SNPs would be harder to call in the lower complexity 
sequence that tends to occur outside the VSGs, because fewer reads would map 
uniquely in these regions. Therefore it seems highly unlikely that mutation 
proceeds more rapidly in VSGs than anywhere else in the subtelomeres. This 
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conclusion supports the hypothesis that hypermutation in VSGs is a consequence 
of their location in the hypermutational environment of the subtelomeres, 
although more evidence, such as a more detailed study of the types of mutation 
occurring, would be required to fully accept the hypothesis.  
Examination of the composition of the VSG NTD archive annotated in both 
genomes tended to support the conclusions of VSG evolution drawn from study 
of the TREU 927 archive (Berriman et al, 2005; Marcello & Barry, 2007b). The 
majority of NTDs examined were pseudogenes, from a variety of causes including 
frameshift mutations, premature stop codons and lack of a CTD. There was some 
indication that a few pseudogenes in EATRO 3 had regained functionality in 
EATRO 2340, but examination of the genes involved did not exclude the 
possibility that the observed changes were artefactual. Both archives exhibited a 
large degree of substructuring, greater than that seen in TREU 927, implying 
that an even greater fraction of diversity in the archive was the result of 
duplication followed by divergence. Further evidence for an important role of 
such a process of duplication was supplied by the suggestion of a highly similar 
copy of many genes given by the large number of genes containing ‘heterozygous 
SNPs’. 
The principal conclusion that can be drawn from the analysis of changes in VSG 
NTD genes is that substitution mutation proceeds differently in the VSG genes 
from in genes in the chromosome cores. The study went some way towards 
dissecting the substitution process in VSGs in more detail, but the detailed 
picture is unclear and few firm conclusions could be reached. There was no 
evidence obtained that the mutation processes were specific to VSG genes 
within the subtelomeres, although there was some tentative evidence that 
substitutions did not occur completely at random within the genes. Examination 
of genes within the archive supported the conclusion from TREU 927 that gene 
duplication is important in the evolution of the archive. 
 
 
 
 
 
Chapter 5: Characterisation of DNA 
polymerase κ  
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5 Characterisation of DNA polymerase κ 
5.1 Introduction 
The first aim of the work in this thesis was to characterise the mutations that 
occur during VSG evolution, as described in the previous two chapters. The 
second aim, which will be covered in this chapter, was to address the problem 
of which mechanisms are involved in generating (whether specifically or 
otherwise) these mutations. This is clearly an immense question, and is unlikely 
to have a single answer, and my work focused on examining the potential for 
involvement of a single mechanism hypothesised to play a role. 
Lesion bypass DNA polymerases are enzymes that can insert bases opposite to 
DNA lesions that would otherwise block DNA synthesis (Prakash et al, 2005). The 
enzymes are error-prone compared with replicative DNA polymerases, primarily 
because of two structural features: their role requires a larger active site than 
replicative DNA polymerases, to accommodate DNA lesions; and they do not have 
5′-3′ proofreading activity (Yang, 2005; Waters et al, 2009). This low replication 
fidelity has led to the suggestion that lesion bypass polymerases have a role in 
the systematic generation of mutations, including in trypanosome VSG genes 
(Goodman, 2002; McKenzie & Rosenberg, 2001). 
A lesion bypass polymerase of particular interest in the context of VSG evolution 
is pol κ, a member of the Y-family of DNA polymerases. Pol κ has undergone a 
T. brucei-specific expansion in gene number. Leishmania major has three copies 
of the pol κ gene, T. cruzi has two, but T. brucei has ten tandemly arranged 
copies, although one is truncated (Rajão et al, 2009). The characterised 
mutation profile of human pol κ (along with that of other human lesion bypass 
polymerases) is similar to the spectrum of mutations that are predicted to occur 
in VSG arrays (Johnson et al, 2000; Ohashi et al, 2000b; 2000a; Hile & Eckert, 
2008; Marcello & Barry, 2007b). The T. brucei family of pol κ genes has diverged 
into two groups based on whether the sequence of the DNA-binding domain 
predicts a Y-family typical domain or an atypical domain. The predicted proteins 
model well onto the solved structure of human pol κ. However, the genes 
encode mutated residues lining the substrate-binding and active sites, which 
may render the enzyme even more permissive in its substrate, and hence more 
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error-prone (Uljon et al, 2004; J.D. Barry and B. Marchetti, unpublished). The 
mean pairwise percentage amino acid identities between the predicted 
translations of the nine full-length pol κ genes in T. brucei TREU 927 and each of 
the two T. cruzi pol κ proteins are 43% (Tc00.1047053503755.10) and 36% 
(Tc00.1047053503755.30); and between T. brucei pol κs and human pol κ is 21%. 
The mean pairwise percentage amino acid identity between all full-length 
T. brucei pol κs is 86%; if the genes with canonical DNA-binding domains (n=2) 
and with atypical DNA-binding domains (n=7) are considered separately, the 
mean percentage identities are 88% and 89% respectively. Figure 5-1 shows an 
alignment of the predicted amino acid sequences of the full-length T. brucei pol 
κ genes and the T. cruzi pol κ protein sequences. 
The expansion of the pol κ gene family and its likely error profile therefore 
made the gene products plausible candidates for DNA polymerases that 
introduce mutations into VSG. This chapter describes work carried out to 
attempt to test the hypothesis that T. brucei has adapted members of the pol κ 
gene family to specifically mutate trypanosome subtelomeres. This question was 
approached in several ways. Firstly, I attempted to characterise the in vitro 
mutation profile of two members of the pol κ family, one from each subfamily. 
The aim of this work was to examine how closely the actual mutation profile of 
the enzymes matched the mutations observed to occur in the subtelomeres. 
Secondly, I studied the two pol κ proteins in vivo, examining their subcellular 
localisation and the effect of their overexpression, to test whether these 
features were consistent with a role for these lesion bypass polymerases at 
subtelomeres. 
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Figure 5-1 – Aligned T. brucei and T. cruzi pol κ protein sequences (continued next page). 
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Figure 5-1 continued. The truncated (487 bp) gene Tb11.01.0060 has not been included. The 
DNA-binding domain is indicated by a red box on the top line of the second page. 
Sequences were aligned and visualised with CLC Genomics Workbench 6. Positions in the 
alignment are shown above each row. Tc1 = Tc00.1047053503755.10; Tc2 = 
Tc00.1047053503755.30; Tb1 = Tb11.01.0010; Tb2 = Tb11.01.0020; Tb3 = Tb11.01.0030; Tb4 = 
Tb11.01.0040; Tb5 = Tb11.01.0050; Tb6 = Tb11.01.0080; Tb7 = Tb11.12.0001; Tb8 = 
Tb11.12.0002; Tb9 = Tb11.12.0003. 
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5.2 Biochemical analysis 
5.2.1 Generation of MBP-tagged pol κ constructs and active site 
mutants 
One pol κ gene was studied from each of the two branches of the family: 
Tb11.12.0001 (referred to as polκ001, atypical DNA binding domain) and 
Tb11.01.0010 (referred to as polκ10, typical DNA binding domain). Expression 
vectors were the gift of Dr Barbara Marchetti and were constructed by 
amplifying the genes from T. brucei genomic DNA and cloning them into the 
vector pMAL-c4x (NEB). The vectors (Figure 5-2) allowed expression in E. coli of 
the trypanosome genes fused to maltose binding protein (MBP) at their N-
termini, when induced with IPTG. 
 
Figure 5-2 – MBP-tagged polκ10 expression construct. 
The central circular scale is in bp from an arbitrary position (the beginning of the lacIq 
promoter). Notable features are the tag (labelled MBP); the pol κ gene (labelled polκ10); and 
the ampicillin resistance selectable marker for bacterial transformation and maintenance 
(labelled bla (ampR)). The MBP-polκ001 construct was identical except for the pol κ gene. 
I generated a predicted null mutant of each of the two MBP-polκ genes, using 
site-directed mutagenesis with primers specific to each gene, using either pMAL-
K10 (primers PL15 and PL16) or pMAL-K001 (primers PL17 and PL18) as the 
template. Mutants were screened using colony PCR with PL19 (pMAL-K10) or 
PL21 (pMAL-K001) and P79 primers, then verified by sequencing using the 
primers P74, P78, T7 and T7term. These mutants were generated to provide a 
negative control to check that any polymerase activity of the MBP-polκ 
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preparations was due to T. brucei pol κ, rather than due to contamination with 
polymerase activity from E. coli proteins. The mutation was of a critical 
aspartate in the catalytic triad conserved in Y-family polymerases, which in the 
related pol η completely abolished polymerase activity (Kondratick et al, 2001). 
Both wild-type constructs and both mutant constructs were used to transform 
Rosetta2 E. coli competent cells (Novagen, gift of Anna Trenaman), a strain 
optimised for protein expression. 
5.2.2 Purification of MBP-polκ fusion proteins by amylose affinity 
chromatography 
Initially, I grew Rosetta2 cells expressing MBP-polκ fusion proteins at 20ºC and 
purified MBP-polκ fusion proteins by amylose affinity chromatography. PAGE 
analysis demonstrated the final preparations of soluble protein each contained a 
protein band of the appropriate apparent size, although much of the fusion 
protein produced appeared to be insoluble. Some extra protein bands were 
visible on the gel after purification, indicating potential contamination or 
degradation. I made an attempt to remove contaminating proteins with 
relatively low maltose affinity by including small concentrations of maltose in 
the wash buffer and by doing a second round of affinity chromatography. 
However, this change did not noticeably improve the protein purity, and the 
second round of purification considerably reduced the protein yield (Figure 5-3). 
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Figure 5-3 – Representative PAGE showing stages in maltose affinity purification of pol κ-
MBP proteins. 
E. coli cells transformed with pMAL-K10 (Lane 1) were induced with IPTG, grown overnight 
at 15ºC, harvested and lysed (Lane 2). Insoluble material in the lysate (Lane 3) was removed 
by centrifugation, and appears to contain a large amount of the fusion protein, which ran 
below its expected molecular weight, probably due to its high concentration. Soluble MBP-
polκ10 was purified by amylose affinity chromatography, and concentrated (Lane 4). A 
second round of amylose affinity purification and concentration was carried out with this 
concentrated preparation (Lane 5). The black arrow indicates approximately the expected 
size of MBP-polκ10 (106 kDa). Lanes have been cropped from the gel for clarity. The size 
markers to the left of the gel image indicate the positions of protein size standards (Protein 
Marker, Broad Range (2-212 kDa) (NEB)). 
5.2.3 Development of assays to characterise pol κ activity 
I developed and optimised several assays to characterise the activity of the pol κ 
DNA polymerase, testing the efficacy of the assays with tagged wild-type pol κ 
proteins. This work was carried out in parallel with generation and preparation 
of the tagged mutant pol κ proteins. Results in this section therefore do not 
contain the appropriate pol κ negative controls, and are shown for the purpose 
of illustrating the development processes. For all assays described I used 
reaction conditions that had been successful for MBP-tagged T. cruzi pol κ 
(Rajão et al, 2009). The conditions included magnesium as the divalent cation, 
which has been shown to be an effective cofactor for human pol κ (Gerlach et al, 
2001). 
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5.2.3.1 Gap-filling assay for characterisation of mutational profile 
I first attempted to adapt for the pol κ proteins a forward mutation assay 
intended to determine the mutagenic profile of a polymerase on undamaged 
DNA (Bebenek & Kunkel, 1995). The template, which I prepared by restriction 
digestion and hybridisation, was M13mp18 dsDNA containing a 407-bp single-
stranded gap in the lacZα gene. In the assay, the gapped template is incubated 
with a polymerase that synthesises DNA across the gap and the products are 
transformed into E. coli and plated on a lawn of E. coli α-complementation cells 
on plates containing X-Gal. If synthesis has been error free, the lacZα gene 
product complements the defective ß-galactosidase activity of the lawn cells, 
allowing hydrolysis of X-Gal and the production of blue plaques. White plaques 
arise from products of reactions in which an error occurred and these can be 
counted and the mutants sequenced. 
I used MBP-polκ fusion proteins as the polymerase in this gap-filling assay. When 
I analysed reaction products by agarose gel electrophoresis, no difference in 
band mobility was observable between the MBP-polκ reactions and the negative 
control (Figure 5-4, bands running at approximately 7 kb in lanes 1 and 2 (MBP-
polκ) and 4 (no-enzyme negative control)). An observable difference would be 
expected between gapped substrate and the product of the gap-filling reaction 
(Bebenek & Kunkel, 1995), and there was an observable difference from the 
negative control in the product of a gap-filling reaction when E. coli Klenow 
fragment DNA polymerase was used (Figure 5-4, lane 3). When I used the 
reaction products to transform E. coli, there was no consistent difference, 
either quantitatively or qualitatively (plaque colour), between the plaques on 
the MBP-polκ and negative control plates. 
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Figure 5-4 – Agarose gel analysis of the products of a typical gap-filling reaction. 
Approximately 300 ng of the polymerase indicated in the lane label was incubated with 
approximately 40 ng of gapped DNA substrate for 3 h at 37ºC, then the reactions were 
stopped by the addition of EDTA, and 20 µl of each 30 µl reaction was analysed by agarose 
gel electrophoresis. Klenow = E. coli Klenow fragment DNA polymerase. The size markers 
to the left of the gel image indicate the positions of DNA size standards (1 kb Plus DNA 
ladder, Invitrogen). 
 
5.2.3.2 Primer extension assay for detection of polymerase activity 
One hypothesis for this lack of activity in the gap-filling assay was that the 
purified polymerases were inactive. Therefore, to test in a simplified system 
whether the MBP-polκ preparations had any polymerase activity, I used a primer 
extension assay based on an experiment used for T. cruzi pol κ (Rajão et al, 
2009).  A 17-bp 5′ fluorescein-labelled primer (M13 primer) was hybridised to a 
31-bp template (DLoopF, Figure 5-5A). The substrate was incubated with 
polymerase to allow extension of the primer. Polymerase activity was detected 
by a mobility shift of the extended primer in denaturing PAGE. A novel second, 
similar assay used a template in which, during the hybridisation step, I added a 
third type of DNA molecule: an unlabelled oligonucleotide (PL3) complementary 
to the part of the template that was not complementary to the fluorescein-
labelled primer. This hybridisation generated a tripartite substrate that could be 
used to check the activity of polymerases in strand displacement DNA synthesis 
(Figure 5-5B).The assay demonstrated that wild-type MBP-polκ preparations did 
indeed have polymerase activity, and were able to synthesise DNA without and 
with strand displacement (Figure 5-5C). 
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Figure 5-5 – Primer extension assays 
A) Schematic diagram of primer extension assay (substrate 1, S1). B) Schematic diagram of 
strand displacement primer extension assay (substrate 2, S2). C) Pilot experiment showing 
both assays. The indicated polymerases (1 µg) or no enzyme were incubated with 200 ng of 
the indicated substrate for 2 h at 37ºC. The products were analysed on polyacrylamide gels 
and imaged using a Typhoon imager. Black arrows indicate the position of the starting 
primer and the fully extended primer. 
5.2.3.3 Reversion assay for estimation of mutation rate 
Given that the purified polymerases appeared to be active, another possible 
explanation for lack of activity in the gap-filling assay was that this assay 
reaction was so far from the polymerases’ physiological role that the enzymes 
were unable to synthesise DNA. I therefore developed a mutation assay that had 
conditions closer to the enzymes’ likely in vitro activity. This assay was loosely 
based on a reversion assay described by Osheroff and colleagues (Osheroff et al, 
1999). I amplified part of the lacZα gene in M13mp18, using primers PL1 and 
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PL2, which added a recognition site for Nb.BbvCI, which includes a stop codon, 
in the multiple cloning site near the 5′ end of the coding region of the gene. I 
then used existing BamHI and BglII sites in the gene to remove the original 
sequence between these sites and replace it with the modified PCR product. 
This generated a version of M13mp18, referred to as M13Stop, with a nicking 
enzyme restriction site and a stop codon within the lacZα gene, close to the 
start of the ORF. The construct was checked by sequencing with primer PL2. The 
insertion of the stop codon resulted in a colourless plaque phenotype when the 
double-stranded bacteriophage was transformed into E. coli. 
I treated the modified bacteriophage template with the enzyme Nb.BbvCI, 
providing a substrate for strand displacement DNA synthesis by the DNA 
polymerases, on otherwise undamaged template. If a single error was made by 
the polymerase in synthesis of the stop codon, for eight out of nine possible 
changes this would result in a functional lacZα gene, and the bacteriophage 
would be able to produce blue plaques again (Figure 5-6). 
 
Figure 5-6 – Schematic diagram of steps in the M13-Stop reversion assay. 
Double-stranded M13-Stop was treated with Nb.BbvCI to generate a nicked template, which 
was incubated with polymerase and the products transformed in E. coli. If an error was 
made in synthesising the stop codon, blue plaques would be produced; otherwise, white 
plaques would be produced. 
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Pilot experiments with wild-type MBP-polκ preparations resulted in the 
generation of some blue colonies, indicating that this approach could be used to 
estimate the mutation rates of pol κ proteins. Given the mutation rate of human 
pol κ on undamaged DNA (Ohashi et al, 2000a), we would expect approximately 
one revertant per 65 plaques in this assay if human pol κ were used. However, 
the preliminary results for T. brucei pol κ indicated a considerably lower 
revertant rate: seven blue plaques out of 5500 scored for MBP-polκ10, and one 
blue plaque out of 900 scored for MBP-polκ001. 
5.2.3.4 Quantification of escape from tet repressor for estimation of 
mutation rate 
As an alternative to in vitro characterisation of mutation rate with purified 
protein, I attempted to adapt a forward mutation approach that has been used 
to characterise spontaneous mutation rates and profiles in E. coli under various 
conditions (Bjedov et al, 2007), using a cell line that was the gift of Dr Ivan 
Matic. In this line, referred to as MG1655 cI-Tet (see Chapter 2 for full 
genotype), cells contain a tetA (tetracycline resistance) gene whose promoter 
has been replaced by the λ pR promoter; and the λ cI (Ind-) gene, which 
produces a protein, cI, that represses expression from λ pR. If a mutation occurs 
that inactivates or prevents expression of cI, the cells will gain tetracycline 
resistance, allowing the mutation rate to be estimated, and the mutation(s) in 
λ cI (Ind-) to be characterised. 
In E. coli, overexpression of the pol κ homologue dinB increases the spontaneous 
mutation rate by factors of up to several hundred (Kim et al, 1997). If T. brucei 
polκ10 is a typical Y-family DNA polymerase that can interact with the E. coli 
DNA synthesis and repair system, its overexpression should give a similar 
phenotype of increased mutation rate. Therefore, to test whether this system 
could be used with T. brucei pol κ, I transformed pMAL-K10 into competent 
MG1655 cI-Tet cells. PAGE of lysates of cells to which IPTG had been added 
indicated that induction of overexpression was successful (Figure 5-7). I grew 
both induced and uninduced E. coli cells from a very small starting count, spread 
the culture on tetracycline plates, incubated overnight, and counted the 
resulting tetracycline-resistant colonies. Initial experiments showed very little 
difference between the number of resistant colonies from induced and 
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uninduced cells (data not shown). It is possible that further experiments might 
have allowed a significant difference to be observed, but it seemed unlikely that 
this approach would be useful. One possible explanation for the lack of a 
positive result was failure of polκ10 to engage with the E. coli replication 
machinery, so we did not consider that this outcome showed that polκ10 was not 
an active polymerase. 
 
Figure 5-7 – Expression of MBP- polκ10 in MG1655 cI-Tet cells. 
MG1655 cI-Tet cells transformed with pMAL-K10 were induced with the indicated 
concentration of IPTG, and their approximate density determined by spectrophotometry. 
Sample of approximately the same number of cells for each culture were lysed with protein 
running buffer and analysed by PAGE. The expected size of MBP-polκ10 is indicated by the 
black arrow. The size markers to the left of the gel image indicate the positions of protein 
size standards (Protein Marker, Broad Range (2-212 kDa) (NEB)). 
5.2.4 Activity of affinity-purified MBP-polκ fusion proteins 
As described above, primer extension assays demonstrated that wild-type pol κ 
preparations contained DNA polymerase activity. However, when the simple 
primer extension experiment was repeated with null mutant MBP-polκ10, a 
similar level of polymerase activity was observed, indicating that most of the 
activity did not come from the pol κ component of the preparations, but was 
likely to be due to E. coli contaminants (Figure 5-8). 
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Figure 5-8 – Primer extension assay with affinity-purified wild-type (WT) and mutant MBP-
polκ10. 
Primer extension assays were carried out as in Figure 5-5 with substrate 1. Black arrows 
indicate the positions of the starting primer and the fully extended primer. ‘Round 1’ and 
‘Round 2’ refer to whether the protein preparation was the product of one or of two rounds 
of affinity chromatography. 
5.2.5 Purification of MBP-polκ fusion proteins by inclusion body 
isolation, solubilisation and refolding 
Because recovery of pol κ was already low due to insolubility of much the fusion 
protein, it seemed more practical to attempt to increase the purity of the pol κ 
preparations by an alternative purification method rather than by gel filtration 
of the affinity chromatography-purified protein. The contaminating polymerase 
activity was presumably due to a soluble E. coli protein, perhaps binding to the 
amylose beads, whereas a large proportion of the MBP-polκ protein produced 
appeared to be insoluble (Figure 5-3). The approach used, therefore, was to 
isolate the insoluble MBP-polκ, which would likely be free of soluble 
contaminant, as native E. coli enzymes should reliably be soluble in E. coli 
cultures. I induced expression of MBP-polκ10, and extracted, washed, and 
solubilised the inclusion body from E. coli lysate. I then set up a screen to 
attempt refolding of MBP-polκ10 (Table 5-1). After refolding, I dialysed solutions 
to remove chaotropic buffers. After this step, any remaining unfolded protein 
should have precipitated. I determined the concentration of soluble protein, 
which indicated good yields of soluble protein (Table 5-1), and PAGE of selected 
conditions suggested good purification (Figure 5-9A). 
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Table 5-1 – Conditions used for refolding screen and protein yields from each condition. 
All refolding reactions also included 21 mM NaCl, 0.88 mM KCl and 55 mM Tris, pH 8.2. 
NA = dialysis was not carried out, NA* = refolding reaction was not carried out. 
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Figure 5-9 – PAGE of stages of inclusion body purification and refolding. 
Chapter 5 177 
Figure 5-9 continued. A) polκ10-MBP. E. coli cells transformed with pMAL-K10 (Lane 1) were 
induced with IPTG, grown for 2 h at 37ºC, harvested and lysed (Lane 2). The lysate was 
centrifuged to pellet insoluble material, and the soluble fraction (Lane 3) was removed. 
Insoluble matter, expected to contain the majority of the fusion protein, was washed twice 
(Lanes 4 and 5 contain the wash supernatant). The washed inclusion body (Lane 6 and 7) 
was solubilised in guanidine hydrochloride solution, and refolding was attempted (Lanes 8, 
9 and 10). B) polκ001-MBP, products of four refolding experiments, carried out as for 
polκ10-MBP. C) polκ10-D230A, products of three refolding experiments. D) polκ001-D229A, 
products of three refolding experiments. Where a volume rather than a mass is given, the 
protein solution was too dilute for the concentration to be determined, so a fixed volume of 
was used. IB = solubilised inclusion body; R1 = refolding with condition 1; similarly R2 = 
refolding with condition 2, and so on. For details of refolding conditions, see Table 5-1. The 
size markers to the left of the gel images indicate the positions of protein size standards 
(Protein Marker, Broad Range (2-212 kDa) (NEB)). 
I tested the activity of the refolded protein preparations in the primer extension 
assay as before (Figure 5-10), which demonstrated that several preparations had 
some polymerase activity. I repeated the expression, purification, solubilisation 
and the refolding screen using MBP-polκ001, with similar results (Table 5-1, 
Figure 5-9B). I produced solubilised protein for both mutant pol κs, and refolded 
each using the conditions that gave the best activity for the corresponding wild-
type pol κ. There was no evidence for any contaminants co-purifying with the 
mutant proteins that were not in the wild-type preparations (Figure 5-9C and D). 
I compared the wild-type proteins with the mutant proteins using the primer 
extension assay, which showed similar activity in each, indicating that the 
contamination problem had not been solved (Figure 5-11). 
 
Figure 5-10 – Primer extension assay with products of refolding screen of solubilised polκ-
MBP inclusion bodies. 
Primer extension assays were carried out as for Figure 5-5, with substrate 1. The substrate 
was incubated with 1 µg of protein product from each set of refolding conditions, indicated 
above each lane and numbered as in Table 5-1. Black arrows indicate the location of faint 
bands corresponding to extended primer. 
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Figure 5-11 – Primer extension assays with refolded proteins showed no difference in 
polymerase activity between wild-type and mutant MBP-polκ preparations. 
A) MBP-polκ10. B) MBP-polκ001. Primer extension assays were carried out as for Figure 5-5, 
with substrate 1. Black arrows indicate the location of faint bands corresponding to 
extended primer. WT = wild-type; M = active site mutant. Refolding conditions are indicated 
above each pair of lanes and are numbered as in Table 5-1. 
5.3 Cell biological analysis 
5.3.1 Generation and fluorescence microscopy of eGFP-tagged 
pol κ parasite lines 
The 10 pol κ genes exist as a tandem array of highly similar sequences on 
chromosome 11. This structure meant that it was impractical to tag or to knock 
out the endogenous genes, previous attempts having failed (J.D. Barry, pers. 
comm.). Therefore, to study the in vivo localisation of the products of the pol κ 
genes used in the biochemical assays, I generated T. brucei cell lines containing 
tagged ectopic copies of the genes. To achieve this, I cloned pol κ genes from 
the pMAL vectors into the plasmid pB2X. This vector was the gift of Dr Michal 
Swiderski, and was generated from pLEW100v5B1D, a variant of pLEW100 (Wirtz 
et al, 1999), by replacing the luciferase gene with a eGFP gene. I carried out 
PCR with primers P86 and P95 to amplify both pol κ genes from the pMAL 
vectors, restore the initial ATG codon, remove the stop codon and add flanking 
SpeI and HindIII restriction sites, then I used SpeI and HindIII to digest the PCR 
products and the vector, and then ligated the PCR products into the vector. This 
cloning procedure created the plasmids pB2X-K10-GFP and pB2X-K001-GFP, the 
sequences of which were confirmed by sequencing with the primers LEWSEQ1 
and either P73 and P76 (for pB2X-K10-GFP) or P74 and P77 (for pB2X-K001-GFP). 
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Each of these plasmids contained a gene encoding pol κ fused to eGFP at its C-
terminus, under the control of an RNA Pol I promoter with a Tet repressor 
binding site; a phleomycin resistance gene under the control of the T7 
polymerase promoter; and the sequence of the trypanosome ribosomal RNA 
spacer, to allow insertion of the construct into the genome (Figure 5-12). I 
transfected these constructs into the BSF RNAi cell line Lister 427 90:13 (Wirtz 
et al, 1999). This cell line constitutively expresses T7 polymerase, which allowed 
expression of the phleomycin resistance gene from the pB2X plasmids, and the 
Tet repressor protein, which suppressed expression of the pol κ fusion protein 
until tetracycline was added. 
 
Figure 5-12 – pB2X-K10-GFP, the construct used for polκ10-GFP overexpression. 
The central circular scale is in bp from an arbitrary position (the 3′ end of the rRNA spacer). 
Notable features are the rRNA spacer, in which the plasmid is cut for transformation, and 
which allows the construct’s integration into the genomic rRNA array; the phleomycin 
resistance selectable marker for parasite transfection (labelled BLE); the tag (labelled 
eGFP); and the pol κ gene (labelled polκ10). The plasmid pB2X-K001-GFP was identical 
except for the pol κ gene. 
Western blot analysis with an anti-GFP polyclonal antibody suggested that an 
eGFP-tagged protein of approximately the expected size was present in 
transfectants when expression of the fusion protein was induced by tetracycline, 
but not in uninduced parasites, for both examined clones from the tagged polκ10 
line (Figure 5-13). The same analysis with tagged polκ001 lines did not give a 
positive result, so results are only shown for polκ10-GFP parasites. 
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Figure 5-13 – Western blot analysis of parasites transformed with polκ10 overexpression 
construct. 
Parasites that had been stably transfected with pB2X-K10-GFP were grown either with 
(induced) or without (negative control, uninduced) tetracycline to induce overexpression of 
eGFP-tagged polκ10. The parasites were harvested and lysed, then the lysate was separated 
by PAGE and transferred to a nitrocellulose membrane. The membrane was probed with an 
anti-GFP primary antibody, followed by a horseradish peroxidase-conjugated secondary 
antibody, which was detected by adding a chemiluminescent substrate and exposing to X-
ray film. The positive control was lysate of E. coli expressing eGFP from a plasmid. Ladder 
= SeeBlue pre-stained standard (Invitrogen); the sizes to the left of the image indicate the 
sizes of these protein standards marked on the image. 
I used parasites from two pol κ10 clones in fluorescence microscopy to 
determine the localisation of eGFP fluorescence. I attempted live cell 
fluorescence imaging, but did not observe any eGFP fluorescence in induced 
parasites that was not also visible in uninduced cells (data not shown). I 
therefore prepared slides for microscopy using methanol fixation. Fluorescence 
appeared to be localised to the nucleus in induced parasites, and nuclear 
localisation was confirmed by high-resolution microscopy (Figure 5-14). 
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Figure 5-14 – Fluorescence microscopy of polκ-GFP overexpressing parasites. 
Parasites that had been stably transfected with pB2X-K10-GFP were grown either with 
(induced) or without (negative control, uninduced) tetracycline to induce overexpression of 
eGFP-tagged pol κ. The parasites were harvested, fixed with methanol and mounted with 
Vectashield mounting medium with DAPI (Vector Laboratories). A) Polκ10-GFP parasites 
with expression induced. B) Control: polκ10-GFP parasites without expression induced. 
Fluorescence was imaged using a DeltaVision fluorescence microscope, and the images 
deconvoluted using Softworx software. Projection uses maximum intensity layer. Images 
shown are representative of the cultures indicated, and of approximately 100 parasites 
checked in each case, almost all showed the same patterns of localisation. The scale bar 
indicates 6 µm for all four panels in one part of the figure. DIC = phase contrast image; GFP 
= fluorescence from eGFP (FITC filter); DAPI = fluorescence from DAPI (DAPI filter); DAPI-
GFP merge = images from eGFP and DAPI superimposed by the software. 
5.3.2 Fluorescence in-situ hybridisation with eGFP-tagged pol κ 
cell lines 
In order to test whether polκ10-GFP co-localises with telomeres within the 
nucleus, I decided to carry out fluorescence in-situ hybridisation (FISH). The 
work in this section was carried out in collaboration with Dr Barbara Marchetti. 
We used a PNA probe labelled with Cy5 to label telomere repeats in methanol-
fixed cells. However, no eGFP fluorescence was visible in parasites that had 
been prepared using the FISH protocol (data not shown). It seems likely that this 
failure was due to the harsh hybridisation conditions denaturing the eGFP 
sufficiently to abolish fluorescence. 
We therefore attempted to use immunofluorescence (IF) to detect eGFP in FISH 
parasites. However, when IF was followed by FISH, we were unable to detect 
any IF signal. Possible explanations for this failure were that the FISH protocol 
disrupted the antibody-GFP interaction, or that it disrupted the nuclear 
structure itself, dispersing the eGFP-labelled protein throughout the cell. We 
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altered the protocol to try and address this issue: we replaced methanol with 
the more powerful fixative formaldehyde, to better preserve cell structure; and 
we re-fixed parasites after incubation with antibody, in order to strengthen the 
antibody-epitope interaction by cross-linking. However, the IF signal was not 
improved by these changes. 
As can be seen from Figure 5-13, the polyclonal anti-GFP antibody showed a 
considerable amount of non-specific binding. We decided that in order to 
optimise the FISH-IF protocol, it would be better to use a tag that can be 
detected more cleanly than eGFP. Additionally, the large size of the eGFP tag 
was potentially disruptive to the function of the tagged protein. The main 
benefit of using eGFP-tagged protein is direct visualisation of the fusion protein 
through eGFP fluorescence; a benefit that is lost if an antibody is required to 
detect eGFP. 
5.3.3 Generation and fluorescence microscopy of MYC-tagged 
pol κ cell lines 
To replace the polκ-GFP cell lines, I generated polκ-12MYC cell lines. As there 
was no MYC version of the overexpression vector I used the 12MYC tag from an 
existing tagging construct (gift of Anna Trenaman). First, I attempted to use PCR 
with PL4 and PL5 followed by restriction digestion with SpeI and XhoI and 
ligation to directly substitute this multiple tag for eGFP in the pB2X-polκ-GFP 
vectors, but this strategy was unsuccessful, probably due to the small size and 
repetitive nature of the 12MYC PCR product. I therefore carried out PCR with 
primers PL8 and PL9 to amplify the 12MYC PCR product and add flanking 5′ 
HindIII and XbaI and 3′ XhoI and EcoRV recognition sites, and with primers PL12 
and PL13 to amplify the pol κ genes from the pMAL vectors and add flanking 5′ 
HindIII and EcoRV and 3′ XbaI recognition sites. I ligated the 12MYC PCR product 
into a TA cloning vector, then digested the 12MYC vector and the pol κ PCR 
product with HindIII and XbaI and ligated the pol κ PCR product into the 12MYC 
vector, creating polκ-12MYC fusion genes. I used HindIII and XhoI to digest pB2X-
GFP and the polκ-12MYC vectors, gel purified the pB2X backbone and the polκ-
12MYC fusion genes, and ligated the fusion genes into pB2X to generate the 
plasmids pB2X-K10-12MYC and pB2X-K001-12MYC. The plasmid sequences were 
confirmed by sequencing with the primer LEWSEQ2 and the same primers as 
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were used for pB2X-K10-GFP and pB2X-K001-GFP. I transfected pB2X-K10-12MYC 
and pB2X-K001-12MYC into BSF 427 90:13. Western analysis with an anti-MYC 
monoclonal antibody confirmed that the cell lines were expressing MYC-tagged 
proteins of the appropriate size (Figure 5-15). 
 
 
 
Figure 5-15 – Western analysis of parasites transfected with pB2X-polκ-12MYC constructs. 
Parasites that had been stably transfected with pB2X-12MYC constructs were grown and 
the lysate transferred to a nitrocellulose membrane as for Figure 5-13. The membrane was 
probed with an anti-MYC primary antibody, followed by a horseradish peroxidase-
conjugated secondary antibody, which was detected by adding a chemiluminescent 
substrate and exposing to X-ray film. The positive control was a lysate of T. brucei 
expressing MYC-tagged BRCA2 (gift of Anna Trenaman). Numbers above lanes indicate 
clone numbers. Un = uninduced. The size markers to the left of the image indicate the 
positions of protein size standards that were run on the same gel (SeeBlue pre-stained 
standard (Invitrogen)). 
I used the polκ-12MYC cell lines for IF analysis with an anti-MYC polyclonal 
antibody and a fluorescence-tagged secondary antibody. Initial experiments 
suggested that both polκ001-12MYC and polκ10-12MYC were located in the 
nucleus (Figure 5-16). However, the localisation work was not taken further 
because at this point the conclusions emerging from my biochemical studies of 
pol κ suggested that my time would better be spent on other aspects of my 
project. 
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Figure 5-16 – Immunofluorescence microscopy of parasites transfected with 12MYC-tagged 
pol κ constructs. 
Parasites stably transfected with pB2X-K10-12MYC or pB2X-K001-12MYC were grown and 
fixed with methanol as for Figure 5-14, then used for immunofluorescence with an anti-MYC 
primary antibody and Alexa594-conjugated secondary antibody. Imaging was performed 
using an Axioskop 2 fluorescence microscope. A) polκ10-12MYC, uninduced. B) polκ10-
12MYC, induced. C) polκ001-12MYC, uninduced. D) polκ001-12MYC, induced. The scale bar 
indicates 10 µm for all four panels in each section of the figure. DIC = phase contrast image; 
Rhod = fluorescence from secondary antibody against anti-MYC antibody, indicating 
location of MYC-tagged pol κ (Rhod filter); DAPI = fluorescence from DAPI (DAPI filter); 
Merge = images from Rhod and DAPI merged using the Axioskop included software. 
5.3.4 Overexpression phenotype of pol κ proteins 
In other eukaryotes, including T. cruzi, overexpression of pol κ increases 
resistance to the DNA-damaging agent hydrogen peroxide (Rajão et al, 2009). I 
therefore checked whether overexpression of either MYC-tagged T. brucei pol κ 
gave a similar phenotype, indicating a similar role. I grew overexpression-
induced and -uninduced parasites in the presence of 200 µM hydrogen peroxide, 
and took cell counts after 24 h and 48 h. There was no observable difference 
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between induced and uninduced cultures exposed to hydrogen peroxide, nor 
between induced and uninduced cultures in standard conditions (Figure 5-17). 
 
Figure 5-17 – Overexpression of polκ-12MYC proteins has no effect on hydrogen peroxide 
tolerance in BSF parasites. 
Parasites stably transfected with pB2X-K10-12MYC (for polκ10-12MYC) or pB2X-K001-
12MYC (for polκ001-12MYC) were grown from a low density in the indicated concentration 
of hydrogen peroxide, either with (induced) or without (negative control, uninduced) 
tetracycline to induce overexpression of tagged pol κ. Cell density was determined every 
24 h and is shown on the y-axis. Error bars represent one standard deviation. A) polκ10-
12MYC. B) polκ001-12MYC. 
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5.4 Discussion 
The work in this chapter aimed to characterise the proteins encoded by two 
members of the T. brucei pol κ gene family, with the aim of determining 
whether these error-prone polymerases had the potential to be involved in VSG 
hyperevolution. However, biochemical characterisation of the mutation profiles 
of the enzymes could not be carried out due to persistent contamination of MBP-
polκ preparations with E. coli DNA polymerase activity. The contamination was 
detected because primer extension assays with wild-type and with active site 
mutant pol κ proteins produced approximately equal amounts of product. 
Contamination was present in preparations of both proteins tested. Further, the 
contaminating activity was present in preparations using two purification 
methods, one of which involved purifying insoluble protein from E. coli cultures; 
and a similar contamination has been seen in amylose affinity preparations of 
MBP-tagged pol κ from T. cruzi (C. Machado, pers. comm.). The persistence of 
the contaminating activity suggests that its presence in the preparations was due 
to specific association with the MBP-polκ protein, rather than association with 
the amylose resin used in the first purification attempt. Its presence in multiple 
experiments with both proteins also makes it unlikely that the apparent 
polymerase activity of the presumed active site mutants was actually due to a 
mix-up between wild-type and mutant plasmids or E. coli cell lines. 
One alternative explanation for the polymerase activity of the mutant 
preparations is that the mutation did not in fact abolish the pol κ activity, and 
the polymerase activity actually came from the mutant protein rather than from 
E. coli protein. Activity of the presumed inactive mutant could be due to mis-
annotation of the active site, or due to the mutated active site residue not 
actually being critical for activity. However, due to the very high conservation of 
the active site across Y-family polymerases (Prakash et al, 2005), both 
possibilities seem unlikely4. Contamination with E. coli protein is a far more 
likely explanation for the activity of the mutant protein. 
                                                
4 If the active site does not work as it does in other Y-family polymerases, then these 
T. brucei enzymes are essentially not Y-family polymerases. In this case, it would be 
beyond the scope of this project to characterise what the T. brucei enzymes actually are, 
especially as there is no reason to assume that they have the characteristics of the Y-
family that led us to investigate them in the first place. 
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As we conclude that the polymerase activity in mutant pol κ preparations was 
due to E. coli protein, it seems reasonable to assume that the same E. coli 
activity contributed a similar amount of activity in the wild-type pol κ 
preparations. Although the amount of product was not quantified in any of the 
primer extension experiments, visual inspection of Figure 5-8 and Figure 5-11 
suggests that usually the mutant produced at least as much product as the wild-
type. The amount of product was not determined simply by the amount of 
substrate added, as in most cases there was still unextended primer visible. 
These results indicate that most, if not all, of the polymerase activity in the 
wild-type preparations also came from E. coli proteins, which in turn implies 
that the trypanosome pol κ proteins themselves contributed little or no 
polymerase activity. This conclusion is supported to some extent by the data 
from the reversion assay (section 5.2.3.3): although the results were only from 
preliminary experiments, the number of revertants indicated that the 
polymerase preparations contain an enzyme with a considerably lower mutation 
rate than human pol κ, a result that is more consistent with a processive E. coli 
replicative polymerase than with a member of the pol κ family. 
The fact that MBP-polκ overexpressed in E. coli and enriched in vitro had little 
activity does not necessarily mean that the T. brucei proteins are not active 
polymerases in vivo. Importantly, it was not possible to tell from the 
experiments described whether the enzymes have no activity at all, or whether 
it was just that the activity was so low as to be undetectable against the 
background of E. coli polymerase activity. Further, low activity in the 
experiment does not necessarily mean the enzymes have a low activity in vivo. 
Firstly, the activity of the enzyme may have been lost because of degradation 
during the expression and purification steps. This possibility cannot be excluded, 
but seems less likely when we consider that multiple preparations of two 
enzymes using two strategies all gave a similar result, and that a similar 
purification protocol yielded active T. cruzi enzyme. A second possibility is that 
the apparent low activities of the MBP-polκ fusion proteins were an inherent 
feature of the experimental setup: for example, the MBP tag may have impeded 
activity in some way; or the reaction conditions may not have been appropriate; 
or perhaps the inherent unprocessive nature of lesion bypass enzymes resulted in 
only a very small amount of fully-extended primer being made in the conditions 
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used. However, as mentioned above, the reaction conditions used (including the 
tag) have previously been successful for obtaining activity with T. cruzi pol κ 
(Rajão et al, 2009); included a divalent cation that has been shown to be an 
effective cofactor for human pol κ (Gerlach et al, 2001); and were able to 
support activity of E. coli Klenow fragment DNA polymerase (e.g. Figure 5-5). In 
an experiment almost identical to that described in section 5.2.3.2, T. cruzi 
MBP-polκ produced an amount of fully extended primer from which the 
fluorescein signal was easily detectable upon scanning the gel (Rajão et al, 
2009). It is therefore unlikely that the low activity of T. brucei fusion proteins 
was due to such an inherent problem with experimental design, although of 
course this explanation is still possible. 
A related potential explanation for the lack of observed activity is that the 
purified enzymes would have been capable of synthesising DNA, but were 
inactive in the polymerase assays because some factor required for activity in 
vivo was not provided. One possibility for such a factor is another protein that 
might be required to form a hetero-oligomeric complex with the pol κ used, for 
example multiple different members of the pol κ family might need to associate 
together for any of them to be active. A second possibility is that the enzymes 
were never offered their true substrate, for example if one or both of the 
enzymes act in vivo on a specific DNA adduct. One candidate to be such a 
substrate is base J. This hypermodified base replaces T, and is found in 
repetitive sequences, primarily in telomeres, including inactive ES and 177-bp 
and 70-bp repeats, and also in regions flanking Pol II transcription units 
(Gommers-Ampt et al, 1993; van Leeuwen et al, 1997; Cliffe et al, 2010). Of the 
two gene products studied, it would be more likely that polκ001, which has the 
atypical DNA-binding domain, would be able to accommodate this glucosylated 
base. No polymerases were identified in a study of proteins binding specifically 
to base J (Cross et al, 1999), but this absence is not necessarily inconsistent with 
a polκ-base J interaction, because any association of polymerase with DNA 
would likely be very transient and thus difficult to detect. However, these 
suggestions are entirely speculative and considerable further experimentation 
would be required to provide evidence for them. 
These alternative explanations cannot be discounted, but after considering them 
it still remains a likely possibility that the in vitro experiments with MBP-polκ 
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described in this chapter indicated that the two genes examined did not encode 
fully active polymerases. The plausibility of this explanation is strengthened by 
the results of cell biological studies. In general, overexpression of pol κ 
increases tolerance to hydrogen peroxide, but in BSF T. brucei neither of the 
pol κ genes examined affected tolerance when overexpressed. Localisation 
experiments indicated that both tagged, overexpressed proteins were present in 
the nucleus, so the lack of an effect on tolerance was probably not due to a 
failure of expression or of nuclear localisation. An obvious conclusion is 
therefore that the pol κ gene products were unable to carry out lesion bypass 
DNA synthesis and thus their overexpression did not increase repair activity in 
the parasite. Of course, this result alone does not demonstrate that the gene 
products were not active lesion bypass polymerases. A rigorous investigation 
would include further controls, including quantification of the amount of extra 
(tagged) pol κ present in transgenic trypanosomes, repetition of the experiment 
at several concentrations of hydrogen peroxide, and an experiment where 
overexpression is induced before hydrogen peroxide is added. An additional 
positive control would be to include T. cruzi pol κ in the experiments, to 
confirm that the problem was with the T. brucei enzymes rather than with some 
aspect of my handling of them. However, when this work is taken in conjunction 
with the in vitro studies of the protein, the results are very suggestive that the 
pol κ gene products were inactive. 
One caveat to this conclusion is that if, as speculated above, pol κ requires an 
extra factor that was not provided in the in vitro experiments, such a 
requirement could prevent the overexpression of pol κ from having a detectable 
effect on hydrogen peroxide tolerance. If several proteins were required for 
activity but only pol κ was overexpressed, the limited supply of the others would 
mean no increase in overall pol κ DNA synthesis could occur, and hence the 
parasite would not be protected. Similarly, if pol κ can only act on DNA with a 
specific adduct, overexpression of pol κ would not increase the rate of repair in 
the regions of the genome that do not contain the modification. If the adduct 
were base J, this category would cover the majority of housekeeping genes, and 
so again the parasite’s essential genes would gain no extra protection from 
damage. 
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Although there are many caveats, the most likely conclusion from the work 
described in this chapter is that the two pol κ gene family members examined 
did not encode active polymerases. The work certainly provided no evidence to 
support the hypothesis that the pol κ gene family encodes polymerases that are 
involved in the hypermutation of subtelomeres.
 
 
 
 
 
Chapter 6: Discussion  
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6 Discussion 
6.1 Introduction 
The purpose of this thesis project was to investigate the processes occurring in 
hyperevolution of VSG genes in T. brucei. The specific aims were to test the 
hypothesis that the subtelomeric VSGs are subject to different and more rapid 
mutagenic processes than are genes in the chromosome cores; and to test the 
hypothesis that members of the expanded pol κ gene family may have a role in 
mutagenesis in the VSG. The key outcomes and findings of the project were: 
1) Good draft quality genomes of EATRO 3 and EATRO 2340 were assembled, 
with a high level of coverage and a substantial amount of subtelomere 
sequence. 
2) A large number of VSG NTD genes were annotated in and paired between 
the EATRO 3 and EATRO 2340 genome assemblies; the archives were 
similar to the published TREU 927 VSG archive in terms of the degree of 
pseudogenicity and substructuring. 
3) Substitution mutations in VSG NTD genes appeared to occur with a higher 
frequency than and different pattern from those in core genes, indicating 
that differences in the evolution of the two genome regions were not 
simply due to relaxation of direct selection on VSG, but rather that 
different substitution mutation processes were operating in each region. 
4) Frequency of mutations in the subtelomeres appeared not to differ 
between VSG and likely non-VSG sequence, implying that a similar 
mutation process operates throughout the subtelomeres 
5) Exhaustive attempts to demonstrate polymerase activity in two members 
of the pol κ family failed, indicating that pol κ proteins are unlikely to 
play a role in promoting mutation in subtelomeres. However, it is also 
possible that the experimental conditions omitted a crucial in vivo factor. 
6.2 New trypanosome genomes and VSG archive 
6.2.1 Genome assembly and annotation 
The work described in Chapter 3 provided a preliminary indication that the 
mutation rate in subtelomeres was higher than that in chromosome cores, and 
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confirmed the close relationship of EATRO 3 and EATRO 2340. The main outcome 
of the work in that chapter, however, was to produce raw data (i.e. genome 
assemblies) for extensive further analysis. New genomes for two isolates of a 
T. b. rhodesiense strain were assembled using paired-end short sequence reads, 
taking advantage of new assembly algorithms that combined assembly to a 
reference genome with de novo contig assembly. Although part of the assembly 
process relied on the previously assembled genome of TREU 927 (Berriman et al, 
2005), the use of de novo assembly allowed a considerable amount of new 
sequence to be obtained in regions where the two EATRO genomes differed 
substantially from TREU 927, i.e. the subtelomeres. The assembled genomes 
therefore demonstrate the power of the relatively high-throughput approaches 
used, particularly when several sequencing technologies are combined, since 
even such difficult regions as subtelomeres could be assembled from the short 
reads. The assemblies are of draft quality with numerous gaps, but the analyses 
in Chapter 3 indicated that the genome assemblies, including likely subtelomere 
sequence, were of sufficiently high quality and coverage for VSG archive 
analysis. Further, the EATRO 2340 genome assembly likely contained 
proportionately more (as well as absolutely more) subtelomere sequence than 
TREU 927: the reference genome contains only one chromosome from each 
homologous pair, i.e. only half the subtelomeres, whereas the EATRO 2340 
assembly has retained many of the missing subtelomere sequence in the contigs 
that were not mapped to chromosomes. The assembled EATRO genomes can be 
described as ‘good enough’: they are not as high quality as a painstakingly 
finished reference genome, but provide plenty of information for a meaningful 
analysis of VSGs and were far less laborious and time-consuming to generate. 
A similar evaluation applies to the other automated or semi-automated analyses 
used throughout the project, particularly gene annotation transfer with RATT, 
VSG NTD gene annotation with VSG-SVM and BLAST, and SNP annotation with 
SAMtools and project-specific Perl scripts. It is unlikely that every datum 
considered was absolutely correct. However, due to the large number of data 
being considered and the stringency of the analyses, it is likely that the broad 
conclusions drawn from analysing the data will be reliable. 
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6.2.2 VSG archive 
The work described in Chapter 4 led to the annotation of 1110 VSG NTDs in 
EATRO 3 and 1797 in EATRO 2340, with 964 from each set identified as being the 
same gene in both genomes. This EATRO 3-EATRO 2340 archive is probably 
incomplete. In TREU 927, the observed VSG density is approximately one gene 
(NTD, CTD or both) per 5 kb (Marcello & Barry, 2007b). If only the assembled 
subtelomere sequence is considered, in EATRO 2340 the density was one NTD per 
8.8 kb, which is not tremendously different. However, pulsed-field gel 
electrophoresis estimated the total size of EATRO 2340 subtelomeres in the 
diploid genome as approximately 31 Mb. Only 15.7 Mb of subtelomeric sequence 
was present in my assemblies, and it seems unlikely that the missing sequence 
contained no VSGs. Despite this incomplete coverage, however, there were still 
far more NTDs annotated in EATRO 2340 than there are in TREU 927 (1797 
compared with 809 NTDs in VSGdb), thus this project considerably increased the 
amount of VSG sequence available for analysis even though the EATRO 2340 
genome assembly contained many more gaps than TREU 927. 
The EATRO 3-EATRO 2340 VSG archive contained a high proportion of non-
functional NTDs. The NTD annotation strategy made use of sequence 
translations, so genes that contained no frameshifts would have been easier to 
annotate, likely meaning that a disproportionate number of the genes recovered 
would have been intact. The high proportion of pseudogenes in the annotated 
archive is therefore particularly striking. It is possible that the number of 
pseudogenes was inflated by sequencing errors, because an error is more likely 
to render an intact gene a pseudogene than restore a pseudogene to 
functionality. This possibility is particularly likely when pseudogenes contained a 
single frameshift, in particular if the frameshift was due to an indel in a 
homopolymeric tract. There were 352 gene pairs annotated as intact in one or 
other genome, and 192 of these were intact in both genomes. Of those that 
were described as intact in one genome and as pseudogenes due to frameshifts 
or premature stop codons in the other, 25 were pseudogenes in EATRO 3 and 
intact in EATRO 2340, and 54 were intact in EATRO 3 and pseudogenes in 
EATRO 2340. The EATRO 3 genome assembly probably contained more errors 
than the EATRO 2340 genome assembly, so the fact that more of the changed 
pairs were pseudogenes in EATRO 2340 implies that most changes were the 
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result of genuine changes, and thus sequencing error did not play a major role in 
generating apparent pseudogenes. 
The abundance of pseudogenes in the EATRO 3-EATRO 2340 archive underlined 
the conclusion drawn from TREU 927 about the importance and necessity to the 
parasite of making use of sequence from pseudogenes in antigenic variation. In 
fact, an even smaller proportion of the EATRO 3-EATRO 2340 archive was intact 
than in TREU 927. Because it is likely that neither archive was complete, 
however, it is difficult to draw any conclusions from this difference. 
Furthermore, the number of intact genes in the EATRO 2340 genome was higher 
than the number in TREU 927 (527 compared with 283), so it is not possible to 
draw any further conclusions about whether there is a minimum number of 
intact genes required for successful antigenic variation. Indeed, any such 
number would be likely to be different between strains of different genotype, 
given there are differences in growth rates and other relevant parameters. 
Examination of closely-related genes within the archive revealed that there was 
considerable substructuring in both EATRO 3 and EATRO 2340, with 69% of 
EATRO 2340 NTDs in families of at least 50% sequence identity, compared with 
40% of TREU 927 NTDs. The families also tended to be larger in EATRO 3-
EATRO 2340 than in TREU 927, where almost all groups were pairs or triplets 
(Marcello & Barry, 2007b): 10% of EATRO 2340 genes were in families with four 
or more members. These EATRO 2340-TREU 927 differences are likely at least 
partly due to the larger number of recovered EATRO 2340 NTDs, but they do 
suggest even more extensive duplication than was inferred from the TREU 927 
archive. The role of duplications in VSG evolution is discussed in more detail 
below. Marcello and Barry (Marcello & Barry, 2007b) found that pseudogenes 
that were combined to construct expressed mosaic VSG genes had high identity 
to one another, in at least parts of the gene, and concluded that the 
substructuring of the TREU 927 archive was key in providing multiple donors that 
were of sufficient identity to assemble mosaic VSG genes. This conclusion was 
reinforced by a more detailed study of the VSG mosaics expressed during 
infection, in which all mosaics examined were found to have been generated 
from donors from the same subfamily (Hall et al, 2013). The extensive 
substructuring of another VSG archive provides further support for this 
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hypothesis, and for the idea that maintaining sets of high-identity genes in the 
genome is crucial. 
The general conclusion to be drawn is that the analyses performed on the 
EATRO 3-EATRO 2340 VSG archive supported the initially surprising conclusions 
from analysis of the TREU 927 archive (Berriman et al, 2005; Marcello & Barry, 
2007b), but suggested that the processes inferred from the TREU 927 genome 
are even more important than previously thought. However, only a few aspects 
of the VSG archive were addressed in this thesis, and the EATRO 3-EATRO 2340 
archive provides data for the exploration of more questions, for example the 
dispersal of gene subfamilies throughout the genome, indications of past 
segmental conversions and recombination, and detailed examination of the 
changes that cause pseudogenisation. Further, the project included very little 
examination of CTDs, but running VSG-SVM on the genome assemblies indicated 
there were numerous CTDs present, so annotating and analysing these fully 
would provide a fuller picture of the EATRO 3-EATRO 2340 VSG archive. 
6.3 VSG evolution 
6.3.1 Possible caveats 
The first potential problem with the work described is the spectre of sequencing 
and assembly errors that is present in all genome-scale studies. Resequencing 
experiments did suggest that there were indeed some errors (false positives) 
among the SNPs considered. However, considerable care was taken throughout 
the VSG analysis to prevent such errors from contributing too much to the SNP 
analyses. In particular, SNPs were called only when there was good coverage of 
the base with high-quality reads; and when it was possible to call a SNP at the 
same position in the gene-pair alignment from sequencing read alignments to 
both genomes. Further, although the EATRO 3 genome assembly was partially 
based on the EATRO 2340 genome assembly, most of the EATRO 3 contigs that 
were not mapped to chromosomes were assembled de novo; the fact that many 
annotated VSG genes could be matched up within such de novo contigs was an 
encouraging indication that such difficult genome regions had reasonably good 
assembly. In general, there are likely to be some errors in the results reported, 
but as long as the potential for errors is kept in mind, and analysis is focused on 
Chapter 6 197 
the general picture rather than on specific data, the study will be informative. 
The work also underlines the importance of at least some verification of these 
type of data by targeted resequencing. 
A second point to consider is that for the purposes of VSG analysis EATRO 3 was 
assumed to be the direct ancestor of EATRO 2340, when in fact the relationship 
may not be quite so direct. As discussed in Chapter 3, EATRO 2340 may well be 
descended from EATRO 3, but another possibility is that is descended from an 
ancestor of EATRO 3 dating from between 1940 and 1960 (the MRCA). However, 
for comparisons of mutation frequency and substitution profile, the precise 
relationship between the isolates is not critical: whatever the true relationship 
and time separation of the two isolates, both are identical for the chromosome 
cores and for the VSGs, since the strain to which they both belong appears to 
have expanded clonally. If the same processes are occurring, we would expect 
the same results for both the chromosome cores and the subtelomeres; the fact 
that we do not implies that the regions are not equivalent.5 
If the relationship is not what was assumed, the substitution profile obtained for 
VSGs may not be the true one. Nevertheless, even with the maximum likely 
separation (MRCA in 1940), EATRO 2340 has had nearly twice as long to 
accumulate mutations than EATRO 3 has had (37 years compared with 20 years). 
If we consider a rough classification of mutations into frequent or infrequent, 
such classifications are likely to be broadly correct. Further, if mutations are 
considered only as transitions or transversions the profile would be correct 
because this classification is independent of the direction of change. For the 
analysis of synonymous and non-synonymous mutations, the analysis was done 
first assuming that EATRO 3 contained the ancestral base, and then assuming 
EATRO 2340 did. The results obtained from both analyses were very similar, so it 
seems reasonable to conclude that the precise relationship made little 
difference to the conclusions drawn. 
                                                
5 This statement only holds true, of course, if we assume that in a given genome region, 
the mutational processes are exactly the same in EATRO 3 as in EATRO 2340. This 
second assumption is much more critical to the work than the first, because if it is not true 
then there is little point in comparing the subtelomeres at all, but it does not seem an 
unreasonable one to make. 
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6.3.2 Distinct substitution processes in subtelomeric genes and 
core genes 
The work provided convincing evidence that the substitution mutation processes 
occurring in VSG NTDs are different from, and faster than, those in core genes, 
rather than simply that more substitutions persist in VSGs because deleterious 
mutations are not removed by direct selection. Point mutations have previously 
been shown to be important in VSG archive evolution (Marcello & Barry, 2007b), 
but this is the first work to compare directly the mutations in VSG genes and 
cores, and demonstrate that such mutations arise more rapidly in VSGs. This 
finding of different mutation processes occurring in VSG NTDs is consistent with 
the idea that selection for VSG diversity has resulted in the evolution of 
mutagenic mechanisms that promote diversity, rather than individual VSG being 
selected for (King & Kashi, 2007; Barry et al, 2012). A high rate of substitution 
mutation would increase the turnover of VSG sequence, providing material for 
the expression and/or mosaic assembly of antigenically new variants. 
A previous study estimated the mutation rate in T. brucei chromosome cores to 
be approximately 10-9 mutations/base/cell/generation (Valdés et al, 1996). In 
the work described in this thesis, the rate of mutation at synonymous sites in 
core genes was estimated to be 3.5×10-9 to 1.2×10-8 
substitutions/base/generation, while the mutation rate of VSG NTDs was 
estimated at 9.4×10-9 to 3.2×10-8 substitutions/base/generation6. The core 
mutation rate was therefore reasonably consistent with the previous estimate. 
These data would tend to suggest that the lower estimate of mutation rate is 
more likely to be correct, i.e. that the divergence time of the parasites is at the 
higher end of the range allowed. However, Valdes and colleagues considered 
their mutation rate to be a minimum, so any divergence time within the 17 to 57 
year range is not necessarily inconsistent with a higher value for the mutation 
rate. 
                                                
6 Note that the ranges given for core and VSG mutation rates are not confidence intervals, 
but were calculated from point estimates of the mutation frequency for each divided by the 
maximum and minimum number of years likely separating the two isolates, which will be 
constant for both genome regions, i.e. if the VSG mutation rate is 9.4×10-9 then the 
corresponding core rate is 3.5×10-9 substitutions/base/generation. Thus the overlapping of 
the quoted core and VSG mutation rate ranges should not be taken to mean that there is 
no significant difference between the two. 
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The overall rate of point mutation in VSG NTDs was 2.4-fold higher than that in 
cores. This is not a dramatic difference, for example it is not on the scale of the 
million-fold increase in the mutation rate in somatic hypermutation in B-cell 
activation (Odegard & Schatz, 2006). As discussed in Chapter 4, there were likely 
to have been more false negatives in the VSGs than in the core genes, so this 
analysis probably underestimated the difference between the two point 
mutation rates. Further, substitution mutations account for only one of several 
mutation processes that act on VSGs (Marcello & Barry, 2007b). The other 
processes include segmental conversions, indels and recombination, all of which 
are potentially more damaging to core genes than are point mutations. They will 
therefore likely be tolerated much less than substitutions in the chromosome 
cores by the DNA maintenance machinery, and so the differences in the rates of 
these processes between cores and VSGs are likely to be higher than for 
substitutions. Considering both of these points, it seems likely that the overall 
difference in mutation rate between core genes and VSGs is considerably higher 
than the given estimate from substitution frequencies. Even a small increase 
over the background mutation rate would be useful to generate new variation, 
and such an increase is provided in substitution frequency. However, given the 
reasonably small rate difference in substitutions between core and VSGs it is 
likely that there is a major contribution from other mutagenic processes that 
will further elevate the mutation rate in VSG. 
The patterns of substitutions, i.e. the relative contribution of each specific 
substitution to the total, differed between VSG NTDs and core genes, even when 
the difference in base composition between the two regions was taken into 
account. Because of uncertainty in the direction of mutation, it is probably 
unwise to draw firm conclusions from the precise pattern. However, one notable 
feature is robust to changes in assumption about the direction or strand in which 
the mutation occurred: the mutations in the core were primarily transitions 
(interchanges between the pyrimidines C and T or between the purines A and G), 
whereas mutations in VSG had a substantial contribution from transversions 
(figures Figure 4-6 and Figure 4-7). Across prokaryotes and eukaryotes there is a 
general bias in mutations in favour of C:G pairs mutating to T:A pairs, and this 
bias is likely to be at least partially the result of deamination of methylated C to 
produce T (Lynch, 2010a; Hershberg & Petrov, 2010). Transitions between the 
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chemically similar pyrimidines or purines therefore tend to dominate mutation 
spectra, and such a profile is what we observe in the trypanosome chromosome 
cores. The VSG mutation profile is therefore somewhat atypical. The increased 
frequency of transversions hints at a mechanism that actively promotes 
mutations of several different types, rather than relying on the accumulation of 
mutations that occur as a by-product of replication. A related possibility is that 
the general bias towards transitions arises because transversions may be easier 
to repair, perhaps because the greater differences between chemical structures 
interchanged in a transversion mutation make a substitution easier to detect. In 
this case, the VSG profile could reflect a relaxation of repair activities rather 
than the induction of new mutations. The observed VSG profile may therefore be 
due to active mutagenesis, relaxed error-correction, or a combination of both 
these processes. 
An observation related to the mutation profile is that mutations in VSG NTDs had 
a much more noticeable strand bias than did those in core genes. That is, the 
pattern of substitutions in VSG NTDs suggested that the mutations that occurred 
on the non-coding strand were different from those on the coding strand. The 
existence of this phenomenon is generally inferred from the compositional 
strand bias it generates, and it has been extensively studied in bacteria (Frank & 
Lobry, 1999; Francino & Ochman, 2001), and has also been shown to occur in 
eukaryotes (Niu et al, 2003; Touchon et al, 2005). Broadly, asymmetry proceeds 
from the two strands being in different environments, such as occurs between 
the leading and lagging strands in DNA replication, and between the template 
(non-coding) and non-template (coding) strands in transcription, the two main 
causes of strand bias so far identified (Francino & Ochman, 2001; Rocha, 2004; 
Mugal et al, 2009). Given that the observed difference in T. brucei NTD 
mutations was between the coding and non-coding strands, an obvious 
conclusion would be that the mutation bias was the result of transcription. 
However, involvement of transcription seems unlikely because the array VSGs 
have no promoters and so are probably never transcribed in situ (although see 
section 6.3.5 for a discussion of one scenario in which transcription might be 
able to contribute to VSG mutation strand bias). Because the VSG genes are 
arranged in directional arrays (usually oriented away from the telomeres), 
however, a link is possible between leading or lagging strand and coding or non-
Chapter 6 201 
coding strand: in a directional array, if the first gene’s coding sequence is on the 
leading strand, so will be the coding sequence of all other genes in the array. 
Such a correlation seems a more plausible explanation of the observed strand 
bias than the existence of an entirely novel and undescribed mechanism 
generating strand bias, although a novel mechanism cannot be ruled out. A 
further consideration is that one important cause of strand mutation bias in 
replication in bacteria is the higher rate of deamination of C to T in the lagging 
strand, probably due to the template strand being single-stranded for longer 
than in leading strand replication (Rocha, 2004). Such a process occurring in the 
non-coding strand could be a contributing factor to the A-richness observed in 
the coding strand, as T mutations accumulated in its complement. It should be 
noted that the A+T content of the VSG genes was not atypical, and the genes 
examined had a G+C content of 50.4%, compared with 51.1% in core genes and 
44.3% in the genome overall; it was the distribution of As and Ts between the 
coding and non-coding strands that was biased. 
The arrangement of directional arrays of genes also applies in the chromosome 
cores, so a difference in the observable strand bias of coding and non-coding 
strands would imply some difference in the replication mechanism of the cores 
and VSG arrays. This idea receives some support from work carried out to locate 
replication origins in T. brucei, which identified no evidence for replication 
origin activity in the VSG arrays, despite a high density of binding of the 
ORC1/CDC6 protein that appears to constitute the trypanosome origin 
recognition complex (Tiengwe et al, 2012a; 2012b). In summary, the observed 
difference in the strand bias of cores and VSG NTDs underlines the different 
mechanisms operating in each region, and the bias in VSG NTDs may occur due 
to the mechanism of replication, and perhaps involves deamination. 
A large number of mutations in the VSG NTDs (252 out of 442 total) were 
predicted to change the sequence of expressed VSG, and thus had potential to 
contribute to antigen diversity. It was found that there was a higher number of 
synonymous mutations per synonymous site than non-synonymous mutations per 
non-synonymous site, with a dN/dS ratio of approximately 0.4. However, as 
discussed previously, this value is unlikely to indicate that the VSG genes are 
under purifying selection, because of the short time separating the two genomes 
and the nature of VSG expression. The principal point to note from the analysis 
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of the synonymity of mutations is that there was a high frequency of non-
synonymous changes, and in fact the number of non-synonymous changes was 
higher than the number of synonymous changes. If we consider selection to be 
acting to produce a mutagenic mechanism that elevates the diversification of 
the archive, the particular facet of such a mechanism that would be operated on 
by selection would be the amount of epitope diversity it produced in the 
expressed protein. That is, a high rate of non-synonymous mutation would 
produce more diversity, and hence would be favoured. The effects of an 
elevated synonymous mutation rate, however, would be much smaller. There 
might be some cost to the parasite if a synonymous mutation resulted in change 
away from the optimal codon, but although there is codon bias in trypanosomes, 
it appears that the bias is less important in VSGs than other genes, probably 
because mechanisms stronger than optimal codon usage promote high VSG 
expression (Horn, 2008). There would be no particular selection pressure for an 
elevated synonymous mutation rate, but neither would there be strong selection 
against it. In order to increase non-synonymous mutations, therefore, the 
parasite could evolve a mechanism that promoted mutations at both kinds of 
site. Indeed, a mechanism that increases mutations generally is easier to 
envisage than a mechanism that specifically acts to produce non-synonymous 
mutations, since a particular base change can be either synonymous or non-
synonymous depending on the sequence context. The particular ratio of dN to dS 
would then result from the interaction of the mutation mechanism and the 
specific base and codon composition of the VSG archive; such interactions are 
accounted for in more sophisticated approaches to estimating and comparing dN 
and dS, (e.g. Zhang et al, 2006), but were not taken into account here because 
of a lack of specific information about them. 
The study found no evidence that substitution mutation frequency in VSG NTDs 
was higher than in the subtelomeres in general. The work therefore supported 
the hypothesis that VSG NTDs had a higher frequency of mutation than did 
chromosome cores because the subtelomeres as a whole experience this 
elevated frequency, and hence hypermutation of VSGs is a consequence of their 
subtelomeric location. More detailed analysis would be required to allow the 
hypothesis to be accepted, but this result provides a solid foundation to be built 
on by further work such as comparison of the mutation profiles in subtelomeres 
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within and outwith VSGs. The location of VSGs in the subtelomeres is therefore 
likely to be an adaptation to promote diversity by exposing the genes to this 
region’s hypermutational environment, and can therefore be viewed as part of 
the consequences of the second-order selection envisaged to operate to produce 
mechanisms promoting antigenic variation (Barry et al, 2012). The adaptive 
nature of VSG genomic location has long been assumed, because of the generally 
elevated rate of ectopic recombination in subtelomeres, but this work provides 
some evidence that the same principle applies to point mutations. 
6.3.3 Further experiments: other mutagenic processes 
For practical reasons, the initial analysis of VSG hyperevolution described in this 
thesis focused on point mutations. However, it seems unlikely that point 
mutations are the only important process in VSG evolution. In this section I will 
discuss other processes that may be involved, and how the data presented in this 
thesis could be used to examine them. The data generated in the project hold 
much more information about VSG evolution than was extracted in the analyses 
discussed, but detailed examination of other components of hyperevolution 
would require the development of more software and analytical tools, and was 
not possible in the timescale of the project. 
6.3.3.1 Segmental conversions 
The substitution mutations identified in VSG NTDs were screened for possible 
segmental conversions using a simple method of searching for clusters of SNPs 
flanked by sequence that was identical between the isolates. None were found 
by this method, but this negative result does not demonstrate that segmental 
conversions do not occur in archive evolution. Firstly, as discussed in Section 
4.4.2, the method used for identifying SNPs is likely to have missed base 
substitutions that are due to conversions, because it relied on mapping reads to 
the genome assembly, and reads with many mismatches would have been 
discarded or mapped elsewhere. Secondly, many of the genes in the archive had 
highly similar partners within the same genome, and conversion between such 
highly similar sequences might not generate enough differences to be detectable 
by the method used. Interestingly, a gene with at least one SNP was more likely 
to have a second SNP than would be expected if mutations occurred 
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independently, although none of the genes with multiple SNPs were annotated 
as having segmental conversions. One process that could bring about these 
observations would be segmental conversions between sequences that were very 
similar, so that the converted tract did not show up as a cluster of SNPs, but 
multiple SNPs were introduced at once. (A second, more speculative, possible 
explanation for the observations is discussed in section 6.3.5.) 
Finally, the method used was somewhat simplistic, and more reliable results 
could be achieved by the method used by Gjini and colleagues (Gjini et al, 
2012), who searched for segmental conversions using a much more sophisticated 
HMM approach to separate regions with differing probabilities of mutations, 
corresponding to segmental conversions and regions where SNPs are due to point 
mutations. In summary, the analyses performed here do not provide evidence 
that segmental conversions do occur, but given that other studies have shown 
that conversions are likely to occur and to be important (Marcello et al, 2007b; 
Hall et al, 2013), this work does not provide enough evidence to conclude that 
they do not. 
Segmental conversions could be searched for more closely in the data available 
using the same fact that may have prevented their identification in the current 
study, i.e. that if a segmental conversion has occurred in one genome, reads 
from the converted tract from that genome will have many mismatches to the 
same region in the other genome, and will probably be poorly mapped. The 
mapped reads could therefore be screened for regions in one genome where the 
number of reads from the second genome mapped to a VSG drops over a short 
stretch of the gene. Strategies based on a similar principle are used to look for 
copy number variation in related genomes, with the difference that such 
strategies look for regions of higher rather than lower than expected coverage 
(e.g. Simpson et al, 2010). In the first SNP annotation method attempted, when 
assembled genes were compared and the SNPs were not double-checked using 
sequencing reads, numerous potential segmental conversions were found; this 
method could be used in combination with screening for low-coverage regions to 
identify the most likely locations of segmental conversions. As has been 
demonstrated by the work of this project, the likely locations would need to be 
confirmed by targeted resequencing, but such a combinatorial approach would 
identify which regions should be targeted in this way. 
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6.3.3.2 Indels 
Insertion-deletion mutations are more difficult to study than substitutions, 
because correct identification of mutations relies on correct alignment of genes, 
which is made less likely by the presence of an indel. This problem is 
exacerbated in large data sets where it is unfeasible to manually check 
individual alignments, and also applies to aligning sequencing reads, which is the 
reason that SAMTools is not reliable when calling indels, and hence why indels 
were not considered in this study. Furthermore, the types of sequence where 
indels are most likely to occur naturally, such as repetitive sequence and 
homopolymeric tracts, are also the types of sequence most prone to sequencing 
errors artificially introducing indels. Analysis of TREU 927 suggested that indels 
do occur in VSG genes with reasonably high frequency, because there are a 
considerable number of VSGs that are pseudogenes due to frameshifts (Berriman 
et al, 2005; Marcello & Barry, 2007b). At least some of the changes that 
appeared to cause intact genes in EATRO 3 to become pseudogenes in 
EATRO 2340 were frameshifts, and so presumably due to indel mutations, 
although it was not ruled out that these sequence changes could have been 
caused by sequencing errors. However beyond this it is difficult to infer from the 
project’s data any information about how indels occur in VSG evolution. 
6.3.3.3 Large-scale rearrangements 
In this project, analysis has been focused on small-scale changes. The effects of 
rearrangement of large chromosome segments have not been considered, mainly 
because I was interested in mutations that would affect the sequence of 
individual VSG genes, and such rearrangements would tend to translocate entire 
VSG cassettes through exchange delimited by the recombination-prone 70-bp 
repeats, and/or the 3′ end of the coding sequence, as occurs in recombinational 
switching, or via different copies of the retroelement ingi, which are dispersed 
throughout the VSG arrays (Marcello & Barry, 2007b). Ectopic recombination of 
chromosome segments is a common feature in the subtelomeres of other 
organisms (Louis & Vershinin, 2005; Freitas-Junior et al, 2000), and there are 
several possible effects on antigenic variation. Although crossing-over points 
would be most likely to occur between cassettes, recombination could result in 
the fusion of the N-terminal portion of one VSG gene to the C-terminal portion 
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of another. Recombination would also change the genomic environment of a 
translocated gene, which may affect which other genes it could interact with, 
and may also affect the activation probability of the gene, although the factors 
determining activation probability are not well understood (Morrison et al, 2005; 
Gjini et al, 2013). The extent of large-scale rearrangements between EATRO 3 
and EATRO 2340 can be examined by taking advantage of the paired-end reads 
generated for the project: if one read of the pair is mapped far away from the 
other in one genome but not the other, this would indicate a rearrangement. 
Such approaches have been used previously to characterise structural variation 
in genomes (e.g. Campbell et al, 2008). 
6.3.3.4 Gene duplications 
Tentative evidence of gene duplication in the time-scale of the study was 
obtained from the reported VSG analysis, provided by several instances where 
there were two NTDs in one genome with high pairwise identity, but a partner 
for only one could be identified in the other genome. Indications of the broader 
importance of duplication in the evolution of the VSG archive were given by the 
extensive substructuring of the archive; and by the presence of numerous SNPs 
called as heterozygosities at the same positions in the same EATRO 3 and 
EATRO 2340 genes, which implied the existence of very similar, unassembled 
homologues of genes that were in the assembly. The importance of gene 
duplication in the assembly of mosaics has been discussed above. A 
complementary role for gene duplication in archive evolution is also possible, 
because duplication of intact genes or genes with intact domains would provide 
another starting point in which mutations could accumulate and generate 
diversity. 
6.3.4 Molecular mechanisms of hyperevolution 
One aim of the project was to test the hypothesis that T. brucei pol κ proteins 
were involved in VSG hyperevolution. However, no evidence was found to 
support the hypothesis. In fact, one interpretation of the results obtained was 
that the genes tested did not encode fully functional polymerases. However, 
homologues of pol κ are found from bacteria to vertebrates (Gerlach et al, 
1999), suggesting an important role in the cell, and it seems peculiar that 
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T. brucei should have tandemly duplicated a non-functional gene family. It 
therefore seems unlikely that the entire pol κ gene family is non-functional. In 
fact, the apparent lack of functionality of the gene members examined may be 
connected with the gene family expansion: if a gene produces a product with 
low functionality, then up-regulating its expression is one strategy to 
compensate for the low functionality, and expression of multiple copies of genes 
appears to achieve this up-regulation in T. brucei (Jackson, 2007b). Such a 
duplication (or series of duplications) is considerably more likely to occur than 
mutations repairing the damaged gene. A possible alternative explanation for 
the apparent lack of functionality, as discussed in section 5.4, is that the 
experiments failed to demonstrate polymerase activity in the gene products 
because the reaction conditions omitted a necessary in vivo factor, for example 
a modified DNA substrate, or a second protein that was required to associate 
with pol κ to form an active polymerase. In vitro experiments with purified pol κ 
from other species, including another trypanosome species, have been successful 
(Ohashi et al, 2000a; Rajão et al, 2009), but it does not necessarily follow that 
T. brucei pol κ proteins must be able to act in isolation. The suggestion that 
T. brucei pol κ acts more-or-less exclusively on a modified DNA substrate could 
be seen as an extreme version of the tendency of lesion bypass polymerases to 
be able to bypass certain DNA lesions much more effectively and with higher 
fidelity than for other lesions (Ohashi et al, 2000b; 2000a; Bjedov et al, 2007; 
McCulloch & Kunkel, 2008). A specific case of this general explanation is that the 
T. brucei-expanded pol κ gene family could act specifically on sequences 
containing base J, which is an intriguing possibility, particularly because of the 
enrichment of base J in repetitive regions and trypanosome telomeres. However, 
the experiments described here did not provide any information that could 
inform such a hypothesis, so the possibility remains speculative. 
The work on pol κ described in this thesis therefore did not support the 
hypothesis that the enzyme is involved in VSG hyperevolution, but neither did 
they conclusively rule out pol κ involvement. Comparisons of the EATRO 3 and 
EATRO 2340 genomes indicated that point mutations occurred at a higher 
frequency in VSG NTDs than in core genes, and DNA polymerases remain a likely 
candidate for introducing such mutations. The observed mutation strand bias in 
VSG NTDs also provides a clue to the mechanism of mutagenesis because, as 
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discussed above, it implies that the process of DNA replication contributes to the 
difference between VSG and core genes. 
It would be feasible to compare the mutations observed with the reported error 
profiles of different polymerases, but this approach is unlikely to be helpful on 
its own for two reasons. Firstly, no trypanosome polymerases have had their 
error profiles established, so we have no idea how conserved the profiles might 
be, given the genes and proteins themselves are substantially different in 
trypanosomes from human or yeast polymerases. Secondly, and more 
fundamentally, it is likely that the observed substitutions were the result of the 
interaction of multiple processes, so comparing them with the profile of an 
individual polymerase can only be useful in terms of which mutations the 
polymerase is able to cause, rather than considering any of the relative 
proportions of mutations7. There are several other approaches that could shed 
light on other candidate mechanisms. The continuing characterisation of the 
mechanisms of DNA replication in T. brucei may provide insight into mutation in 
subtelomeres. A technology such as PICh (Proteomics of Isolated Chromatin 
segments, Déjardin & Kingston, 2009), which uses a specific nucleic acid probe 
to pull down a particular DNA sequence and the proteins associated with it, 
could be used to identify proteins that associate with the VSG arrays, although 
the likely transient nature of the interactions might limit the usefulness of this 
approach. 
Finally, whatever factors are involved in hypermutation, the mechanistic basis of 
the difference in mutational processes between cores and subtelomeres remains 
to be examined. One broad possibility is that a difference between cores and 
subtelomeres could be achieved by the physical interactions of each with 
different structures, or their localisation in different parts of the nucleus. Such 
differential localisation of chromosome regions can already be seen in the 
tethering of telomeres at the nuclear periphery, which could bring subtelomeres 
into a somewhat different environment from chromosome cores (Dubois et al, 
                                                
7 If it had been possible to determine the error profile of pol κ, the argument would still 
have applied that merely having a profile consistent with what was seen in VSGs would 
not have been sufficient to demonstrate involvement in hyperevolution. However, pol κ 
was worth investigating in this context because there were particular reasons to think that 
it could have a role in hyperevolution, namely the gene family expansion, and the likely 
more permissive substrate binding site, and because the localisation of the protein was 
also investigated and could have provided another strand of evidence. 
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2012), although such an arrangement would probably produce a gradient of 
activity rather than a sharp delineation. A second possibility is linked to the 
finding that sequence in the subtelomeres, specifically the repetitive, AT-rich 70 
bp repeats, is particularly prone to DNA breaks, and that the repair of these 
breaks by recombination may be a trigger for VSG switching (Boothroyd et al, 
2009; Alsford et al, 2009). Although the original study was focused on switching, 
the idea that DNA sequence can be adapted to be easy to damage, for the sake 
of the consequences of repair activity, is also applicable to subtelomere 
mutation. Such a mechanism might rely, as switching is proposed to do, on the 
properties of the demonstrably destabilising TAA:TTA motif in the 70 bp repeats 
(Boothroyd et al, 2009; Ohshima et al, 1996). Alternatively, a potential 
mechanism might involve some other sequence feature prone to causing 
blockages that require repair, perhaps by error-prone lesion bypass polymerases 
during replication — a possibility to which the observation of strand bias in VSG 
mutation is relevant, because of its possible links to replication, as discussed 
above. However, any sort of DNA repair has the potential to introduce errors, so 
a mutagenic mechanism that involved inducing repair need not necessarily 
involve polymerases. A further means to target subtelomeres, which would be 
relevant if polymerases are involved, has been hinted at above: perhaps the 
target genome regions contain some DNA modification, such as base J, that the 
polymerases require to function. Whatever the process, the evidence provided in 
this thesis that some such mechanism exists to allow mutational mechanisms to 
differentiate between subtelomeres and cores provides a fascinating basis for 
future work on the subject. 
6.3.5 Potential for a role for the expression site in archive 
evolution 
Array VSGs are activated when an entire gene or a part of it is copied into the 
active ES by a mechanism involving homologous recombination (Barry & 
McCulloch, 2001). This process is asymmetrical: the newly activated VSG now 
has two copies in the genome, but the previous VSG is lost from the ES. If the 
previous VSG had been copied from an intact array VSG, then the gene will 
persist in the genome despite being lost from the ES. However, if the previous 
VSG was a mosaic, then this switching mechanism probably means that the 
replaced gene would be lost altogether. It is assumed that this conversion 
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process only occurs in the array to ES direction, but the possibility of duplicative 
transposition from the ES VSG into the arrays has not really been examined, 
although it has been hypothesised that switching by telomere exchange between 
the ES and minichromosomes could act to preserve ES mosaics (Taylor & 
Rudenko, 2006). This hypothesis is consistent with the observation that many 
minichromosomal VSGs are important early in infection, and so are presumably 
intact (Liu et al, 1985; Robinson et al, 1999). 
If it were possible for VSGs to be copied from the ES into the arrays, events in 
the ES would have the potential to contribute to archive evolution. Such a 
process might confer the ability to retain mosaic genes as new, intact array VSG, 
which could contribute to continuing regeneration of the archive. Additionally, 
there is some evidence that, although point mutations are unlikely to contribute 
to increasing the scope of antigenic variation within an infection, the process of 
being copied into the ES and transcribed could in itself be somewhat mutagenic: 
single base mutations in the ES copy compared with the genome copy have been 
observed, albeit infrequently (Graham & Barry, 1996; Hall et al, 2013); and, 
more generally, there appears to be a link between transcription and an 
elevated mutation rate, which has been inferred from genomic compositional 
strand bias (Francino & Ochman, 2001; Mugal et al, 2009). The results reported 
in this thesis provide some hints that such retention of ES VSGs might be a 
possibility. Firstly, one hypothesis to explain the overdispersion in the number of 
SNPs per gene could be that those NTDs with an unexpectedly large number of 
mutations represented genes that had been copied back from the ES. Secondly, 
the mutations observed in VSG NTDs did appear to have a strand bias. Finally, 
there was some indication that genes that were pseudogenes in EATRO 3 had 
become intact genes in EATRO 2340. However, intriguing as such a possibility 
would be, there are alternative explanations for all these observations: genes 
with many SNPs could be the result of segmental conversion within the archive; 
the strand bias could be associated with replication rather than transcription, as 
discussed above; and it was not possible to rule out technical artefacts as the 
reason for pseudogenes that appearing to become intact genes. Therefore, the 
hypothesis of a contribution to VSG evolution from ES will probably need to 
remain as speculation. 
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6.4 Wider implications of the work 
6.4.1 Antigenic variation 
The finding of this work that is perhaps most relevant in considering the broader 
picture of antigenic variation is the rate of evolution of VSGs. Leaving aside the 
observation of non-random distribution of mutations, the estimated mutation 
rate of 9.4×10-9 to 3.2×10-8 mutations/base/generation implies that a typical 
VSG NTD of 1000 bp would be expected to have a substitution mutation less than 
once per hundred thousand generations. Even for a repertoire of several 
thousand genes, this rate implies a given parasite could wait tens of generations 
for any of its VSGs to change. It therefore seems reasonable to conclude that 
point mutation in VSG NTDs, rapid though it is compared with the process in 
chromosome cores, is unlikely to be able to generate new sequence quickly 
enough to make a substantial contribution to antigenic variation within a single 
infection of a single host. This finding complements previous work suggesting 
that single point mutations are unlikely to change VSG sufficiently to allow 
evasion of the polyclonal antibody response (Graham & Barry, 1996; Hall et al, 
2013). It can certainly be envisaged that an antigenically novel VSG could be 
encoded by a mosaic created by combining parts of various genes each 
containing point mutations, but again the rate of point mutation suggests that 
VSGs from this scenario are unlikely to contribute significantly in the relatively 
short term of a single infection. 
The role of VSG hyperevolution, then, is more likely to be in the promotion of 
VSG diversity in the longer term, and on a larger scale. The accumulation of 
point mutations over a longer timescale would introduce new diversity to the 
archive, which could be combined in new ways by recombination. Such a process 
could give an advantage at the scale of the parasite population, if it were to 
provide enough novel diversity to overcome immunity in a host that had 
previously been exposed to a similar strain, i.e. the development of strain-
specific repertoires could facilitate reinfection. An effect at this level is 
consistent with the idea that VSG hyperevolution has evolved under second-
order selection for VSG diversity: such a selection process presumably occurs at 
the level of the population rather than the individual (Barry et al, 2012). 
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6.4.2 Subtelomere hyperevolution 
Do the reported results provide simply an interesting story about the evolution 
of a family of trypanosome genes, or can wider conclusions be drawn? Most 
studies of subtelomere evolution have focused on the effects of recombination, 
so it is an important finding of this study that another mutagenic process in 
trypanosome subtelomeres, point mutation, appears to be not only elevated but 
also mechanistically distinct from what occurs in chromosome cores. 
Substitution processes are difficult to study in the subtelomeres of other 
organisms because these regions tend to be more repetitive than in 
trypanosomes, but the finding has particular relevance for other organisms that 
have subtelomeric antigenic variation gene families. A second broadly relevant 
conclusion is that the VSGs hypermutate simply because of their location in 
subtelomeres. This study of the evolution of the trypanosome VSG arrays 
therefore underlines the importance of subtelomeres in providing an 
environment for hyperevolution, and complements previous findings that 
movement of a gene family into subtelomeres can trigger the expansion and 
accelerated evolution of that family (Glusman et al, 2001; Brown et al, 2010). 
6.5 Concluding remarks 
The significance of subtelomeres to variation only relatively recently became 
apparent, when the availability of genome sequences meant it became possible 
to explore their contents in detail, but the power of subtelomeres to drive 
evolution is now widely appreciated. Subtelomere hyperevolution has been 
studied in a range of organisms, but trypanosomes stand out due to the scale of 
their principal subtelomeric gene family and its critical role in their survival 
strategy. The work presented here has given some hints about how 
hyperevolution and mutation proceeds in subtelomeres in this system, suggesting 
an environment that is substantially different from that experienced by genes in 
the chromosome core; and the results have also given some insight into the 
process of antigenic variation. Hopefully, in the future we can look forward to 
more details being revealed by other studies tracking the events of 
hyperevolution. The project has underlined that the importance of studying 
trypanosomes arises not only from their niche as a devastating human and 
veterinary pathogen, but also because their biology is inherently fascinating and 
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can be effectively used as a model to investigate and illuminate strategies that 
are widely used by eukaryotes.
 214 
Appendices 
Appendix 1: Population genetics and serology of 
EATRO 3, EATRO 2340 and related strains 
EATRO 3 and EATRO 2340 were two of a series of samples from a sleeping 
sickness focus in SE Uganda (see section 3.1.1). EATRO 3 and EATRO 2340 were 
shown serologically to share a VSG set with one another and with many other 
samples from the focus; samples that were found to belong to this variable 
antigen type are shown in red in Table A-1 (Barry et al, 1983; J.D. Barry, pers. 
comm.). Isolates that are shown in black belong to other variable antigen types. 
Some of these stocks were analysed by microsatellite and minisatellite 
genotyping, and where available these data are also shown in Table A-1 (L. 
Morrison and A. MacLeod, unpublished). 
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Table A-1 – Serology and genetic markers in samples from the SE Uganda sleeping 
sickness focus. 
See text for details.  
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Appendix 2: Details of electronic appendices 
Appendix E1: Scripts and modules developed for or used in the 
project. 
The purpose and usage of the scripts are given in Chapter 3. Unless otherwise 
indicated, the scripts were written as part of the project. 
Appendix E2: Genome assemblies and VSG NTDs of EATRO 3 
and EATRO 2340. 
Each genome is given as a single GenBank file with multiple entries. VSG NTDs 
are annotated within the GenBank files. 
Appendix E3: VSG NTD matches. 
The appendix comprises a table showing VSG NTDs from EATRO 3 and 
EATRO 2340 genomes for which the corresponding gene was considered to have 
been found in the other genome. The VSG NTD used as the query is given in the 
first column, followed by details of the hit quality, and the corresponding gene 
in the other genome, if applicable. Genes not in this table were not considered 
in the SNP analysis. 
Appendix E4: Changes in VSG NTDs. 
The appendix comprises a table showing changes annotated between the 
EATRO 3 and EATRO 2340 VSG archives. Changes were annotated using Method 2 
(see section 4.4.2). The first column describes the gene as named in Appendix 
E3. GT = genotype. As discussed in section 4.4.2, most SNPs were found to be 
heterozygous, so two alleles are given for the gene in each genome. 
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